<SEC-DOCUMENT>0001078782-18-000285.txt : 20180308
<SEC-HEADER>0001078782-18-000285.hdr.sgml : 20180308
<ACCEPTANCE-DATETIME>20180308160602
ACCESSION NUMBER:		0001078782-18-000285
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		7
FILED AS OF DATE:		20180308
DATE AS OF CHANGE:		20180308

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			VOLITIONRX LTD
		CENTRAL INDEX KEY:			0000093314
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				911949078
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-206781
		FILM NUMBER:		18676484

	BUSINESS ADDRESS:	
		STREET 1:		1 SCOTTS RD #24-05 SHAW CENTRE
		CITY:			SINGAPORE
		STATE:			U0
		ZIP:			228208
		BUSINESS PHONE:		1 (646) 650-1351

	MAIL ADDRESS:	
		STREET 1:		1 SCOTTS RD #24-05 SHAW CENTRE
		CITY:			SINGAPORE
		STATE:			U0
		ZIP:			228208

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	STANDARD CAPITAL CORP
		DATE OF NAME CHANGE:	19990812
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>424b5030718_424b5.htm
<DESCRIPTION>PRELIMINARY PROSPECTUS SUPPLEMENT
<TEXT>
<HTML>
<!-- Produced by Justeene Blankenship using EDGARsuite software, Advanced Computer Innovations, Inc., Copyright (C) 2008-2017 [PPXAC8S3T1P2VKXCJE4E]. www.edgarsuite.com -->
<HEAD>
<TITLE>Preliminary Prospectus Supplement</TITLE>
</HEAD>
<BODY>
<DIV style=margin-left:36pt;width:540pt><TABLE align=center style=border-collapse:collapse;width:552.6pt><TR style=height:7.2pt><TD valign=middle style=width:55.8pt rowspan='33'><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><IMG src=f424b5030718_424b51.jpg width=60 height=809 alt=Document4.jpg title=Document4.jpg>&nbsp;</P>
</TD><TD colspan=7 valign=top style=width:496.8pt><P align=right style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt><B>Filed Pursuant to Rule 424(b)(5)</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=right style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt><B>Registration No. 333-206781</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=center style='font:10pt Times New Roman;margin:0;color:#C00000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#FF0000'><FONT style=font-size:10pt;color:#C00000>SUBJECT TO COMPLETION, DATED MARCH 8, 2018</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>PROSPECTUS SUPPLEMENT</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P style='font:9pt Times New Roman;margin:0'>(To Prospectus dated September 18, 2015)</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=center style='font:12pt Times New Roman;margin:0;color:#FF0000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=center style='font:10pt Times New Roman;margin:0'><IMG src=f424b5030718_424b52.jpg width=96 height=76 alt='Picture 1' title='Picture 1'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>&#160;</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=center style='font:12pt Times New Roman;margin:0'><B>VOLITIONRX LIMITED</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares of Common Stock</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'><I>We are offering &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock. Our common stock is listed on the NYSE American under the symbol &#8220;VNRX.&#8221; On March 7, 2018, the last reported sale price of our common stock was $2.86 per share.</I></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'><B>Investing in our common stock involves a high degree of risk. You should carefully review the risks and uncertainties described under the heading &#8220;Risk Factors&#8221; beginning on page S-5 of this prospectus supplement. </B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'><B>Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=bottom style=width:496.8pt><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'><B>______________________________</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:221.05pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.9pt><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style='width:44.75pt;border-bottom:0.5pt solid #000000'><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'><B>Per Share</B></P>
</TD><TD valign=top style=width:16.7pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.7pt><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style='width:44.9pt;border-bottom:0.5pt solid #000000'><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'><B>Total</B></P>
</TD><TD valign=top style=width:137.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:221.05pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>Public offering price</P>
</TD><TD valign=bottom style=width:15.9pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>$</P>
</TD><TD valign=bottom style=width:44.75pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:16.7pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.7pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>$</P>
</TD><TD valign=bottom style=width:44.9pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=top style=width:137.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:221.05pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>Underwriting discount<SUP>(1)</SUP></P>
</TD><TD valign=bottom style=width:15.9pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>$</P>
</TD><TD valign=bottom style=width:44.75pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:16.7pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.7pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>$</P>
</TD><TD valign=bottom style=width:44.9pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=top style=width:137.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:221.05pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>Proceeds, before expenses, to us</P>
</TD><TD valign=bottom style=width:15.9pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>$</P>
</TD><TD valign=bottom style=width:44.75pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:16.7pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.7pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>$</P>
</TD><TD valign=bottom style=width:44.9pt><P align=right style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD><TD valign=top style=width:137.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9pt Times New Roman;margin:0;text-indent:-19.2pt;margin-left:25.5pt;color:#000000'>(1) &nbsp;Gives effect to the fact that the underwriting discount for shares sold to (A) officers, directors and certain specified existing investors of VolitionRx, or the insiders, shall be 3% of the aggregate purchase price, and (B) all other investors in this offering shall be 6% of the aggregate purchase price; subject to a minimum blended discount of 5% of the aggregate purchase price so long as at least 50% of the aggregate purchase price is from investors other than insiders. See &#8220;Underwriting&#8221; for additional disclosure regarding underwriting discounts, commissions and estimated offering expenses.</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt>Certain insiders may purchase shares in this offering. Because the Company has not entered into any binding agreements or received any commitments to purchase from any insiders, such insiders may elect not to purchase any shares in this offering</FONT>.</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt>We have granted the underwriters an option for a period of 30 days from the date of this prospectus supplement to purchase up to an additional   &nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;shares of common stock to cover overallotments at the public offering price, less underwriting discounts and commissions. If the underwriters exercise their option in full, the total underwriting discounts and commissions payable by us will be $ &nbsp;&nbsp; &nbsp;&nbsp; &nbsp; , and the total proceeds to us, before expenses, will be $ &nbsp; &nbsp;&nbsp; &nbsp;&nbsp; </FONT><I>.</I></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=top style=width:496.8pt><P align=justify style='font:9.5pt Times New Roman;margin:0;color:#000000'><I>The underwriters expect to deliver the shares against payment on or about March &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018, subject to customary closing conditions.</I></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=bottom style=width:496.8pt><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'><B>______________________________</B></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=bottom style=width:496.8pt><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'><I>Sole Book &#8211;&nbsp;Running Manager</I></P>
<P align=center style='font:18pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:18pt><B>Oppenheimer &amp; Co.</B></FONT><I> &nbsp;</I></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=bottom style=width:496.8pt><P align=center style='font:10pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;color:#000000'><FONT style=font-size:10pt><I>Co-Manager</I></FONT></P>
<P align=center style='font:14pt Times New Roman Bold;margin:0;color:#000000'><FONT style='font-family:Times New Roman'><B>National Securities Corporation</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=7 valign=bottom style=width:496.8pt><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
<P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'>The date of this prospectus supplement is March &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018.</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=8 valign=top style='width:552.6pt;border-bottom:0.5pt solid #000000'><P align=center style='font:9.5pt Times New Roman;margin:0;color:#000000'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>T</B></FONT><A name=TABLE_OF_CONTENTS /><FONT style=font-size:10pt><B>ABLE OF CONTENTS </B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:100%><TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=top><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Page</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>PROSPECTUS SUPPLEMENT </B></FONT></P>
</TD><TD valign=top><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>ABOUT THIS PROSPECTUS SUPPLEMENT</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-1</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>PROSPECTUS SUPPLEMENT SUMMARY</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-2</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>RISK FACTORS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-5</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-16</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>USE OF PROCEEDS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-17</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>PRICE RANGE OF OUR COMMON STOCK</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-17</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>DIVIDEND POLICY</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-17</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>CAPITALIZATION</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-18</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>DILUTION</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-18</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>DESCRIPTION OF COMMON STOCK</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-19</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>UNDERWRITING</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-20</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>LEGAL MATTERS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-26</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>EXPERTS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-26</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-26</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>WHERE YOU CAN FIND MORE INFORMATION</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>S-27</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>PROSPECTUS </B></FONT></P>
</TD><TD valign=top><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>ABOUT THIS PROSPECTUS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>1</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>THE COMPANY</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>1</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>RISK FACTORS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>2</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>2</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>USE OF PROCEEDS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>2</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>GENERAL DESCRIPTION OF SECURITIES</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>3</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>DESCRIPTION OF CAPITAL STOCK</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>3</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>DESCRIPTION OF THE WARRANTS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>4</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>PLAN OF DISTRIBUTION</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>5</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>LEGAL MATTERS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>6</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>EXPERTS</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>6</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>6</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>WHERE YOU CAN FIND MORE INFORMATION</FONT></P>
</TD><TD valign=bottom><P align=right style='font:10pt Times New Roman;margin:0;margin-right:7.2pt'><FONT style=font-size:10pt>7</FONT></P>
</TD></TR>
</TABLE>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>A</B></FONT><A name=S_ABOUT_THIS /><FONT style=font-size:10pt><B>BOUT THIS PROSPECTUS SUPPLEMENT</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This document is part of a registration statement that was filed with the Securities and Exchange Commission, or the SEC, using a &#8220;shelf&#8221; registration process and consists of two parts. The first part is the prospectus supplement, including the documents incorporated by reference herein, which describes the specific terms of this offering. The second part, the accompanying prospectus, including the documents incorporated by reference therein, provides more general information. In general, when we refer only to the prospectus, we are referring to both parts of this document combined. Before you invest, you should carefully read this prospectus supplement, the accompanying prospectus, all information incorporated by reference herein and therein, as well as the additional information described under the heading &#8220;Where You Can Find More Information.&#8221; These documents contain information you should carefully consider when deciding whether to invest in our common stock. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus supplement may add, update or change information contained in the accompanying prospectus. To the extent there is a conflict between the information contained in this prospectus supplement and the accompanying prospectus, you should rely on information contained in this prospectus supplement, provided that if any statement in, or incorporated by reference into, one of these documents is inconsistent with a statement in another document having a later date, the statement in the document having the later date modifies or supersedes the earlier statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>You should rely only on the information contained in this prospectus supplement, the accompanying prospectus, any document incorporated by reference herein or therein, or any free writing prospectuses we may provide to you in connection with this offering. Neither we nor any of the underwriters have authorized anyone to provide you with any different information. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may provide to you. The information contained in this prospectus supplement, the accompanying prospectus, and in the documents incorporated by reference herein or therein is accurate only as of the date such information is presented. Our business, financial condition, results of operations and prospects may have changed since that date.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus supplement and the accompanying prospectus do not constitute an offer to sell or the solicitation of an offer to buy any securities other than the shares of common stock to which it relates, nor do this prospectus supplement and the accompanying prospectus constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Unless otherwise indicated, information contained in or incorporated by reference into this prospectus concerning our industry and the markets in which we operate, including market position and market opportunity, is based on information from our management&#8217;s estimates, as well as from industry publications and research, surveys and studies conducted by third parties. Management estimates are derived from publicly available information, our knowledge of our industry and assumptions based on such information and knowledge, which we believe to be reasonable. However, assumptions and estimates of our future performance, and the future performance of our industry are subject to numerous known and unknown risks and uncertainties, including those described under the heading &#8220;Risk Factors&#8221; beginning on page S-5 of this prospectus supplement. These and other important factors could result in our estimates and assumptions being materially different from future results. You should read the information contained in, or incorporated by reference into, this prospectus completely and with the understanding that future results may be materially different and worse from what we expect. See the information included under the heading &#8220;Cautionary Note Regarding Forward-Looking Information.&#8221;</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Unless otherwise stated in this prospectus supplement and the accompanying prospectus, references to &#8220;Company,&#8221; &#8220;VolitionRx,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221; refer to VolitionRx Limited and its wholly-owned subsidiaries. Nucleosomics<SUP>&#174;</SUP>, Nu.Q<SUP>TM</SUP> and Hypergenomics<SUP>&#174;</SUP> and their respective logos are trademarks and/or service marks of VolitionRx and its subsidiaries. All other trademarks, service marks and trade names referred to in this prospectus supplement and the accompanying prospectus are the property of their respective owners.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-1</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><TABLE align=center style='border-collapse:collapse;width:540pt;border:0.5pt solid #000000'><TR style=height:7.2pt><TD valign=top style='width:540pt;border-top:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt><B>PROSPECTUS SUPPLEMENT SUMMARY</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt><I>This prospectus supplement summary discusses the key aspects of the offering and highlights certain information appearing elsewhere in this prospectus supplement, in the accompanying prospectus and in the documents we incorporate by reference herein and therein. However, as this is a summary, it does not contain all of the information that you should consider before deciding to invest in our common stock. You are encouraged to carefully read this entire prospectus, the accompanying prospectus, any free writing prospectus that we have been authorized to use and the documents incorporated by reference herein and in the accompanying prospectus. You should pay special attention to the information provided under the heading &#8220;Risk Factors&#8221; in this prospectus supplement and in the accompanying prospectus and under the heading &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our financial statements and the related notes in our Annual Report on Form 10-K for the fiscal year ended December 31, 2017, incorporated by reference herein.</I></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt><B>Company Overview</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>We are a multi-national life sciences company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers. </FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>Our tests are based on the science of Nucleosomics<SUP>&#174;</SUP>, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid &#8211; an indication that disease is present.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>The principle behind what we are doing relies on bringing together two main lines of research: the chromosomes of cancer cells differ from those of healthy cells &#8211; both in terms of DNA sequence (due to genetic cancer mutations) and in protein structure&#160;- due to epigenetic changes. There are chromosome fragments from dead cancer cells circulating in the blood as nucleosomes. Each such circulating nucleosome contains a small (approx. 140bp) fragment of tumor DNA.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>Our Nucleosomics technology exploits the different compositions of circulating nucleosome structures present in the serum of cancer patients to detect and identify cancer diseases.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>We have developed a novel suite of blood assays for epigenetically altered circulating nucleosomes as biomarkers in cancer. Nu.Q<SUP>TM </SUP>products are simple, low-cost, ELISA platform tests and can incorporate other off patent, low cost ELISA tests in our panels (e.g. CEA, PSA, CA125) for higher accuracy.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>Our diagnostic target in the blood is the same tumor chromosome fragment, but our approach is to test for chromosome protein and nucleic acid changes in intact chromosome fragments by ELISA, rather than chemically extracting, amplifying, and sequencing the ctDNA and discarding the rest of the nucleosome. ELISA is possible because the targets of our tests occur globally across all nucleosomes within a tumor cell, whereas individual ctDNA changes must be identified within the three billion base-pair genomes. This means that the targets of our tests are exponentially more prevalent in circulating blood, and detectable using simple laboratory methods.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><FONT style=font-size:10pt><I>How is Nu.Q different from ctDNA?</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.85pt;margin-right:3.85pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>When a cancer cell dies, the nuclear components are metabolized into 20 million individual DNA-Nu complexes and released into circulation. A cancer mutation will occur in one of the DNA-Nu complexes.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.85pt;margin-right:3.85pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>ctDNA sequencing methods (in development) must target that one in 20 million<B> </B>DNA-Nu complexes. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.85pt;margin-right:3.85pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Nu.Q targets all 20 million circulating DNA-Nu complexes because nucleosome modifications occur globally.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.85pt;margin-right:3.85pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Nu.Q<SUP> </SUP>is a simple, low-cost ELISA and can incorporate other ELISA tests in our panels.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:3.85pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>Using our Nucleosomics technology, we have developed 39 epigenetic Nu.Q assays, which are designed to detect the level and structure of nucleosomes in blood. Epigenetics is the science of how genes are switched &#8220;on&#8221; or &#8220;off&#8221; in the body&#8217;s cells. A major factor controlling the switching &#8220;on&#8221; and &#8220;off&#8221; is the structuring of DNA. The DNA in human cells is packaged as protein complexes in a &#8220;beads on a string&#8221; structure. Each individual protein/DNA &#8220;bead&#8221; is called a nucleosome. These nucleosomes then form additional structures with increasingly dense packing, culminating in chromosomes containing hundreds of thousands of nucleosomes as depicted in Figure 1 below.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-2</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><TABLE align=center style='border-collapse:collapse;width:540pt;border:0.5pt solid #000000'><TR style=height:7.2pt><TD valign=top style=width:540pt><P align=center style='font:10pt Times New Roman;margin:0'><IMG src=f424b5030718_424b53.jpg width=168 height=168 alt='Picture 7' title='Picture 7'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Figure 1 &#8211; A nucleosome</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>Cancer is characterized by uncontrolled and often rapid cell growth which exceeds the corresponding rate of cell death. When cells die, the DNA fragments into individual nucleosomes which are released into the blood as illustrated in Figure 2 below. The cell debris in the bloodstream is eventually recycled back into the body. When a cancer is present, the number of dying cells can overwhelm the recycling process, leaving the excess fragments, including the nucleosomes, in the blood. Importantly, the structure of nucleosomes is not uniform but subject to immense variety, and nucleosomes in cancer cells have differences in structure from those in healthy cells.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=center style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'><IMG src=f424b5030718_424b54.jpg width=303 height=222 alt='Picture 8' title='Picture 8'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'><FONT style=font-size:10pt>Figure 2 &#8211; Release of nucleosomes into blood</FONT></P>
<P style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>Blood nucleosome levels can be raised in conditions other than cancer, including in auto-immune disease, inflammatory disease, endometriosis, sepsis, and in the immediate aftermath of major trauma (for example following a heart attack, surgery or car accident). Our primary focus is on cancer diagnosis, but we also intend to pursue diagnostic opportunities in other disease areas.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'><KBD style=margin-left:28.15pt></KBD><FONT style=font-size:10pt>We have incurred losses since inception, have negative cash flows from operations, and currently have no revenues, and we do not anticipate earning significant revenues until such time as we are able to fully market our intended products. For this reason, our auditors stated in their report on our most recent audited financial statements that our losses and negative cash flow from operations raise substantial doubt that we will be able to continue as a going concern without further financing. See <I>Item 8. Financial Statements and Supplementary Data</I> of our Annual Report on Form 10-K filed with the SEC on March 1, 2018 for a discussion of our ability to continue as a going concern. Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our plan of operations described herein, obtain financing and eventually attain profitable operations.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'><FONT style=font-size:10pt><B>Corporate Information</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.85pt;margin-right:8.35pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:540pt><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:27pt;margin-left:7.85pt;margin-right:8.35pt'><FONT style=font-size:10pt>We are a Delaware corporation. Our executive offices are located at 1 Scotts Road, #24-05 Shaw Centre, Singapore 228208, and our telephone number is +1 (646) 650-1351. We maintain a website at www.volitionrx.com. Our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K, and all amendments to such reports are available to you free of charge through the Investors section of www.volitionrx.com as soon as practicable after such materials have been electronically filed with, or furnished to, the Securities and Exchange Commission. The information contained on our website is not incorporated by reference into this prospectus. We have included our website address only as an inactive textual reference and do not intend it to be an active link to our website.</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style='width:540pt;border-bottom:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-3</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><TABLE align=center style='border-collapse:collapse;width:100.1%;border:0.5pt solid #000000'><TR style=height:7.2pt><TD colspan=3 valign=middle bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-top:0.5pt solid #000000;border-right:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt><B>The Offering</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=middle bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Issuer:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>VolitionRx Limited</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Offering Price:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>$  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Common Stock offered by us:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt><B> &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;  </B>shares (or  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the underwriters exercise in full their option to purchase additional shares)</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Common Stock to be outstanding immediately after this offering:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt><B> &nbsp; &nbsp;&nbsp;&nbsp;&nbsp;  </B>shares (or  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares if the underwriters exercise in full their option to purchase additional shares)</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Option to purchase additional shares:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>The underwriters have an option to purchase a maximum of  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us to cover over-allotments. The underwriters can exercise this option at any time within 30 days from the date of this prospectus supplement.</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Use of proceeds:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>We intend to use the net proceeds from this offering for continued product development, clinical studies, product commercialization, working capital and other general corporate purposes. See the information included under the heading &#8220;Use of Proceeds.&#8221;</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Risk factors:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Investing in our common stock involves a high degree of risk. See the information included under the heading &#8220;Risk Factors&#8221; beginning on page S-5 of this prospectus supplement for a discussion of factors that you should carefully consider before deciding to invest in our common stock.</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Trading symbol:</FONT></P>
</TD><TD valign=middle bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD><TD valign=top bgcolor=#FFFFFF style=padding-top:0.75pt;padding-right:0.75pt><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Our common stock is currently quoted on the NYSE American under the symbol &#8220;VNRX.&#8221;</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:37.55pt;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Certain insiders may purchase shares in this offering. &#160;Because the Company has not entered into any binding agreements or received any commitments to purchase from any insiders, such insiders may elect not to purchase any shares in this offering.</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:37.55pt;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:37.55pt;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Unless otherwise indicated, the number of shares of our common stock to be outstanding after this offering is based on 26,519,394 shares of our common stock outstanding as of December 31, 2017, and excludes:</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>1,731,680 shares of our common stock issuable upon the exercise of common stock purchase warrants outstanding as of December 31, 2017, with a weighted average exercise price of approximately $2.36 per share;</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>2,939,134 shares of our common stock issuable upon the exercise of stock options outstanding as of December 31, 2017, with an exercise price of approximately $4.09 per share; and</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>829,000 additional shares of common stock reserved for future issuance under our 2015 Stock Incentive Plan, as of December 31, 2017.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:37.55pt;margin-left:7.2pt;margin-right:7.2pt'><FONT style=font-size:10pt>Unless otherwise indicated, this prospectus reflects and assumes the following:</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>no exercise of the outstanding options and warrants described above; and</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>no exercise by the underwriters of their option to purchase additional shares of our common stock.</FONT>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD colspan=3 valign=top bgcolor=#FFFFFF style='padding-top:0.75pt;padding-right:0.75pt;border-bottom:0.5pt solid #000000;border-right:0.5pt solid #000000'><P align=justify style='font:10pt Times New Roman;margin:0;margin-left:7.2pt;margin-right:7.2pt'>&nbsp;</P>
</TD></TR>
</TABLE>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-4</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>R</B></FONT><A name=S_RISK_FACTORS /><FONT style=font-size:10pt><B>ISK FACTORS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt;background-color:#FFFFFF><I>Investing in our common stock involves a high degree of risk. Before making an investment decision, you should carefully consider the risks described below, together with all of the other information included in this prospectus supplement, the accompanying prospectus, and the information incorporated by reference herein and therein. </I></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt;background-color:#FFFFFF><I>If any of the risks described below, or those incorporated by reference into this prospectus, actually occur, our business, financial condition or results of operations could suffer. In that case, the trading price of our common stock may decline and you may lose all or part of your investment. The risks and uncertainties we have described are not the only ones we face. Additional risks and uncertainties not presently known to us or that we currently deem immaterial may also affect our business, financial condition and results of operations. Certain statements below are forward-looking statements. See the information included under the heading &#8220;Cautionary Note Regarding Forward-Looking Information.&#8221;</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Risks Associated with our Company</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We have not generated any significant revenue since our inception and we may never achieve profitability.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We are a clinical stage company and have incurred losses since our formation. As of December 31, 2017, we have an accumulated total deficit of approximately $55.7 million. As we continue the discovery and development of our future diagnostic products, our expenses are expected to increase significantly. Even as we begin to market and sell our intended products, we expect our losses to continue as a result of ongoing research and development expenses, as well as increased manufacturing, sales and marketing expenses. These losses, among other things, have had and will continue to have an adverse effect on our working capital, total assets and stockholders&#8217; equity. Because of the numerous risks and uncertainties associated with our product development and commercialization efforts, we are unable to predict when we will become profitable, and we may never become profitable. Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. If we are unable to achieve and then maintain profitability, our business, financial condition and results of operations will be negatively affected and the market value of our common stock will decline.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We may need to raise additional capital in the future. If we are unable to secure adequate funds on terms acceptable to us, we may be unable to execute our plan of operations.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We will require additional capital to fully fund our current strategic plan, which includes successfully commercializing our Nu.Q colorectal cancer pipeline and developing future products. If we incur delays in commencing commercialization of our Nu.Q colorectal cancer pipeline or other future products or in achieving significant product revenue, or if we encounter other unforeseen adverse business developments, we may exhaust our capital resources prior to the commencement of commercialization.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We cannot be certain that additional capital will be available when needed or that our actual cash requirements will not be greater than anticipated. Financing opportunities may not be available to us, or if available, may not be available on favorable terms. The availability of financing opportunities will depend on various factors, such as market conditions and our financial condition and outlook. In addition, if we raise additional funds through the issuance of equity or convertible debt securities, the percentage ownership of our stockholders could be significantly diluted, and these newly-issued securities may have rights, preferences or privileges senior to those of existing stockholders. If we obtain debt financing, a substantial portion of our operating cash flow may be dedicated to the payment of principal and interest on such indebtedness, and the terms of the debt securities issued could impose significant restrictions on our operations. If we are unable to obtain financing on terms favorable to us, we may be unable to execute our plan of operations and we may be required to cease or reduce development or commercialization of any future products, sell some or all of our technology or assets or merge with another entity.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>It is difficult to forecast our future performance, which may cause our financial results to fluctuate unpredictably.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our limited operating history and the rapid evolution of the market for diagnostic products make it difficult for us to predict our future performance. A number of factors, many of which are outside of our control, may contribute to fluctuations in our financial results, such as:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our ability to develop or procure antibodies for clinical use in our future products;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our ability to translate preliminary clinical results to larger prospective symptomatic and screening populations;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the demand for our intended products;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our ability to obtain any necessary financing;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our ability to market and sell our future products;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>market acceptance of our future products and technology;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>performance of any future strategic business partners;</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-5</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our ability to obtain regulatory clearances or approvals;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our success in collecting payments from third-party payors and customers;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>changes in technology that may render our future products uncompetitive or obsolete;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>competition with other cancer diagnostics companies; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>adverse changes in the healthcare industry.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Our future success depends on our ability to retain our officers and directors, scientists, and other key employees and to attract, retain and motivate qualified personnel.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our success depends on our ability to attract, retain and motivate highly qualified management and scientific personnel. In particular, we are highly dependent on Cameron Reynolds, our President and Chief Executive Officer, our other officers and directors, scientists and key employees. The loss of any of these persons or their expertise would be difficult to replace and could have a material adverse effect on our ability to achieve our business goals. In addition, the loss of the services of any one of these persons may impede the achievement of our research, development and commercialization objectives by diverting management&#8217;s attention to the identification of suitable replacements, if any. There can be no assurance that we will be successful in hiring or retaining qualified personnel and our failure to do so could have a material adverse effect on our business, financial condition and results of operations.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Recruiting and retaining qualified scientific personnel and, in the future, sales and marketing personnel will also be critical to our success. We may not be able to attract and retain these personnel on acceptable terms given the competition among pharmaceutical, biotechnology and diagnostic companies for similar personnel. We also experience competition for the hiring of scientific personnel from universities and research institutions. We do not maintain &#8220;key person&#8221; insurance on any of our employees. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research, development and commercialization strategies. Our consultants and advisors, however, may have other commitments or employment that may limit their availability to us.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We expect to expand our product development, research and sales and marketing capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We are focused on developing our pipeline for future products. Our efforts will result in significant growth in the number of our consultants, advisors, and employees and the scope of our operations. In order to manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities, and continue to recruit and train additional qualified personnel. Due to our limited resources, we may not be able to effectively manage the expansion of our operations or recruit and train additional qualified personnel. The expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plan or disrupt our operations.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We have limited experience with direct sales and marketing and any failure to build and manage a direct sales and marketing team effectively, or to successfully engage third party providers for such services, could have a material adverse effect on our business.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our products will require several dynamic and evolving sales models tailored to different worldwide markets, users and products. In 2015, we decided to focus our sales strategy on the clinical in vitro diagnostic device, or IVD, market with the CE Marking of our first product in Europe. Following CE Marking of our first product in Europe we intend to enter the European markets and, following the completion of any necessary regulatory clearances, certain Asian markets. Even when we have received a CE Mark, we must still seek regulatory clearance in other jurisdictions. A failure to obtain these regulatory clearances in other jurisdictions could negatively affect our business. Pending completion of our review of the regulatory environment in the United States, including the effect of recent pronouncements regarding LDTs by the FDA, we may decide to enter the United States market through a CLIA certified laboratory in the United States. We intend to progressively grow to large volumes of tests sold to centralized laboratories and eventually reach the mass diagnostics testing market. The exact nature of the ideal sales strategy will evolve as we continue to develop our intended products and seek entry into the IVD markets. We have limited experience with direct sales and marketing and we currently intend to engage a network of distributors to help commercialize our products worldwide. Any failure to build and manage a direct sales and marketing team effectively, or to successfully engage third party providers for such services, could have a material adverse effect on our business. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>There are significant risks involved in building and managing our sales and marketing organization, as well as identifying and negotiating deals with the right sales and distribution partners, including risks related to our ability to:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>identify appropriate partners;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>negotiate beneficial partnership and distribution agreements;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>hire qualified individuals as needed;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>generate sufficient leads within our targeted market for our sales force;</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-6</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>provide adequate training for effective sales and marketing;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>protect intellectual property rights;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>retain and motivate our direct sales and marketing professionals; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>effectively oversee geographically dispersed sales and marketing teams.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our failure to adequately address these risks could have a material adverse effect on our ability to increase sales and use of our future products, which would cause our revenues to be lower than expected and harm our results of operations.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Our Second Amended and Restated Certificate of Incorporation exculpates our officers and directors from certain liability to our Company and our stockholders.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our Second Amended and Restated Certificate of Incorporation contains a provision limiting the liability of our officers and directors for their acts or failures to act, except for acts involving intentional misconduct, fraud or a knowing violation of law. This limitation on liability may reduce the likelihood of derivative litigation against our officers and directors and may discourage or deter our stockholders from suing our officers and directors based upon breaches of their duties to our Company.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We have identified material weaknesses in our internal control over financial reporting that have not yet been remediated, and the failure to address these material weaknesses, or the identification of any others, could impact the reliability of our financial reporting and harm investors&#8217; views of us, which could adversely impact our stock price.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our management is responsible for establishing and maintaining adequate internal control over financial reporting. As defined in Exchange Act Rule 13a-15(f), internal control over financial reporting is a process designed by, or under the supervision of, the principal executive and principal financial officer and effected by the board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles and includes those policies and procedures that:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>pertain to the maintenance of records that in reasonable detail accurately and fairly reflect our transactions and dispositions of assets;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that our receipts and expenditures are being made only in accordance with authorizations of our management and/or directors; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of our assets that could have a material effect on the financial statements.</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We have determined that we have material weaknesses in our internal control over financial reporting as of December 31, 2017. See<I> Item 9A</I>. <I>Controls and Procedures </I>of our Annual Report on Form 10-K<I> </I>filed with the SEC on March 1, 2018 for a complete discussion of these material weaknesses in our internal control over financial reporting and remediation efforts. Although we are undertaking steps to address these material weaknesses, the existence of a material weakness is an indication that there is more than a remote likelihood that a material misstatement of our financial statements will not be prevented or detected in the current or any future period. There can be no assurance that we will be able to fully implement our plans and controls, as further described in <I>Item 9A</I> of our Annual Report on Form 10-K<I> </I>filed with the SEC on March 1, 2018, to address these material weaknesses, or that the plans and controls, if implemented, will be successful in fully remediating these material weaknesses. In addition, we may in the future identify further material weaknesses in our internal control over financial reporting that we have not discovered to date. If we fail to successfully remediate the identified material weaknesses, or we identify further material weaknesses in our internal controls, the market&#8217;s confidence in our financial statements could decline and the market price of our common stock could be adversely impacted. Additionally, for so long as we remain as a smaller reporting company, under current rules our accounting firm will not be required to provide an opinion regarding our internal controls over financial reporting. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We have a &#8220;going concern&#8221; opinion from our auditors, indicating the possibility that we may not be able to continue to operate.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our independent registered public accountants have expressed substantial doubt about our ability to continue as a going concern. This opinion could materially limit our ability to raise additional funds by issuing new debt or equity securities or otherwise. If we fail to raise sufficient capital when needed, we will not be able to complete our proposed business plan. As a result we may have to liquidate our business and investors may lose their investments. Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our plan of operations described herein, obtain financing and eventually attain profitable operations. Investors should consider our independent registered public accountant&#8217;s comments when deciding whether to invest in the Company.</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-7</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Our management has broad discretion over the use of our available cash and might not spend available cash in ways that increase the value of your investment</I></B>.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>As of December 31, 2017, we had $10.1 million in combined cash and marketable securities compared to $21.7 million as of December 31, 2016. Our management currently expects to deploy these resources primarily to expand our commercialization activities, to fund our product development efforts and for general corporate and working capital purposes. However, our management has broad discretion to pursue other objectives. You will be relying on the judgment of our management regarding the application and prioritization of our resources. Our management might not apply our cash in ways that increase or permit any return of your investment.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Risks Associated with our Business</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Failure to successfully develop, manufacture, market, and sell our future products will have a material adverse effect on our business, financial condition, and results of operations.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We are in the process of developing a suite of diagnostic tests as well as additional products. The successful development and commercialization of our intended products is critical to our future success. Our ability to successfully develop, manufacture, market, and sell our future products is subject to a number of risks, many of which are outside our control. There can be no assurance that we will be able to develop and manufacture products in commercial quantities at acceptable costs, successfully market any products, or generate revenues from the sale of any products. Failure to achieve any of the foregoing would have a material adverse effect on our business, financial condition, and results of operations.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Our business is dependent on our ability to successfully develop and commercialize diagnostic products. If we fail to develop and commercialize diagnostic products, we may be unable to execute our plan of operations.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our current business strategy focuses on discovering, developing and commercializing diagnostic products. The success of our business will depend on our ability to fully develop and commercialize the diagnostic products in our current development pipeline as well as continue the discovery and development of other diagnostics products. Currently, we are heavily dependent on our Nu.Q colorectal cancer pipeline. The commercial success of our Nu.Q colorectal cancer pipeline will impact our ability to generate revenues.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Prior to commercializing the Nu.Q Colorectal Cancer Screening Triage Test and other diagnostic products, we will be required to undertake time-consuming and costly development activities with uncertain outcomes, including conducting clinical studies and obtaining regulatory clearance or approval in the United States and in Europe. Delays in obtaining approvals and clearances could have material adverse effects on us and our ability to fully carry out our plan of operations. We have limited experience in taking products through these processes and there are considerable risks involved in these activities. The science and methods that we are employing are innovative and complex, and it is possible that our development programs will ultimately not yield products suitable for commercialization or government approval. Products that appear promising in early development may fail to be validated in subsequent studies, and even if we achieve positive results, we may still fail to obtain the necessary regulatory clearances or approvals. Few research and development projects result in commercial products, and perceived viability in early clinical studies often is not replicated in later studies. At any point, we may abandon development of a product, or we may be required to expend considerable resources obtaining additional clinical and nonclinical data, which would adversely impact the timing for generating potential revenue from those products. Further, our ability to develop and launch diagnostic tests is dependent on our receipt of substantial additional funding. If our discovery and development programs yield fewer commercial products than we expect, we may be unable to execute our business plan, and our business, financial condition and results of operations may be adversely affected.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>The results of pre-clinical studies and completed clinical trials are not necessarily predictive of future results, and our current product candidates may not have favorable results in later studies or trials which, in turn, could have a material adverse effect on our business.</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>As described above, we must conduct extensive testing of our product candidates and new indications of our marketed products before we can obtain regulatory approval to market and sell them. Success in pre-clinical studies or completed clinical trials does not ensure that later studies or trials, including continuing pre-clinical studies and large-scale clinical trials, will be successful nor does it necessarily predict future results. Favorable results in early studies or trials may not be repeated in later studies or trials, and product candidates in later stage trials may fail to show acceptable safety and efficacy despite having progressed through earlier trials. We may be required to demonstrate through large, long-term outcome trials that our product candidates are safe and effective for use in a broad population prior to obtaining regulatory approval. The failure of clinical trials to demonstrate the safety and effectiveness of our clinical candidates for the desired indication(s) would preclude the successful development of those candidates for such indication(s), in which event our business, prospects, results of operations and financial condition may be adversely affected.</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-8</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Our failure to obtain necessary regulatory clearances or approvals on a timely basis would significantly impair our ability to distribute and market our future products on the clinical IVD market.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We are subject to regulation by the FDA in the United States, the Conformit&#233; Europ&#233;enne in Europe and other regulatory bodies in other countries where we intend to sell our future products. Before we are able to place our intended products in the clinical IVD markets in the United States and Europe, we will be required to obtain clearance or approval of our future products from the FDA and receive a CE Mark, respectively</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>The European Union has recently adopted regulations that may impose additional requirements to obtain a CE Mark, which could result in delays and further expense, in terms of staff costs to us as compared to the current CE Mark process. The new regulations will require each product submission to be thoroughly audited by Notified Bodies, instead of the current self-certification process. The EU MDR will be fully applicable in 2020 and the EU IVDR will be fully applicable in 2022.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Additionally, even if we receive the required government clearance or approval of our intended products, we are still subject to continuing regulation and oversight. Under the FDA, diagnostics are considered medical devices and are subject to ongoing controls and regulations, including inspections, compliance with established manufacturing practices, device-tracking, record-keeping, advertising, labeling, packaging, and compliance with other standards. The process of complying with such regulations with respect to current and new products can be costly and time-consuming. Failure to comply with these regulations could have a material adverse effect on our business, financial condition, and results of operations. Furthermore, any FDA regulations governing our future products are subject to change at any time, which may cause delays and have material adverse effects on our operations. In Europe, IVD companies are currently able to self-certify that they meet the appropriate regulatory requirements (which is subject to change with the EU MDR and the EU IVDR noted above) but are subject to inspection for enforcement. European national agencies, such as customs authorities and/or the Departments of Health, Industry and Labor, conduct market surveillance to ensure the applicable requirements have been met for products marketed within the European Union.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Reductions or changes in </I></B></FONT><A name=T60 /><FONT style=font-size:10pt><B><I>reimbursement policies could limit our ability to sell our products.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><A name=T9 /><A name=T16 /><A name=T19 /><A name=T20 /><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Market acceptance and sales of our products will depend, in part, on reimbursement policies and may be affected by healthcare reform measures. Government authorities and third-party payors, such as private health insurers and health maintenance organizations, decide which products they will pay for and establish reimbursement levels for those products. To manage healthcare costs, many governments and third-party payors in the United States increasingly scrutinize the pricing of new products and require greater levels of evidence of favorable clinical outcomes and cost-effectiveness before extending coverage. We cannot be sure that reimbursement will be available for our products and, if reimbursement is available, the level of such reimbursement. Reimbursement may impact the demand for, or the price of, our products. If reimbursement is not available or is available only at limited levels, we may not be able to successfully commercialize our future products.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>If the marketplace does not accept the products in our development pipeline or any other diagnostic products we might develop, we may be unable to generate sufficient revenue to sustain and grow our business.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our intended products may never gain significant acceptance in the research or clinical marketplace and therefore may never generate substantial revenue or profits. Physicians, hospitals, clinical laboratories, researchers or others in the healthcare industry may not use our future products unless they determine that they are an effective and cost-efficient means of detecting and diagnosing cancer. If our research and studies do not satisfy providers, payors and others as to the reliability and effectiveness, we may experience reluctance or refusal on the part of the physician to use our future products. In addition, we will need to expend a significant amount of resources on marketing and educational efforts to create awareness of our future products and to encourage their acceptance and adoption. If the market for our future products does not develop sufficiently or the products are not accepted, our revenue potential will be harmed.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>The cancer diagnostics market is highly competitive and subject to rapid technological change; accordingly, we will face fierce competition and our intended products may become obsolete.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>The cancer diagnostics market is extremely competitive and characterized by evolving industry standards and new product enhancements. Cancer diagnostic tests are technologically innovative and require significant planning, design, development, and testing at the technological, product, and manufacturing process levels. These activities require significant capital commitments and investment. There can be no assurance that our intended products or proprietary technologies will remain competitive following the introduction of new products and technologies by competing companies within the industry. Furthermore, there can be no assurance that our competitors will not develop products that render our future products obsolete or that are more effective, accurate or can be produced at lower costs. There can be no assurance that we will be successful in the face of increasing competition from new technologies or products introduced by existing companies in the industry or by new companies entering the market.</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-9</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We expect to face intense competition from companies with greater resources and experience than us, which may increase the difficulty for us to achieve significant market penetration.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>The market for cancer diagnostics is intensely competitive, subject to rapid change, and significantly affected by new product introductions and other market activities of industry participants. Our competitors include large multinational corporations and their operating units, including Abbott Laboratories Inc., Cepheid Inc., Philips, GE Healthcare, Siemens, Gen-Probe Incorporated, MDxHealth SA, EpiGenomics AG, Roche Diagnostics, Exact Sciences Corporation and several others. Most of these companies have substantially greater financial, marketing and other resources than we do. Most of these companies are either publicly traded or a division of a publicly traded company, and enjoy several competitive advantages, including:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>significantly greater name recognition;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>established relationships with healthcare professionals, companies and consumers;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>additional lines of products, and the ability to offer rebates or bundle products to offer higher discounts or incentives to gain a competitive advantage;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>established supply and distribution networks; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>greater resources for product development, sales and marketing, and intellectual property protection.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Many of these other companies have developed and will continue to develop new products that will compete directly with our future products. In addition, many of our competitors spend significantly greater funds for the research, development, promotion, and sale of new and existing products. These resources may allow them to respond more quickly to new or emerging technologies and changes in consumer requirements. We also face competition in our search for third parties to assist us with sales and marketing and our product candidates, which may negatively impact our ability to enter into favorable sales and marketing arrangements. For all the foregoing reasons, we may not be able to compete successfully against our competitors.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Declining global economic or business conditions may have a negative impact on our business. </I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Continuing concerns over United States healthcare reform legislation and energy costs, geopolitical issues, the availability and cost of credit and government stimulus programs in the United States and other countries have contributed to increased volatility and diminished expectations for the global economy. These factors, combined with low business and consumer confidence and high unemployment precipitated a global economic slowdown and recession. If the economic climate does not improve or continues to deteriorate, our business, including our access to the Research Use Only, or RUO, or clinical IVD markets for diagnostic tests, could be adversely affected, resulting in a negative impact on our business, financial condition and results of operations.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>On June 23, 2016, the United Kingdom held a referendum in which voters approved an exit from the European Union, commonly referred to as &#8220;Brexit&#8221;. As a result of the referendum, the British government has begun to negotiate the terms of the United Kingdom&#8217;s future relationship with the European Union. Although it is unknown what those terms will be, it is possible that there will be greater restrictions on imports and exports between the European Union countries and the United Kingdom and increased regulatory complexities. These changes may adversely affect our ability to market our future products in the United Kingdom which could have an adverse effect on our business, financial condition, and results of operations.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We will rely on third parties to manufacture and supply our intended products. Any problems experienced by these third parties could result in a delay or interruption in the supply of our intended products to our customers, which could have a material negative effect on our business.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We will rely on third parties to manufacture and supply our intended products. The manufacture of our intended diagnostic products will require specialized equipment and utilize complicated production processes that would be difficult, time-consuming and costly to duplicate. If the operations of third party manufacturers are interrupted or if they are unable to meet our delivery requirements due to capacity limitations or other constraints, we may be limited in our ability to fulfill our future sales orders. Any prolonged disruption in the operations of third party manufacturers could have a significant negative impact on our ability to sell our future products, could harm our reputation and could cause us to seek other third party manufacturing contracts, thereby increasing our anticipated development and commercialization costs. In addition, if we are required to change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards required by the FDA and with all applicable regulations and guidelines. The delays associated with the verification of a new manufacturer could negatively affect our ability to develop products or receive approval of any products in a timely manner.</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-10</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>The manufacturing operations of our future third party manufacturers will likely be dependent upon third party suppliers, making us vulnerable to supply shortages and price fluctuations, which could harm our business.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>The operations of our future third party manufacturers will likely be dependent upon third party suppliers. A supply interruption or an increase in demand beyond a supplier&#8217;s capabilities could harm the ability of our future manufacturers to manufacture our intended products until new sources of supply are identified and qualified.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Reliance on these suppliers could subject us to a number of risks that could harm our business, including:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>interruption of supply resulting from modifications to or discontinuation of a supplier&#8217;s operations;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>delays in product shipments resulting from uncorrected defects, reliability issues, or a supplier&#8217;s variation in a component;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>a lack of long-term supply arrangements for key components with our suppliers;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>inability to obtain adequate supply in a timely manner, or to obtain adequate supply on commercially reasonable terms;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>difficulty and cost associated with locating and qualifying alternative suppliers for components in a timely manner;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>production delays related to the evaluation and testing of products from alternative suppliers, and corresponding regulatory qualifications;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>delay in delivery due to suppliers prioritizing other customer orders over ours;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>damage to our brand reputation caused by defective components produced by the suppliers; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>fluctuation in delivery by the suppliers due to changes in demand from us or their other customers.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Any interruption in the supply of components of our future products or materials, or our inability to obtain substitute components or materials from alternate sources at acceptable prices in a timely manner, could impair our ability to meet the demand of our future customers, which would have an adverse effect on our business.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We will depend on third party distributors in the future to market and sell our future products which will subject us to a number of risks.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We will depend on third party distributors to sell, market, and service our future products in our intended markets. We are subject to a number of risks associated with reliance upon third party distributors including:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>lack of day-to-day control over the activities of third party distributors;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>third party distributors may not commit the necessary resources to market and sell our future products to our level of expectations;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>third party distributors may terminate their arrangements with us on limited or no notice or may change the terms of these arrangements in a manner unfavorable to us; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>disagreements with our future distributors could result in costly and time-consuming litigation or arbitration which we could be required to conduct in jurisdictions with which we are not familiar.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>If we fail to establish and maintain satisfactory relationships with our future third party distributors, our revenues and market share may not grow as anticipated, and we could be subject to unexpected costs which could harm our results of operations and financial condition.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><A name=_Hlk507004558 />&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>If the patents that we rely on to protect our intellectual property prove to be inadequate, our ability to successfully commercialize our future products will be harmed and we may never be able to operate our business profitably.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our success depends, in large part, on our ability to protect proprietary methods, discoveries and technologies that we develop under the patents and intellectual property laws of the United States, the European Union and other countries, so that we can seek to prevent others from unlawfully using our inventions and proprietary information. We have 17 patent families related to our diagnostic tests, with five patents granted in the United States and four patents granted in the European Union. Additionally, we have 12 patent applications in the name of our subsidiaries pending in the United States and the 13 patent applications in the European Union.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>If we are not able to protect our proprietary technology and information, our competitors may use our inventions to develop competing products. We cannot assure you that any of the pending patent applications will result in patents being issued. In addition, due to technological changes that may affect our future products or judicial interpretation of the scope of our patents, our intended products might not, now or in the future, be adequately covered by our patents. </FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-11</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>If third parties assert that we have infringed their patents and proprietary rights or challenge the validity of our patents and proprietary rights, we may become involved in intellectual property disputes and litigation that would be costly, time consuming, and delay or prevent the development or commercialization of our future products.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our ability to commercialize our intended products depends on our ability to develop, manufacture, market and sell our future products without infringing the proprietary rights of third parties. Third parties may allege that our future products or our methods or discoveries infringe their intellectual property rights. Numerous United States and foreign patents and pending patent applications, which are owned by third parties, exist in fields that relate to our intended products and our underlying methodologies, discoveries and technologies. A third party may sue us for infringing its patent rights. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our ability to successfully commercialize our intended products depends on our ability to protect our proprietary technology and information. Likewise, we may need to resort to litigation to enforce a patent issued or licensed to us or to determine the scope and validity of third party proprietary rights. In addition, a third party may claim that we have improperly obtained or used its confidential or proprietary information. The cost to us of any litigation or other proceeding relating to intellectual property rights, even if resolved in our favor, could be substantial, and the litigation could divert our management&#8217;s attention from other aspects of our business. Some of our competitors may be able to sustain the costs of complex patent litigation more effectively than we can because they have substantially greater resources. Uncertainties resulting from the initiation and continuation of any litigation could limit our ability to continue our operations. Additionally, we cannot be certain of the level of protection, if any, that will be provided by our patents if they are challenged in court, where our competitors may raise defenses such as invalidity, unenforceability or possession of a valid license.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>If we are found to infringe upon intellectual property rights of third parties, we might be forced to pay damages, potentially including treble damages. In addition to any damages we might have to pay, a court could require us to stop the infringing activity or obtain a license. Any license required under any patent may not be made available on commercially acceptable terms, if at all. In addition, such licenses are likely to be non-exclusive and, therefore, our competitors may have access to the same technology licensed to us. If we fail to obtain a required license and are unable to design around a patent, we may be unable to effectively market some or all of our future products, which could limit our ability to generate revenue or achieve profitability and possibly prevent us from generating revenue sufficient to sustain our operations.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>If we are unable to protect our trade secrets, we may be unable to protect our interests in proprietary technology, processes and know-how that is not patentable or for which we have elected not to seek patent protection.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>In addition to patented technology, we rely upon trade secret protection to protect our interests in proprietary know-how and for processes for which patents are difficult or impossible to obtain or enforce. We may not be able to protect our trade secrets adequately. Although we use reasonable efforts to protect our trade secrets, our employees, consultants, contractors and outside scientific advisors may unintentionally or willfully disclose our information to competitors. Enforcing a claim that a third party illegally obtained and is using any of our trade secrets is expensive and time consuming, and the outcome is unpredictable. In addition, courts outside the United States are sometimes less willing to protect trade secrets. We rely, in part, on non-disclosure and confidentiality agreements with our employees, consultants and other parties to protect our trade secrets and other proprietary technology. These agreements may be breached and we may not have adequate remedies for any breach. Moreover, others may independently develop equivalent proprietary information, and third parties may otherwise gain access to our trade secrets and proprietary knowledge. Any disclosure of confidential information into the public domain or to third parties could allow our competitors to learn our trade secrets and use the information in competition against us, which could adversely affect our competitive advantage.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Defects in our products may subject us to substantial damages which could materially harm our business or financial condition.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>The products we develop could lead to product liability claims based on allegations that one or more of our products contained a design or manufacturing defect which resulted in the failure to detect the disease for which it was designed. A product liability claim could result in substantial damages and be costly and time consuming to defend, either of which could materially harm our business or financial condition. We cannot assure you that our product liability insurance would protect our assets from the financial impact of defending a product liability claim. Any product liability claim brought against us, with or without merit, could increase our product liability insurance rates or prevent us from securing insurance coverage in the future.</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-12</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Risks Associated with our Common Stock</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>The market prices and trading volume of our stock may be volatile.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>The market price of our common stock is likely to be highly volatile and the trading volume may fluctuate and cause significant price variation to occur. We cannot assure you that the market prices of our common stock will not fluctuate or decline significantly in the future. Some of the factors that could negatively affect the prices of our shares or result in fluctuations in those prices or in trading volume of our common stock could include the following, many of which will be beyond our control:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>competition;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>comments by securities analysts regarding our business or prospects;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>additions or departures of key personnel;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our ability to execute our business plan;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>issuance of common stock or other securities;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>operating results that fall below expectations;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>loss of any strategic relationship;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>industry developments;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>economic and other external factors; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>period-to-period fluctuations in our financial results.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>In addition, the securities markets have from time to time experienced significant price and volume fluctuations that are unrelated to the operating performance of particular companies. These market fluctuations may also materially and adversely affect the market price and trading volume of our common stock.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Share ownership by our executive officers and directors make it more difficult for third parties to acquire us or effectuate a change of control that might be viewed favorably by other stockholders.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>As of February 27, 2018, our executive officers and directors beneficially owned, in the aggregate, approximately 29.9% of our outstanding shares. As a result, if the executive officers and directors were to oppose a third party&#8217;s acquisition proposal for, or a change in control of, the Company, such officers and directors may have sufficient voting power to be able to block or at least delay such an acquisition or change in control from taking place, even if other stockholders would support such a sale or change of control. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Our corporate governance documents, and certain corporate laws applicable to us, could make a takeover attempt, which may be beneficial to our stockholders, more difficult.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our Board of Directors, or Board, has the power, under our charter documents to:</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>issue additional shares of common stock without having to obtain stockholder approval for such action;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>enable our Board to fill vacant directorships except for vacancies created by the removal of a director;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>enable our Board to amend our bylaws without stockholder approval subject to certain exceptions; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>require compliance with an advance notice procedure with regard to business to be brought by a stockholder before an annual or special meeting of stockholders and with regard to the nomination by stockholders of candidates for election as directors.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>These provisions may discourage potential acquisition proposals and could delay or prevent a change of control, including under circumstances in which our stockholders might otherwise receive a premium over the market price of our common stock.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We do not expect to pay dividends in the foreseeable future.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We have never declared or paid cash dividends on our common stock. We do not intend to declare dividends for the foreseeable future, as we anticipate that we will reinvest any future earnings in the development and growth of our business. Therefore, investors will not receive any funds unless they sell their common stock, and stockholders may be unable to sell their shares on favorable terms or at all. We cannot assure you of a positive return on investment or that you will not lose the entire amount of your investment in our common stock.</FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-13</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We may in the future issue additional shares of our common stock which would reduce investors&#8217; ownership interests in the Company and which may cause our stock price to decline.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Our Second Amended and Restated Certificate of Incorporation and amendments thereto authorize the issuance of 100,000,000 shares of common stock, par value $0.001 per share. The future issuance of all or part of our remaining authorized common stock may result in substantial dilution in the percentage of our common stock held by our then existing stockholders. We may value any common stock issued in the future on an arbitrary basis. The issuance of common stock for future services or acquisitions or other corporate actions may have the effect of diluting the percentage ownership of our stockholders and, depending upon the prices at which such shares are sold or issued, on their investment in our common stock and, therefore, could have an adverse effect on any trading market for our common stock.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Future sales of our common stock could depress the market price of our common stock.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Sales of a substantial number of shares of our common stock in the public market or the perception that large sales of our shares could occur, could cause the market price of our common stock to decline or limit our future ability to raise capital through an offering of equity securities.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>If equity research analysts do not publish research or reports about our business, or if they do publish such reports but issue unfavorable commentary or downgrade our common stock, the price and trading volume of our common stock could decline.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>The trading market for our common stock could be affected by whether and to what extent equity research analysts publish research or reports about us and our business. If one or more equity analysts cover us and publish research reports about our common stock, the price of our stock could decline rapidly if one or more securities analysts downgrade our stock or if those analysts issue or offer unfavorable commentary or cease publishing reports about us. If any of these analysts ceases coverage of us, we could lose visibility in the market, which in turn could cause our common stock price or trading volume to decline and our common stock to be less liquid.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We are a smaller reporting company and we cannot be certain if the reduced disclosure requirements applicable to smaller reporting companies will make our common stock less attractive to investors.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>We are currently a &#8220;smaller reporting company,&#8221; meaning that we are not an investment company, an asset-backed issuer, or a majority-owned subsidiary of a parent company that is not a smaller reporting company and have a public float of less than $75 million measured as of the last business day of our most recently completed second fiscal quarter and annual revenues of less than $50 million during the most recently completed fiscal year. &#8220;Smaller reporting companies&#8221; are able to provide simplified executive compensation disclosures in their filings; are exempt from the provisions of Section 404(b) of the Sarbanes-Oxley Act requiring that independent registered public accounting firms provide an attestation report on the effectiveness of internal control over financial reporting; and have certain other decreased disclosure obligations in their SEC filings, including, among other things, only being required to provide two years of audited financial statements in annual reports. Decreased disclosures in our SEC filings due to our status as a &#8220;smaller reporting company&#8221; may make it harder for investors to analyze our results of operations and financial prospects.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Risks Related to this Offering</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Purchasers in this offering will experience immediate and substantial dilution in the book value of their investment.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The public offering price of our common stock is substantially higher than the net tangible book value per share of our common stock before giving effect to this offering. Our net tangible book value as of December 31, 2017 was approximately $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; , or $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. After giving effect to the sale of  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our common stock at the offering price of $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share and after deducting the underwriting fees and estimated offering expenses payable by us, if you purchase our common stock in this offering, you will incur immediate substantial dilution of approximately $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. Furthermore, if outstanding options or warrants are exercised, you could experience further dilution. </FONT><FONT style=font-size:10pt;background-color:#FFFFFF>See the information included under the heading &#8220;Dilution.&#8221;</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>A substantial number of shares of common stock may be sold in the market following this offering, which may depress the market price for our common stock.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Sales of a substantial number of shares of our common stock in the public market following this offering, or the perception that such sales might occur, could cause the market price of our common stock to decline. A substantial number of the outstanding shares of our common stock are, and the shares of common stock sold in this offering upon issuance will be, freely tradable without restriction or further registration under the Securities Act of 1933, as amended, or the Securities Act.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-14</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Upon the completion of this offering, approximately  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares of our outstanding common stock beneficially owned by our executive officers, directors and certain of our other existing stockholders will be subject to lock-up agreements with the underwriters of this offering that restrict the sale of shares of our common stock by those parties for a period of 90 days after the date of this prospectus supplement. However, all of the shares sold in this offering and the remaining shares of our common stock outstanding prior to this offering (which include certain shares that are held by our affiliates other than our officers and directors) will not be subject to lock-up agreements with the underwriters and, except to the extent such shares are subject to lock-up agreements, will be freely tradable without restriction under the Securities Act. The market price of our common stock could decline as a result of sales by our stockholders in the market following completion of this offering or the perception that these sales could occur. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>We have broad discretion to determine how to use the funds raised in this offering, and may use them in ways that may not enhance our operating results or the price of our common stock.</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Our management will have broad discretion over the use of proceeds from this offering, and we could spend the proceeds from this offering in ways our stockholders may not agree with or that do not yield a favorable return. We intend to use the net proceeds of this offering for continued product development, clinical studies, product commercialization, working capital and other general corporate purposes. However, our use of these proceeds may differ substantially from our current plans. If we do not invest or apply the proceeds of this offering in ways that improve our operating results, we may fail to achieve expected financial results, which could have a material adverse effect on our business, financial condition, operating results and cash flow, and which could cause our stock price to decline. </FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-15</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus supplement, the accompanying prospectus, and the documents incorporated by reference herein and therein, contain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21 of the Exchange Act. These forward-looking statements are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical fact included in this prospectus supplement, the accompanying prospectus, or the documents incorporated by reference herein or therein, are forward-looking statements. Such statements are typically characterized by terminology such as &#8220;may,&#8221; &#8220;believe,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;anticipate,&#8221; &#8220;expect,&#8221; &#8220;estimate(s),&#8221; &#8220;should,&#8221; &#8220;continue,&#8221; &#8220;potential,&#8221; &#8220;plan,&#8221; &#8220;forecast,&#8221; &#8220;goal,&#8221; &#8220;seek,&#8221; &#8220;intend,&#8221; &#8220;strategy,&#8221; and similar expressions.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Our forward-looking statements are based on our management&#8217;s current assumptions and expectations about future events and trends, which affect or may affect our business, strategy, operations or financial performance. Although we believe that these forward-looking statements are based upon reasonable assumptions, they are subject to numerous known and unknown risks and uncertainties and are made in light of information currently available to us. Many important factors, including those described under the heading &#8220;Risk Factors&#8221; beginning on page S-5 of this prospectus supplement, may adversely and materially affect our results as indicated in forward-looking statements. You should read this prospectus supplement, the accompanying prospectus, and the documents we incorporate by reference herein and therein completely and with the understanding that our actual future results may be materially different and worse from what we expect.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Some significant factors that may impact our estimates and forward-looking statements include:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our inability to generate any significant revenue or achieve profitability;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our need to raise additional capital in the future;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our expectations to expand our product development, research and sales and marketing capabilities could give rise to difficulties in managing our growth;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our limited experience with direct sales and marketing;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>The material weaknesses in our internal control over financial reporting that we have identified;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>The possibility that we may not be able to continue to operate, as indicated by the &#8220;going concern&#8221; opinion from our auditors;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our ability to successfully develop, manufacture, market, and sell our future products;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our ability to timely obtain necessary regulatory clearances or approvals to distribute and market our future products;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>The acceptance by the marketplace of our future products;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>The highly competitive and rapid changing nature of the cancer diagnostics market;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our reliance on third parties to manufacture and supply our intended products, and such manufacturers&#8217; dependence on third party suppliers;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Our dependence on third party distributors; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:41.4pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Protection of our patents, intellectual property and trade secrets.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Moreover, we operate in an evolving environment. New risk factors and uncertainties emerge from time to time and it is not possible for our management to predict all risk factors and uncertainties, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. We qualify all of our forward-looking statements by these cautionary statements.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Forward-looking statements speak only as of the date they were made, and, except to the extent required by law or the rules of the NYSE American, we undertake no obligation to update or review any forward-looking statement because of new information, future events or other factors. You should, however, review the risks and uncertainties we describe in the reports we will file from time to time with the SEC after the date of this prospectus supplement. See the information included under the heading &#8220;Where You Can Find More Information.&#8221; </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Forward-looking statements involve risks and uncertainties and are not guarantees of future performance. As a result of the risks and uncertainties described above, the forward-looking statements discussed in this prospectus supplement, the accompanying prospectus, and the documents incorporated by reference herein and therein might not occur and our future results and our performance may differ materially from those expressed in these forward-looking statements due to, but not limited to, the factors mentioned above. Because of these uncertainties, you should not place undue reliance on these forward-looking statements when making an investment decision.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-16</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>U</B></FONT><A name=S_USE_OF /><FONT style=font-size:10pt><B>SE OF PROCEEDS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We estimate that the net proceeds from this offering will be approximately $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million if the underwriters fully exercise their option to purchase additional shares, after deducting the underwriting discounts and estimated offering expenses payable by us.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We currently anticipate that we will use the net proceeds received by us for continued product development, clinical studies, product commercialization, working capital and other general corporate purposes. </FONT><FONT style=font-size:10pt;background-color:#FFFFFF>Our expected use of the net proceeds from this offering is based upon our present plans and business condition. As of the date of this prospectus supplement, we cannot predict with certainty all of the particular uses for the net proceeds to be received upon the completion of this offering or the amounts that we will actually spend on the uses set forth above. The amounts and timing of our actual use of proceeds will vary depending on numerous factors, including the factors described under the heading &#8220;Risk Factors&#8221; beginning on page S-</FONT><FONT style=font-size:10pt>5</FONT><FONT style=font-size:10pt;background-color:#FFFFFF> of this prospectus supplement. As a result, management will retain broad discretion over the allocation of the net proceeds from this offering, and investors will be relying on the judgment of our management regarding the application of the net proceeds.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>PRICE RANGE OF OUR COMMON STOCK</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Since February 6, 2015, our common stock has been traded on the NYSE American under the symbol &#8220;VNRX.&#8221; The following tables set forth the intraday high and low sales prices per share for our common stock for the periods indicated as reported on the NYSE American. </FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:432pt><TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>Year Ended December 31, 2018</B></FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>High</B></FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>Low</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>First Quarter (through March 7, 2018)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$4.00</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$2.53</FONT></P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:432pt><TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>Year Ended December 31, 2017</B></FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>High</B></FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>Low</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>First Quarter (Jan. 1 &#8211; Mar. 31)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$5.45</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$4.01</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Second Quarter (Apr. 1 &#8211; Jun. 30)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$4.20</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$2.92</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Third Quarter (Jul. 1 &#8211; Sept. 30)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$3.59</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$2.45</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Fourth Quarter (Oct. 1 &#8211; Dec. 31)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$3.75</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$2.08</FONT></P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:432pt><TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>Year Ended December 31, 2016</B></FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>High</B></FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>Low</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>First Quarter (Jan. 1 &#8211; Mar. 31)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$4.43</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$3.20</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Second Quarter (Apr. 1 &#8211; Jun. 30)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$4.19</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$3.05</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Third Quarter (Jul. 1 &#8211; Sept. 30)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$5.86</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$3.05</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:292.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Fourth Quarter (Oct. 1 &#8211; Dec. 31)</FONT></P>
</TD><TD valign=top style=width:74.7pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$5.39</FONT></P>
</TD><TD valign=top style=width:64.8pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$3.75</FONT></P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt;background-color:#FFFFFF>On </FONT><FONT style=font-size:10pt>March 7, 2018</FONT><FONT style=font-size:10pt;background-color:#FFFFFF>, the last reported sale price of our common stock on the NYSE American was $</FONT><FONT style=font-size:10pt>2.86 </FONT><FONT style=font-size:10pt;background-color:#FFFFFF>per share. On </FONT><FONT style=font-size:10pt>March 7, 2018</FONT><FONT style=font-size:10pt;background-color:#FFFFFF>, there were approximately </FONT><FONT style=font-size:10pt>168</FONT><FONT style=font-size:10pt;background-color:#FFFFFF> holders of record of our common stock. The number of holders of record does not include shares held in &#8220;street name&#8221; through brokers.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>D</B></FONT><A name=S_DIVIDEND_POLICY /><FONT style=font-size:10pt><B>IVIDEND POLICY</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We have not previously paid cash dividends on our common stock. It is our current intention to invest our cash flow and earnings in the growth of our business and, therefore, we have no plans to pay cash dividends for the foreseeable future. Investors should not purchase our common stock with the expectation of receiving cash dividends.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-17</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>CAPITALIZATION</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The following table sets forth our cash, cash equivalents and capitalization, as of December 31, 2017, as follows:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>on an actual basis; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>on an as adjusted basis, giving effect to the sale and issuance by us of shares of our common stock in this offering at the public offering price of $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, after deducting the underwriting discount and estimated offering expenses payable by us.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>You should read this data in conjunction with our historical financial statements and the related notes incorporated by reference in this prospectus supplement and the sections entitled &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; contained in our most recently filed Annual Report on Form 10-K and other information on file with the SEC that is incorporated by reference in this prospectus supplement and the accompanying prospectus.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse;width:537.3pt><TR style=height:7.2pt><TD valign=bottom style=width:364.5pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:14.4pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=3 valign=bottom style='width:158.4pt;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>As of December 31, 2017</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:364.5pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:14.4pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:72pt;white-space:nowrap;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Actual</B></FONT></P>
</TD><TD valign=bottom style=width:14.4pt;white-space:nowrap><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:72pt;white-space:nowrap;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>As Adjusted</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Cash, cash equivalents and short-term investments</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>10,116,263</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Debt obligations</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>(4,666,530)</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Stockholders&#8217; Equity:</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>9,957,868</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-6.75pt;margin-left:6.75pt'><FONT style=font-size:10pt>Common stock, par value $0.001 per share: 100,000,000 shares authorized, 26,519,394 shares issued and outstanding, actual;  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, as adjusted</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>26,519</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Additional paid-in capital</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>65,774,870</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Accumulated other comprehensive loss</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>(129,343)</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>(129,343)</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Accumulated Deficit</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>(55,714,178)</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:364.5pt><P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Total stockholders&#8217; equity</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>9,957,868</FONT></P>
</TD><TD valign=bottom style=width:14.4pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style=width:72pt><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>In the table above, the number of shares outstanding after this offering is based on 26,519,394 shares of our common stock outstanding as of December 31, 2017. The number of shares of our common stock outstanding after this offering excludes the following:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>1,731,680 shares of our common stock issuable upon the exercise of common stock purchase warrants outstanding as of December 31, 2017, with a weighted average exercise price of approximately $2.36 per share;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>2,939,134 shares of our common stock issuable upon the exercise of stock options outstanding as of December 31, 2017, with an exercise price of approximately $4.09 per share; </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>829,000 additional shares of common stock reserved for future issuance under our 2015 Stock Incentive Plan, as of December 31, 2017; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any shares issued upon the exercise by the underwriters of the option to purchase up to  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us to cover over-allotments, if any.</FONT><A name=dilution />&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;margin-left:36pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>D</B></FONT><A name=S_DILUTION /><FONT style=font-size:10pt><B>ILUTION</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference between the public offering price per share of our common stock and the &#8220;as adjusted&#8221; net tangible book value per share of our common stock upon the closing of this offering. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Net tangible book value per share of our common stock is determined by subtracting our total liabilities from the amount of our total tangible assets (total assets less intangible assets) and then dividing the difference by the number of shares of our common stock deemed to be outstanding at that date. As of December 31, 2017, we had a net tangible book value of $9.4<B> </B>million, or $0.35<B> </B>per share of common stock.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Investors purchasing in this offering will incur immediate and substantial dilution. After giving effect to the issuance and sale by us of shares of common stock in this offering at the public offering price of $ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, and after deducting underwriting discounts and estimated offering expenses payable by us, our as adjusted net tangible book value as of December 31, 2017 would have been approximately $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;million, or approximately $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share. This amount represents an immediate increase in as adjusted net tangible book value of $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share to our existing stockholders and an immediate dilution in as adjusted net tangible book value of approximately $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  per share to new investors purchasing shares of common stock in this offering. Dilution per share to new investors is determined by subtracting as adjusted net tangible book value per share after this offering from the public offering price per share paid by new investors.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-18</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The following table illustrates this dilution on a per share basis:</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR style=height:7.2pt><TD valign=middle style=width:360pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:6.85pt'><FONT style=font-size:10pt>Public offering price per share</FONT></P>
</TD><TD valign=middle style=white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:36.3pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:7.95pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:9pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=middle style=width:40.5pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:360pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style=font-size:10pt>Net tangible book value per share as of December 31, 2017</FONT></P>
</TD><TD valign=middle style=white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=bottom style='width:36.3pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt;border-bottom:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>0.35</FONT></P>
</TD><TD valign=middle style=width:7.95pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:9pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:40.5pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:360pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:13.5pt'><FONT style=font-size:10pt>Increase in as adjusted net tangible book value per share attributable to this offering</FONT></P>
</TD><TD valign=middle style=white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style='width:36.3pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt;border-top:0.5pt solid #000000'><P align=right style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=middle style=width:7.95pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:9pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:40.5pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:360pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:6.85pt'><FONT style=font-size:10pt>As adjusted net tangible book value per share after this offering</FONT></P>
</TD><TD valign=bottom style=white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=bottom style=width:36.3pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:7.95pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:9pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style='width:40.5pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt;border-bottom:0.25pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=middle style=width:360pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0;margin-left:6.85pt'><FONT style=font-size:10pt>Dilution per share to new investors purchasing in this offering</FONT></P>
</TD><TD valign=middle style=white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:36.3pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:7.95pt;padding-top:0.75pt;padding-right:0.75pt><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
</TD><TD valign=middle style=width:9pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt><P align=right style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>$</FONT></P>
</TD><TD valign=middle style='width:40.5pt;white-space:nowrap;padding-top:0.75pt;padding-right:0.75pt;border-top:0.25pt solid #000000;border-bottom:3px double #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;</FONT></P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>If the underwriters fully exercise their option to purchase additional shares of our common stock, the as adjusted net tangible book value per share after giving effect to this offering would be $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which amount represents an immediate increase in as adjusted net tangible book value of $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share of our common stock to existing stockholders, and an immediate dilution to new investors purchasing in this offering of $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The table above excludes the following shares:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>1,731,680 shares of our common stock issuable upon the exercise of common stock purchase warrants outstanding as of December 31, 2017, with a weighted average exercise price of approximately $2.36 per share;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>2,939,134 shares of our common stock issuable upon the exercise of stock options outstanding as of December 31, 2017, with an exercise price of approximately $4.09 per share; </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>829,000 additional shares of common stock reserved for future issuance under our 2015 Stock Incentive Plan, as of December 31, 2017; and</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:43.2pt;margin-right:7.2pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any shares issued upon the exercise by the underwriters of the option to purchase up to  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us to cover over-allotments, if any.</FONT>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>D</B></FONT><A name=S_DESCRIPTION_OF /><FONT style=font-size:10pt><B>ESCRIPTION OF COMMON STOCK</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>General</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Our authorized capital stock consists of 100,000,000 shares of our common stock, par value $0.001 per share. As of March 7, 2018, there were 26,530,793 shares of our common stock outstanding, which was held of record by 168 stockholders.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Common Stock</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Our common stock was quoted on the OTC Bulletin Board beginning on April 12, 2007 under the symbol &#8220;SNDC.OB.&#8221; Effective October 11, 2011 our symbol was changed to &#8220;VNRX.OB&#8221; to reflect the Company&#8217;s name change. Effective February 6, 2015, we up-listed our common stock onto the NYSE MKT (now NYSE American) and it currently trades under the symbol &#8220;VNRX.&#8221;</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Holders of shares of our common stock are entitled to one vote per share held of record on all matters submitted to a vote of stockholders, including the election of directors. The holders are entitled to receive dividends when, as and if declared by our board of directors, in its discretion, out of funds legally available therefor. In the event of our liquidation, dissolution or winding up, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of liabilities. The holders of our common stock have no preemptive or other subscription rights, and there are no conversion rights or redemption or sinking fund provisions with respect to such shares. All of the outstanding shares of our common stock are, and the shares of our common stock when issued will be, fully paid and non-assessable.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The material terms and provisions of our common stock are further described under the heading &#8220;Description of Capital Stock&#8221; starting on page 3 of the accompanying prospectus. </FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-19</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>U</B></FONT><A name=S_UNDERWRITING /><FONT style=font-size:10pt><B>NDERWRITING</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We entered into an underwriting agreement with the underwriters named below on March  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2018. Oppenheimer &amp; Co. Inc. is acting as the representative of the underwriters. The underwriting agreement provides for the purchase of a specific number of shares of common stock by each of the underwriters. The underwriters&#8217; obligations are several, which means that each underwriter is required to purchase a specified number of shares of common stock, but is not responsible for the commitment of any other underwriter to purchase shares of common stock. Subject to the terms and conditions of the underwriting agreement, each underwriter has severally agreed to purchase the number of shares of common stock set forth opposite its name below:</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR style=height:7.2pt><TD valign=bottom style=width:180.8pt;white-space:nowrap><P style='font:10pt Times New Roman;margin:0'><FONT style='font-size:10pt;border-bottom:1px solid #000000'><B>Underwriter</B></FONT></P>
</TD><TD valign=bottom style=white-space:nowrap><P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:52.9pt;white-space:nowrap;border-bottom:1pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Number of</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Ordinary</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Shares</B></FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:180.8pt;padding-left:10pt><P style='font:10pt Times New Roman;margin:0;margin-left:-9.75pt;background-color:#FFFFFF'><FONT style=font-size:10pt>Oppenheimer &amp; Co. Inc.</FONT></P>
</TD><TD valign=bottom><P style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'>&nbsp;</P>
</TD><TD valign=bottom style=width:52.9pt><P align=center style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:180.8pt><P style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'><FONT style=font-size:10pt>National Securities Corporation </FONT></P>
</TD><TD valign=bottom><P style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'>&nbsp;</P>
</TD><TD valign=bottom style='width:52.9pt;border-bottom:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;</FONT></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:180.8pt><P style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'>&nbsp;</P>
</TD><TD valign=bottom><P style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'>&nbsp;</P>
</TD><TD valign=bottom style='width:52.9pt;border-top:0.5pt solid #000000'><P align=center style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=bottom style=width:180.8pt;padding-left:10pt><P style='font:10pt Times New Roman;margin:0;margin-left:-9.75pt;background-color:#FFFFFF'><FONT style=font-size:10pt>Total</FONT></P>
</TD><TD valign=bottom><P style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'>&nbsp;</P>
</TD><TD valign=bottom style='width:52.9pt;border-bottom:3px double #000000'><P align=center style='font:10pt Times New Roman;margin:0;background-color:#FFFFFF'><FONT style=font-size:10pt> &nbsp;&nbsp;&nbsp;</FONT></P>
</TD></TR>
</TABLE>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The underwriters have agreed to purchase all of the shares of common stock offered by this prospectus (other than those covered by the over-allotment option described below) if any are purchased.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The shares of common stock offered hereby are expected to be ready for delivery on or about March  &nbsp;&nbsp;&nbsp;&nbsp; &nbsp;, 2018 against payment in immediately available funds.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The underwriters are offering the shares of common stock subject to various conditions and may reject all or part of any order. The representative of the underwriters has advised us that the underwriters propose initially to offer the shares of common stock to the public at the public offering price set forth on the cover page of this prospectus supplement and to dealers at a price less a concession not in excess of $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share of common stock to brokers and dealers. After the shares of common stock are released for sale to the public, the representative may change the offering price, the concession, and other selling terms at various times.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We have granted the underwriters an over-allotment option. This option, which is exercisable for up to 30 days after the date of this prospectus supplement, permits the underwriters to purchase a maximum of  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;additional shares of common stock from us to cover over-allotments, if any. If the underwriters exercise all or part of this option, they will purchase shares of common stock covered by the option at the public offering price that appears on the cover page of this prospectus supplement, less applicable underwriting discounts and commissions. If this option is exercised in full, the total price to the public will be $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  , and the total proceeds to us, before expenses, will be $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  . The underwriters have severally agreed that, to the extent the over-allotment option is exercised, they will each purchase a number of additional shares of common stock proportionate to each underwriter&#8217;s initial amount reflected in the foregoing table.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The following table provides information regarding the amount of the discounts and commissions to be paid to the underwriters by us, before expenses:</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<TABLE align=center style=border-collapse:collapse><TR style=height:7.2pt><TD valign=top style=width:193.5pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=bottom style='width:77.05pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:0.5pt solid #000000'><P align=center style='font:9.5pt Times New Roman;margin:0'><B>Per Shares of</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Common Stock</B></P>
</TD><TD valign=bottom style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=bottom style='width:73.7pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:0.5pt solid #000000'><P align=center style='font:9.5pt Times New Roman;margin:0'><B>Total</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Without</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Exercise of</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Over-</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Allotment</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Option</B></P>
</TD><TD valign=bottom style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD colspan=2 valign=bottom style='width:78.2pt;padding-left:5.4pt;padding-right:5.4pt;border-bottom:0.5pt solid #000000'><P align=center style='font:9.5pt Times New Roman;margin:0'><B>Total With</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Full</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Exercise of</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Over-</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Allotment</B></P>
<P align=center style='font:9.5pt Times New Roman;margin:0'><B>Option</B></P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:193.5pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0'>Public offering price</P>
</TD><TD valign=bottom style='width:14.05pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style='width:63pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:11.8pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style='width:61.9pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style='width:15.9pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style='width:62.3pt;padding-left:5.4pt;padding-right:5.4pt;border-top:0.5pt solid #000000'><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:193.5pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0'>Underwriting discounts and commissions(1)</P>
</TD><TD valign=bottom style=width:14.05pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style=width:63pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style=width:61.9pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.9pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style=width:62.3pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:193.5pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:14.05pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>&nbsp;</P>
</TD><TD valign=bottom style=width:63pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>&nbsp;</P>
</TD><TD valign=bottom style=width:61.9pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.9pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>&nbsp;</P>
</TD><TD valign=bottom style=width:62.3pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
<TR style=height:7.2pt><TD valign=top style=width:193.5pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0'>Proceeds, before expenses, to us</P>
</TD><TD valign=bottom style=width:14.05pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style=width:63pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style=width:61.9pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=top style=width:11.8pt;padding-left:5.4pt;padding-right:5.4pt><P align=center style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD><TD valign=bottom style=width:15.9pt;padding-left:5.4pt;padding-right:5.4pt><P style='font:9.5pt Times New Roman;margin:0;margin-left:-3.6pt'>$</P>
</TD><TD valign=bottom style=width:62.3pt;padding-left:5.4pt;padding-right:5.4pt><P align=right style='font:9.5pt Times New Roman;margin:0'>&nbsp;</P>
</TD></TR>
</TABLE>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:9pt Times New Roman;margin:0;margin-left:29.7pt'>(1) We have agreed to pay the underwriters a commission of 3% of the aggregate purchase price for shares of common stock sold to officers, directors and certain specified existing holders, or insiders, and 6% of the aggregate purchase price for shares of common stock sold to all other investors; <I>provided </I>that a minimum blended commission of 5% of the aggregate purchase price shall apply so long as at least 50% of such proceeds are raised from sales to investors other than insiders.</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt>Certain insiders may purchase shares in this offering. &#160;Because the Company has not entered into any binding agreements or received any commitments to purchase from any insiders, such insiders may elect not to purchase any shares in this offering.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-20</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt>We estimate that our total expenses of the offering, excluding the estimated underwriting discounts and commissions, will be approximately $  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, which includes the fees and expenses for which we have agreed to reimburse the underwriters, including fees and expenses of their counsel (other than expenses related to blue-sky and FINRA filings), up to a maximum aggregate amount of (i) $50,000, in the event that there is no closing of the offering, or (ii) $100,000, in the event that there is a closing of the offering.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt>We have agreed to indemnify the underwriters against certain liabilities, including liabilities under the Securities Act of 1933.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt>We and our officers, directors and certain of our other existing stockholders have agreed to a 90-day &#8220;lock-up&#8221; with respect to our shares of common stock and other of our securities that they beneficially own, including securities that are convertible into shares of common stock and securities that are exchangeable for or exercisable into shares of common stock. This means that, subject to certain exceptions, for a period of 90 days following the date of this prospectus supplement, we and such persons may not offer, sell, pledge or otherwise dispose of these securities without the prior written consent of Oppenheimer &amp; Co. Inc.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The restrictions described in the immediately preceding paragraph do not apply to transfers of shares of common stock or any security convertible into common stock:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>as a bona fide gift or gifts; </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>by will or intestate succession;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>to any trust for the direct or indirect benefit of the stockholder or immediate family of the stockholder;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>to a charity or educational institution;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>the transfer to affiliates, limited partners, members or stockholders of the signatory; or</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt;background-color:#FFFFFF>to any investment fund or other entity controlled or managed by, directly or indirectly, or under common control or management with, any &#8220;lock-up&#8221; party;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt;background-color:#FFFFFF>provided that in the case of any transfer or distribution as described in the bullet points above, such transfer shall not involve a disposition for value and each recipient or transferee agrees to be subject to the restrictions described in the immediately preceding paragraph.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:29.7pt'><FONT style=font-size:10pt>Rules of the SEC may limit the ability of the underwriters to bid for or purchase shares of common stock before the distribution of the shares of common stock is completed. However, the underwriters may engage in the following activities in accordance with the rules:</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Stabilizing transactions &#8212;&nbsp;The representative may make bids or purchases for the purpose of pegging, fixing or maintaining the price of the shares of common stock, so long as stabilizing bids do not exceed a specified maximum. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Over-allotments and syndicate covering transactions &#8212;&nbsp;The underwriters may sell more shares of common stock in connection with this offering than the number of shares of common stock that they have committed to purchase. This over-allotment creates a short position for the underwriters. This short sales position may involve either &#8220;covered&#8221; short sales or &#8220;naked&#8221; short sales. Covered short sales are short sales made in an amount not greater than the underwriters&#8217; over-allotment option to purchase additional shares of common stock in this offering described above. The underwriters may close out any covered short position either by exercising its over-allotment option or by purchasing shares of common stock in the open market. To determine how they will close the covered short position, the underwriters will consider, among other things, the price of the shares of common stock available for purchase in the open market, as compared to the price at which they may purchase shares of common stock through the over-allotment option. Naked short sales are short sales in excess of the over-allotment option. The underwriters must close out any naked short position by purchasing shares of common stock in the open market. A naked short position is more likely to be created if the underwriters are concerned that, in the open market after pricing, there may be downward pressure on the price of the shares of common stock that could adversely affect investors who purchase shares of common stock in this offering. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Penalty bids &#8212;&nbsp;If the representative purchases shares of common stock in the open market in a stabilizing transaction or syndicate covering transaction, it may reclaim a selling concession from the underwriters and selling group members who sold those shares of common stock as part of this offering. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>Passive market making &#8212;&nbsp;Market makers in the shares of common stock who are underwriters or prospective underwriters may make bids for or purchases of shares of common stock, subject to limitations, until the time, if ever, at which a stabilizing bid is made. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Similar to other purchase transactions, the underwriters&#8217; purchases to cover the syndicate short sales or to stabilize the market price of our shares of common stock may have the effect of raising or maintaining the market price of our shares of common stock or preventing or mitigating a decline in the market price of our shares of common stock. As a result, the price of the shares of common stock may be higher than the price that might otherwise exist in the open market. The imposition of a penalty bid might also have an effect on the price of the shares of common stock if it discourages resales of the shares of common stock.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-21</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Neither we nor the underwriters make any representation or prediction as to the effect that the transactions described above may have on the price of the shares of common stock. These transactions may occur on the NYSE American or otherwise. If such transactions are commenced, they may be discontinued without notice at any time.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B> </B></FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt;background-color:#FFFFFF><B>Relationships</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Certain of the underwriters and their affiliates may provide from time to time in the future certain commercial banking, financial advisory, investment banking and other services for us and such affiliates, and for the selling stockholders and their affiliates, in the ordinary course of their business, for which they will receive customary fees and commissions, as applicable, and reimbursement for out-of-pocket expenses. In addition, from time to time, certain of the underwriters and their affiliates may effect transactions for their own account or the account of customers, and hold on behalf of themselves or their customers, long or short positions in our debt or equity securities or loans, and may do so in the future.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Electronic Delivery of Preliminary Prospectus</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>A prospectus supplement in electronic format may be delivered to potential investors by one or more of the underwriters participating in this offering. The prospectus supplement in electronic format will be identical to the paper version of such prospectus supplement. Other than the prospectus supplement in electronic format, the information on any underwriter&#8217;s website and any information contained in any other website maintained by an underwriter is not part of this prospectus supplement, the accompanying prospectus or the registration statement of which this prospectus supplement and the accompanying prospectus form a part.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Notice to Non-U.S. Investors</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><KBD style=margin-left:36pt></KBD><FONT style=font-size:10pt>Other than in the United States and as described below, no action has been taken by us or the underwriters that would permit a public offering of the shares of common stock offered by this prospectus in any jurisdiction where action for that purpose is required. The shares of common stock offered by this prospectus may not be offered or sold, directly or indirectly, nor may this prospectus or any other offering material or advertisements in connection with the offer and sale of any such shares of common stock be distributed or published in any jurisdiction, except under circumstances that will result in compliance with the applicable rules and regulations of that jurisdiction. Persons into whose possession this prospectus comes are advised to inform themselves about and to observe any restrictions relating to the offering and the distribution of this prospectus. This prospectus does not constitute an offer to sell or a solicitation of an offer to buy any shares of common stock offered by this prospectus in any jurisdiction in which such an offer or a solicitation is unlawful.</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Belgium</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B> </B></FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The offering is exclusively conducted under applicable private placement exemptions and therefore it has not been and will not be notified to, and this document or any other offering material relating to the shares of common stock has not been and will not be approved by, the Belgian Banking, Finance and Insurance Commission (&#8220;Commission bancaire, financi&#232;re et des assurances/Commissie voor het Bank, Financie en Assurantiewezen&#8221;). Any representation to the contrary is unlawful.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Each underwriter has undertaken not to offer sell, resell, transfer or deliver directly or indirectly, any shares of common stock, or to take any steps relating/ancillary thereto, and not to distribute or publish this document or any other material relating to the shares of common stock or to the offering in a manner which would be construed as: (a) a public offering under the Belgian Royal Decree of 7 July 1999 on the public character of financial transactions; or (b) an offering of securities to the public under Directive 2003/71/EC which triggers an obligation to publish a prospectus in Belgium. Any action contrary to these restrictions will cause the recipient and the company to be in violation of the Belgian securities laws.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Canada</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This document constitutes an &#8220;exempt offering document&#8221; as defined in and for the purposes of applicable Canadian securities laws. No prospectus has been filed with any securities commission or similar regulatory authority in Canada in connection with the offer and sale of the securities described herein (the &#8220;Securities&#8221;). No securities commission or similar regulatory authority in Canada has reviewed or in any way passed upon this document or on the merits of the Securities and any representation to the contrary is an offence.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Canadian investors are advised that this document has been prepared in reliance on section 3A.3 of National Instrument 33-105 Underwriting Conflicts (&#8220;NI 33-105&#8221;). Pursuant to section 3A.3 of NI 33-105, this document is exempt from the requirement to provide investors with certain conflicts of interest disclosure pertaining to &#8220;connected issuer&#8221; and/or &#8220;related issuer&#8221; relationships as would otherwise be required pursuant to subsection 2.1(1) of NI 33-105.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-22</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><I>Resale Restrictions</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The offer and sale of the securities in Canada is being made on a private placement basis only and is exempt from the requirement to prepare and file a prospectus under applicable Canadian securities laws. Any resale of Securities acquired by a Canadian investor in this offering must be made in accordance with applicable Canadian securities laws, which may vary depending on the relevant jurisdiction, and which may require resales to be made in accordance with Canadian prospectus requirements, a statutory exemption from the prospectus requirements, in a transaction exempt from the prospectus requirements or otherwise under a discretionary exemption from the prospectus requirements granted by the applicable local Canadian securities regulatory authority. These resale restrictions may under certain circumstances apply to resales of the securities outside of Canada.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt><B> </B></FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><I>Representations of Purchasers</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Each Canadian investor who purchases the securities will be deemed to have represented to the issuer and to each dealer from whom a purchase confirmation is received, as applicable, that the investor (i) is purchasing as principal, or is deemed to be purchasing as principal in accordance with applicable Canadian securities laws, for investment only and not with a view to resale or redistribution; (ii) is an &#8220;accredited investor&#8221; as such term is defined in section 1.1 of National Instrument 45-106 <I>Prospectus Exemptions</I> (&#8220;NI 45-106&#8221;) or, in Ontario, as such term is defined in section 73.3(1) of the <I>Securities Act</I> (Ontario); and (iii) is a &#8220;permitted client&#8221; as such term is defined in section 1.1 of National Instrument 31-103 <I>Registration Requirements, Exemptions and Ongoing Registrant Obligations</I>.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><I>Taxation and Eligibility for Investment</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Any discussion of taxation and related matters contained in this document does not purport to be a comprehensive description of all of the tax considerations that may be relevant to a Canadian investor when deciding to purchase the securities and, in particular, does not address any Canadian tax considerations. No representation or warranty is hereby made as to the tax consequences to a resident, or deemed resident, of Canada of an investment in the securities or with respect to the eligibility of the securities for investment by such investor under relevant Canadian federal and provincial legislation and regulations.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><I>Rights of Action for Damages or Rescission</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Securities legislation in certain of the Canadian jurisdictions provides certain purchasers of securities pursuant to an offering memorandum, including where the distribution involves an &#8220;eligible foreign security&#8221; as such term is defined in Ontario Securities Commission Rule 45-501 <I>Ontario Prospectus and Registration Exemptions</I> and in Multilateral Instrument 45-107 <I>Listing Representation and Statutory Rights of Action Disclosure Exemptions</I>, as applicable, with a remedy for damages or rescission, or both, in addition to any other rights they may have at law, where the offering memorandum, or other offering document that constitutes an offering memorandum, and any amendment thereto, contains a &#8220;misrepresentation&#8221; as defined under applicable Canadian securities laws. These remedies, or notice with respect to these remedies, must be exercised or delivered, as the case may be, by the purchaser within the time limits prescribed under, and are subject to limitations and defences under, applicable Canadian securities legislation. In addition, these remedies are in addition to and without derogation from any other right or remedy available at law to the investor.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><I>Language of Documents</I></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Upon receipt of this document, each Canadian investor hereby confirms that it has expressly requested that all documents evidencing or relating in any way to the sale of the securities described herein (including for greater certainty any purchase confirmation or any notice) be drawn up in the English language only. <I>Par la r&#233;ception de ce document, chaque investisseur canadien confirme par les pr&#233;sentes qu&#8217;il a express&#233;ment exig&#233; que tous les documents faisant foi ou se rapportant de quelque mani&#232;re que ce soit &#224; la vente des valeurs mobili&#232;res d&#233;crites aux pr&#233;sentes (incluant, pour plus de certitude, toute confirmation d&#8217;achat ou tout avis) soient r&#233;dig&#233;s en anglais seulement.</I></FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-23</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>France</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Neither this prospectus supplement nor any other offering material relating to the shares of common stock has been submitted to the clearance procedures of the Autorit&#233; des march&#233;s financiers in France. The shares of common stock have not been offered or sold and will not be offered or sold, directly or indirectly, to the public in France. Neither this prospectus supplement nor any other offering material relating to the shares of common stock has been or will be: (a) released, issued, distributed or caused to be released, issued or distributed to the public in France; or (b) used in connection with any offer for subscription or sale of the shares of common stock to the public in France. Such offers, sales and distributions will be made in France only: (i) to qualified investors (investisseurs qualifi&#233;s) and/or to a restricted circle of investors (cercle restreint d&#8217;investisseurs), in each case investing for their own account, all as defined in and in accordance with Articles L.411-2, D.411-1, D.411-2, D.734-1, D.744-1, D.754-1 and D.764-1 of the French Code mon&#233;taire et financier; (ii) to investment services providers authorised to engage in portfolio management on behalf of third parties; or (iii) in a transaction that, in accordance with article L.411-2-II-1&#176;-or-2&#176;-or 3&#176; of the French Code mon&#233;taire et financier and article 211-2 of the General Regulations (R&#232;glement G&#233;n&#233;ral) of the Autorit&#233; des march&#233;s financiers, does not constitute a public offer (appel public &#224; l&#8217;&#233;pargne). Such shares of common stock may be resold only in compliance with Articles L.411-1, L.411-2, L.412-1 and L.621-8 through L.621-8-3 of the French Code mon&#233;taire et financier.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Israel</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This document does not constitute a prospectus under the Israeli Securities Law, 5728-1968 (the &#8220;Securities Law&#8221;), and has not been filed with or approved by the Israel Securities Authority. In the State of Israel, this document is being distributed only to, and is directed only at, and any offer of the shares of common stock is directed only at, investors listed in the first addendum to the Israeli Securities Law (the &#8220;Addendum&#8221;), consisting primarily of joint investment in trust funds, provident funds, insurance companies, banks, portfolio managers, investment advisors, members of the Tel Aviv Stock Exchange, underwriters, venture capital funds, entities with equity in excess of NIS 50 million and &#8220;qualified individuals&#8221;, each as defined in the Addendum (as it may be amended from time to time), collectively referred to as qualified investors (in each case purchasing for their own account or, where permitted under the Addendum, for the accounts of their clients who are investors listed in the Addendum). Qualified investors will be required to submit written confirmation that they fall within the scope of the Addendum, are aware of the meaning of same and agree to it.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I> </I></B></FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Italy</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The offering of the shares of common stock offered hereby in Italy has not been registered with the Commissione Nazionale per la Societ&#224; e la Borsa (&#8220;CONSOB&#8221;) pursuant to Italian securities legislation and, accordingly, the shares of common stock offered hereby cannot be offered, sold or delivered in the Republic of Italy (&#8220;Italy&#8221;) nor may any copy of this prospectus supplement or any other document relating to the shares of common stock offered hereby be distributed in Italy other than to professional investors (operatori qualificati) as defined in Article 31, second paragraph, of CONSOB Regulation No. 11522 of 1 July, 1998 as subsequently amended. Any offer, sale or delivery of the shares of common stock offered hereby or distribution of copies of this prospectus supplement or any other document relating to the shares of common stock offered hereby in Italy must be made:</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(a)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>by an investment firm, bank or intermediary permitted to conduct such activities in Italy in accordance with Legislative Decree No. 58 of 24 February 1998 and Legislative Decree No. 385 of 1 September 1993 (the &#8220;Banking Act&#8221;);</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(b)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>in compliance with Article 129 of the Banking Act and the implementing guidelines of the Bank of Italy; and </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(c)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>in compliance with any other applicable laws and regulations and other possible requirements or limitations which may be imposed by Italian authorities. </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Sweden</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus supplement has not been nor will it be registered with or approved by Finansinspektionen (the Swedish Financial Supervisory Authority). Accordingly, this prospectus supplement may not be made available, nor may the shares of common stock offered hereunder be marketed and offered for sale in Sweden, other than under circumstances which are deemed not to require a prospectus under the Financial Instruments Trading Act (1991: 980).</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-24</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>Switzerland</I></B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The shares of common stock offered pursuant to this prospectus supplement will not be offered, directly or indirectly, to the public in Switzerland and this prospectus supplement does not constitute a public offering prospectus as that term is understood pursuant to art. 652a or art. 1156 of the Swiss Federal Code of Obligations. The company has not applied for a listing of the shares of common stock being offered pursuant to this prospectus supplement on the SWX Swiss Exchange or on any other regulated securities market, and consequently, the information presented in this prospectus supplement does not necessarily comply with the information standards set out in the relevant listing rules. The shares of common stock being offered pursuant to this prospectus supplement have not been registered with the Swiss Federal Banking Commission as foreign investment funds, and the investor protection afforded to acquirers of investment fund certificates does not extend to acquirers of shares of common stock.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Investors are advised to contact their legal, financial or tax advisers to obtain an independent assessment of the financial and tax consequences of an investment in shares of common stock.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B><I>United Kingdom/Germany/Norway/The Netherlands</I></B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>In relation to each Member State of the European Economic Area which has implemented the Prospectus Directive (each, a &#8220;Relevant Member State&#8221;) an offer to the public of any shares of common stock which are the subject of the offering contemplated by this prospectus supplement may not be made in that Relevant Member State other than the offers contemplated in this prospectus supplement in name(s) of Member State(s) where prospectus will be approved or passported for the purposes of a non-exempt offer once this prospectus supplement has been approved by the competent authority in such Member State and published and passported in accordance with the Prospectus Directive as implemented in name(s) of relevant Member State(s) except that an offer to the public in that Relevant Member State of any shares of common stock may be made at any time under the following exemptions under the Prospectus Directive, if they have been implemented in that Relevant Member State:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(a)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>to legal entities which are authorized or regulated to operate in the financial markets or, if not so authorized or regulated, whose corporate purpose is solely to invest in securities; </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(b)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>to any legal entity which has two or more of (1) an average of at least 250 employees during the last financial year; (2) a total balance sheet of more than &#8364;43,000,000 and (3) an annual net turnover of more than &#8364;50,000,000, as shown in its last annual or consolidated accounts; </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(c)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>by the representative to fewer than 100 natural or legal persons (other than qualified investors as defined in the Prospectus Directive); or </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(d)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>in any other circumstances falling within Article 3(2) of the Prospectus Directive, provided that no such offer of shares of common stock shall result in a requirement for the publication by the company or any underwriter of a prospectus pursuant to Article 3 of the Prospectus Directive. </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>For the purposes of this provision, the expression an &#8220;offer to the public&#8221; in relation to any shares of common stock in any Relevant Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares of common stock to be offered so as to enable an investor to decide to purchase any shares of common stock, as the same may be varied in that Member State by any measure implementing the Prospectus Directive in that Member State and the expression &#8220;Prospectus Directive&#8221; means Directive 2003/71/EC and includes any relevant implementing measure in each Relevant Member State.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt>Each underwriter has represented, warranted and agreed that:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(a)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>it has only communicated or caused to be communicated and will only communicate or cause to be communicated any invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000 (the FSMA)) received by it in connection with the issue or sale of any shares of common stock in circumstances in which section 21(1) of the FSMA does not apply to the company; and </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;font:10pt Times New Roman;text-indent:0'><FONT style=font-size:10pt>(b)</FONT></KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>it has complied with and will comply with all applicable provisions of the FSMA with respect to anything done by it in relation to the shares of common stock in, from or otherwise involving the United Kingdom. </FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-25</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>L</B></FONT><A name=S_LEGAL_MATTERS /><FONT style=font-size:10pt><B>EGAL MATTERS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Certain legal matters relating to this offering will be passed upon for us by Stradling Yocca Carlson &amp; Rauth, P.C., Newport Beach, California. Certain legal matters relating to this offering will be passed upon for the underwriters by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo P.C., New York, New York.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>E</B></FONT><A name=S_EXPERTS /><FONT style=font-size:10pt><B>XPERTS</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Sadler, Gibb &amp; Associates, LLC, an independent registered public accounting firm, has audited our financial statements as of December 31, 2017 and 2016 included in our Annual Report on Form 10-K for the year ended December 31, 2017, as set forth in their report, which is incorporated by reference in this prospectus. Our financial statements are incorporated by reference in reliance on Sadler, Gibb &amp; Associates, LLC&#8217;s report, given on their authority as experts in accounting and auditing. </FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>I</B></FONT><A name=S_INCORPORATION_OF /><FONT style=font-size:10pt><B>NCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The SEC allows us to &#8220;incorporate&#8221; into this prospectus information that we file with the SEC in other documents. This means that we can disclose important information to you by referring to other documents that contain that information. Any information that we incorporate by reference into this prospectus is considered part of this prospectus.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Information contained in this prospectus and information that we file with the SEC in the future and incorporate by reference in this prospectus automatically modifies and supersedes previously filed information, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We incorporate by reference, as of their respective dates of filing, the documents listed below that we have filed with the SEC and any additional documents that we may file in the future with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including any documents filed after the date of the initial registration statement of which this prospectus is a part until the offering of the security covered by this prospectus has been completed, other than, in each case, documents or information deemed to have been &#8220;furnished&#8221; and not &#8220;filed&#8221; in accordance with SEC rules:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our Annual Report on Form 10-K for the year ended December 31, 2017, as filed with the SEC on March 1, 2018;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the description of our common stock contained in our registration statement on Form 8-A as filed with the SEC on February 3, 2015, as updated or amended in any amendment or report filed for such purpose.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We hereby undertake to provide without charge to each person, including any beneficial owner, to whom this prospectus is delivered, upon written or oral request, a copy of any or all documents that are incorporated by reference into this prospectus, but not delivered with the prospectus, other than exhibits to such documents unless such exhibits are specifically incorporated by reference into the documents that this prospectus incorporates. To request such materials, please contact Mr. Rodney Rootsaert, our Corporate Secretary, at c/o Corporate Secretary, VolitionRx Limited, 1 Scotts Road, #24-05 Shaw Centre, Singapore, 228208, by email at notice@volitionrx.com, or by facsimile at +32 8172 5651. These documents are also available free of charge through the Investors section on our website at http://www.volitionrx.com as soon as practicable after such materials have been electronically filed with, or furnished to, the SEC.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>You should rely only on the information contained in this prospectus, in any accompanying prospectus supplement, or in any document incorporated by reference herein or therein. We have not authorized anyone to provide you with any different information. We take no responsibility for, and can provide no assurance as to the reliability of, any other information that others may provide to you. The information contained in this prospectus, in any applicable prospectus supplement, and in the documents incorporated by reference herein or therein is accurate only as of the date such information is presented. Our business, financial condition, results of operations and prospects may have changed since that date. </FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>S-26</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>W</B></FONT><A name=S_WHERE_YOU /><FONT style=font-size:10pt><B>HERE YOU CAN FIND MORE INFORMATION</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We file annual, quarterly and current reports and other information with the SEC. You may read and copy any document we file at the SEC&#8217;s Public Reference Room located at 100 F Street, N.E., Washington, D.C. 20549. You may obtain information on the operation of the public reference room by calling the SEC at 1-800-SEC-0330. Our filings with the SEC also are available from the SEC&#8217;s internet site at http://www.sec.gov, which contains reports, proxy and information statements, and other information regarding issuers that file electronically.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus supplement and the accompanying prospectus are part of a registration statement that we filed with the SEC. As permitted by SEC rules, this prospectus supplement and the accompanying prospectus form a part of the registration statement, but do not contain all of the information that is included in the registration statement. The registration statement contains more information regarding us and our securities, including certain exhibits. You can obtain a copy of the registration statement from the SEC at the address listed above or from the SEC&#8217;s website.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin-top:10pt;margin-bottom:0pt'>S-27</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt><B>$50,000,000</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><IMG src=f424b5030718_424b55.jpg width=137 height=86 alt='Picture 1' title='Picture 1'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>VOLITIONRX LIMITED</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>1 Scotts Road</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>#24-05 Shaw Centre</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Singapore 228208</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>+1 (646) 650-1351</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Common Stock</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Preferred Stock</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Warrants</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt><B>_______________________</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may, from time to time in one or more offerings, sell up to $50,000,000 in the aggregate, inclusive of any exercise price thereof, of:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:30pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>shares of our common stock;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>shares of our preferred stock;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>warrants to purchase shares of our common stock and/or preferred stock; or</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any combination of the foregoing.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus provides a general description of the securities we may offer. The prospectus supplement may also add, update or change information in this prospectus. You should read this prospectus and any prospectus supplement, as well as the documents incorporated by reference or deemed to be incorporated by reference herein or therein, carefully before you invest in any of the securities offered pursuant to this prospectus. <B>This prospectus may not be used to offer or sell our securities unless accompanied by a prospectus supplement relating to the offered securities.</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>These securities may be sold directly by us, through dealers or agents designated from time to time, to or through underwriters or dealers or through a combination of these methods on a continuous or delayed basis. For additional information on the methods of sale, you should refer to the section entitled &#8220;Plan of Distribution&#8221; in this prospectus. We will describe the plan of distribution for any particular offering of our securities in a prospectus supplement. If any agents, underwriters or dealers are involved in the sale of any securities with respect to which this prospectus is being delivered, we will set forth in a prospectus supplement the names of such agents or underwriters and any applicable fees, commissions, discounts and over-allotment options. We will also set forth in a prospectus supplement the price to the public of such securities and the net proceeds that we expect to receive from such sale.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><A name=P254131968 /><FONT style=font-size:10pt>Our common stock is currently quoted on the NYSE MKT under the symbol &#8220;VNRX.&#8221;</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt;background-color:#FFFFFF>As of September 3, 2015, the aggregate market value of our outstanding common stock held by non-affiliates, or public float, was approximately $47,028,724, based on 18,059,715 shares of outstanding common stock, of which approximately 5,175,133 shares were held by affiliates, and a price of $3.65 per share, which was the last reported sale price of our common stock on the NYSE MKT on such date. We have not offered any securities pursuant to General Instruction I.B.6 of Form S-3 during the prior 12 calendar month period that ends on and includes the date of this prospectus. Pursuant to General Instruction I.B.6 of Form S-3, in no event will we sell securities registered on this registration statement in a public primary offering with a value exceeding more than one-third of our public float in any 12-month period so long as our public float remains below $75.0 million.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:30pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>INVESTING IN THE SECURITIES WE MAY OFFER INVOLVES VARIOUS RISKS. WE STRONGLY RECOMMEND THAT YOU READ CAREFULLY THE RISKS WE DESCRIBE IN THIS PROSPECTUS AS WELL AS IN ANY ACCOMPANYING PROSPECTUS SUPPLEMENT AND THE RISK FACTORS IN OUR MOST CURRENT REPORTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. FOR A FULLER UNDERSTANDING OF THE RISKS AND UNCERTAINTIES THAT WE FACE, SEE THE SECTION ENTITLED &#8220;RISK FACTORS&#8221; ON PAGE 2.</B></FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>NEITHER THE SECURITIES AND EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR PASSED UPON THE ADEQUACY OR ACCURACY OF THIS PROSPECTUS. ANY REPRESENTATION TO THE CONTRARY IS A CRIMINAL OFFENSE.</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt>The date of this prospectus is September 18, 2015</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt> <B>TABLE OF CONTENTS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>ABOUT THIS PROSPECTUS</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>1</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>THE COMPANY</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>1</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>RISK FACTORS</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>2</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>2</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>USE OF PROCEEDS</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>2</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>GENERAL DESCRIPTION OF SECURITIES</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>3</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>DESCRIPTION OF CAPITAL STOCK</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>3</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>DESCRIPTION OF THE WARRANTS</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>4</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>PLAN OF DISTRIBUTION</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>5</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>LEGAL MATTERS</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>6</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>EXPERTS</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>6</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>6</FONT></KBD>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><KBD style='position:absolute;font:10pt Times New Roman'><FONT style=font-size:10pt>WHERE YOU CAN FIND MORE INFORMATION</FONT></KBD><KBD style='position:absolute;text-align:right;font:10pt Times New Roman;width:503.5pt'><FONT style=font-size:10pt>7</FONT></KBD>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><A name=_Toc428977351 />&nbsp;</P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>ABOUT THIS PROSPECTUS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus is part of a registration statement that we filed with the Securities and Exchange Commission, or the SEC, using a &#8220;shelf&#8221; registration process. Under this shelf registration process, we may from time to time offer and sell any combination of the securities described in this prospectus in one or more offerings with an aggregate initial offering price not to exceed $50,000,000. We have provided to you in this prospectus a general description of the securities we may offer. Each time we sell any of our securities under this prospectus, we will, to the extent required by law, provide a prospectus supplement that will contain specific information about the terms of the offering. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may add, update or change any of the information contained in this prospectus or in any accompanying prospectus supplement we may authorize to be delivered to you. To the extent there is a conflict between the information contained in this prospectus and any accompanying prospectus supplement, you should rely on the information in the prospectus supplement, provided that if any statement in one of these documents is inconsistent with a statement in another document having a later date-for example, a document incorporated by reference in this prospectus or any prospectus supplement-the statement in the document having the later date modifies or supersedes the earlier statement. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus. This prospectus, together with any accompanying prospectus supplement, includes all material information relating to an offering pursuant to this registration statement.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>You should rely only on the information contained in this prospectus, in any accompanying prospectus supplement, or in any document incorporated by reference herein or therein. We have not authorized anyone to provide you with any different information. We take no any responsibility for, and can provide no assurance as to the reliability of, any other information that others may provide to you. The information contained in this prospectus, in any applicable prospectus supplement, and in the documents incorporated by reference herein or therein is accurate only as of the date such information is presented. Our business, financial condition, results of operations and prospects may have changed since that date. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus and any accompanying prospectus supplement does not constitute an offer to sell or the solicitation of an offer to buy any securities other than the registered securities to which they relate, nor does this prospectus and any accompanying prospectus supplement constitute an offer to sell or the solicitation of an offer to buy securities in any jurisdiction to any person to whom it is unlawful to make such offer or solicitation in such jurisdiction. This prospectus may not be used to offer or sell our securities unless accompanied by a prospectus supplement relating to the offered securities.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt> </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus does not contain all of the information included in the registration statement. For a more complete understanding of the offering of the securities, you should refer to the registration statement, including its exhibits. The registration statement containing this prospectus, including the exhibits to the registration statement, provides additional information about us and the securities offered pursuant to this prospectus. The registration statement, including the exhibits, can be read on the SEC&#8217;s website or at the SEC&#8217;s offices mentioned under the heading &#8220;Where You Can Find More Information.&#8221;</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may sell the securities to or through underwriters, dealers or agents or directly to purchasers. We and our agents reserve the sole right to accept or reject in whole or in part any proposed purchase of securities. The prospectus supplement, which we will provide to you each time we offer securities, will set forth the names of any underwriters, dealers or agents involved in the sale of the securities, and any applicable fee, commission or discount arrangements with them. See &#8220;Plan of Distribution.&#8221;</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Unless we state otherwise or the context indicates otherwise, references to the &#8220;Company&#8221;, &#8220;VolitionRx&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, and &#8220;our&#8221; in this prospectus refer to VolitionRx Limited and its subsidiaries. Our fiscal year ends on December 31 of each calendar year. Nucleosomics<SUP>&#174;</SUP>, NuQ<SUP>&#174;</SUP> and HyperGenomics<SUP>&#174;</SUP> and their respective logos are trademarks and/or service marks of VolitionRx Limited and its subsidiaries. All other trademarks, service marks and trade names referred to in this prospectus are the property of their respective owners.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977352 /><FONT style=font-size:10pt><B>THE COMPANY</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><A name=P254131970 /><FONT style=font-size:10pt>We are a clinical stage life sciences company focused on developing blood-based diagnostic tests that meet the need for accurate, fast, inexpensive and scalable tests for detecting and diagnosing cancer and other diseases. We have developed twenty blood assays to date that can be used individually or in combination to generate a profile which forms the basis of a blood test for a particular cancer or disease. We intend to commercialize our products in the future through various channels within the European Union, the United States and eventually throughout the rest of the world.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>1</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We do not anticipate earning significant revenues until such time as we are able to fully market our intended products on the clinical in-vitro diagnostics, or IVD, market. For this reason, our auditors stated in their report on our most recent audited financial statements that our losses and negative cash flow from operations raise substantial doubt that we will be able to continue as a going concern without further financing. Our ability to continue as a going concern is dependent upon our ability to successfully accomplish our plan of operations described herein, obtain financing and eventually attain profitable operations.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We are a Delaware corporation. Our executive offices are located at 1 Scotts Road, #24-05 Shaw Centre, Singapore 228208, and our telephone number is +1 (646) 650-1351. We maintain a website at <I>www.volitionrx.com</I>. The information contained on our website is not incorporated by reference into this prospectus. We have included our website address only as an inactive textual reference and do not intend it to be an active link to our website.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977353 /><FONT style=font-size:10pt><B>RISK FACTORS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Before making an investment decision, you should carefully consider the risks described under &#8220;Risk Factors&#8221; in the applicable prospectus supplement and in our most recent Annual Report on Form 10-K, or any updates in our Quarterly Reports on Form 10-Q, together with all of the other information appearing in this prospectus or incorporated by reference into this prospectus and any applicable prospectus supplement, in light of your particular investment objectives and financial circumstances. The risks so described are not the only risks facing our company. Additional risks not presently known to us or that we currently deem immaterial may also impair our business operations. Our business, financial condition or results of operations could be materially adversely affected by any of these risks. The trading price of our securities could decline due to any of these risks, and you may lose all or part of your investment. </FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977354 /><FONT style=font-size:10pt><B>CAUTIONARY NOTE REGARDING FORWARD-LOOKING INFORMATION</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>This prospectus and the documents incorporated by reference herein include forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;) and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). All statements other than statements of historical fact contained in this prospectus, including statements regarding estimates, future events, our future financial performance, business strategy and plans and objectives of management for future operations, including with respect to us specifically and the cancer diagnostics industry in general, are forward-looking statements. We have attempted to identify estimates and forward-looking statements by terminology including &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;can,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;predicts,&#8221; &#8220;should,&#8221; or &#8220;will&#8221; or the negative of these terms or other comparable terminology. Although we do not make estimates or forward-looking statements unless we believe we have a reasonable basis for doing so, we cannot guarantee their accuracy. Our estimates and forward-looking statements are based on our current assumptions and expectations about future events and trends, which affect or may affect our business, strategy, operations or financial performance. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, which may cause our or our industry&#8217;s actual results, levels of activity, performance or achievements to vary from those expressed or implied by these estimates and forward-looking statements.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Factors that could cause or contribute to such differences in results and outcomes include, but are not limited to, those discussed under the section entitled &#8220;Risk Factors&#8221; in this prospectus and in any documents incorporated by reference herein. Readers should carefully review this information as well as other risks and uncertainties described in other filings with the SEC that we may make after the filing date of this prospectus.</FONT></P>
<P style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time and it is not possible for us to predict all risk factors, nor can we address the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause our actual results to differ materially from those contained in any estimates or forward-looking statements. All estimates and forward-looking statements speak only as of the date they were made, and, except to the extent required by applicable law or regulation, we undertake no obligation to update or to review any estimate and/or forward-looking statement. In light of these risks and uncertainties, we cannot assure you that the estimates or forward-looking statements contained in this prospectus will in fact occur. You should not place undue reliance on these estimates and forward-looking statements.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977355 /><FONT style=font-size:10pt><B>USE OF PROCEEDS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We intend to use the net proceeds we receive from the sale of our securities offered by us hereby for working capital and other general corporate purposes. We may set forth additional information regarding the use of proceeds from the sale of securities we offer under this prospectus in a prospectus supplement relating to the specific offering. We have not determined the amount of net proceeds to be used specifically for the foregoing purposes. As a result, our management will have broad discretion in the allocation of the net proceeds.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>2</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977356 />&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>GENERAL DESCRIPTION OF SECURITIES</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We, directly or through agents, dealers or underwriters designated from time to time, may offer, issue and sell, together or separately, in one or more offerings, up to $50,000,000 in the aggregate, inclusive of any exercise price thereof, of: </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:34.55pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>shares of our common stock, par value $0.001 per share; </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>shares of our preferred stock, par value $0.001 per share; </FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>warrants to purchase shares of our common stock and/or preferred stock; or</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any combination of the foregoing, either individually or as units consisting of one or more of the foregoing, each on terms to be determined at the time of sale.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The common stock, the preferred stock and the warrants are collectively referred to herein as the securities. This prospectus provides you with a general description of the securities we may offer. Each time we offer securities, we will provide you with a prospectus supplement that describes the specific amounts, prices and terms of the securities we offer. The securities involve various risks that we will describe in the section entitled &#8220;Risk Factors&#8221; that will be included in each prospectus supplement.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977357 /><FONT style=font-size:10pt><B>DESCRIPTION OF CAPITAL STOCK</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Common Stock</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We have authority under our amended and restated certificate of incorporation to issue up to 100,000,000 shares of our common stock, par value $0.001 per share. As of September 3, 2015, there were 18,059,715 shares of our common stock issued and outstanding.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Holders of shares of our common stock are entitled to one vote per share held of record on all matters submitted to a vote of stockholders, including the election of directors. The holders are entitled to receive dividends when, as and if declared by our board of directors, in its discretion, out of funds legally available therefor, subject to preferences that may be applicable to any outstanding shares of our preferred stock. In the event of our liquidation, dissolution or winding up, the holders of our common stock are entitled to share ratably in all of our assets remaining after payment of liabilities and after payment of any preferential amounts to which holders of shares of any series of our preferred stock that may be outstanding in the future, may be entitled. The holders of our common stock have no preemptive or other subscription rights, and there are no conversion rights or redemption or sinking fund provisions with respect to such shares. All of the outstanding shares of our common stock are, and the shares of our common stock when issued will be, fully paid and non-assessable.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Preferred Stock</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We have authority under our restated certificate of incorporation, as amended, to issue up to 1,000,000 shares of our preferred stock, par value $0.001 per share, all of which are presently undesignated. As of September 3, 2015, there were no shares of our preferred stock issued and outstanding.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Our board of directors may from time to time issue the undesignated preferred stock in one or more series and, in connection with the creation of each such series, fix the number of shares of such series and the designations, powers, preferences, rights, qualifications, limitations, and restrictions of such series, to the fullest extent permitted under the Delaware General Corporation Law. Any preferred stock issued by us in the future may decrease the amount of earnings and assets available for distribution to holders of our common stock or adversely affect the rights and power, including voting rights, of the holders of our common stock without any further vote or action by our stockholders. In addition, the rights of holders of our common stock will be subject to, and may be adversely affected by, the rights of the holders of any preferred stock that may be issued by us in the future.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>3</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977358 />&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>DESCRIPTION OF THE WARRANTS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may issue warrants to purchase shares of our common stock and/or our preferred stock. The warrants may be issued independently or together with shares of our common stock and/or our preferred stock and may be attached to or separate from the shares of our common stock and/or our preferred stock. The warrants are to be issued under warrant agreements to be entered into between us and/or a bank or trust company, as warrant agent, all as shall be set forth in the prospectus supplement relating to warrants being offered pursuant to such prospectus supplement. The following description of the warrants will apply to the warrants offered by this prospectus unless we provide otherwise in the applicable prospectus supplement. The applicable prospectus supplement for a particular series of warrants may specify different or additional terms. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Warrants</B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The applicable prospectus supplement will describe the following terms of warrants offered:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:34.5pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the title of the warrants;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the securities for which the warrants are exercisable;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the price or prices at which the warrants will be issued;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the provisions, if any, for changes to or adjustments in the exercise price;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the provisions, if any, for call rights or put rights relating to the warrants or the underlying securities;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the date on which the right to exercise the warrants shall commence and the date on which the right will expire;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>if applicable, the number of warrants issued with each share of our common stock and/or our preferred stock;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>if applicable, the date on and after which the warrants and the related common stock and/or preferred stock will be separately transferable;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>a discussion of any material federal income tax consequences of holding or exercising the warrants; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any other terms of the warrants, including terms, procedures and limitations relating to the exchange and exercise of the warrants.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:34.5pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Holders of warrants will not be entitled, by virtue of being such holders, to vote, consent, receive dividends, receive notice as stockholders with respect to any meeting of stockholders for the election of our directors or any other matter, or to exercise any rights whatsoever as our stockholders. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The exercise price payable and the number of shares of our common stock and/or our preferred stock purchasable upon the exercise of each warrant will be subject to adjustment in certain events, including the issuance of a stock dividend to holders of our common stock and/or our preferred stock or a stock split, reverse stock split, combination, subdivision or reclassification of our common stock and/or our preferred stock. In lieu of adjusting the number of shares of our common stock and/or our preferred stock purchasable upon exercise of each warrant, we may elect to adjust the number of warrants. No fractional shares will be issued upon exercise of the warrants, but we will pay the cash value of any fractional shares otherwise issuable. Notwithstanding the foregoing, in case of any consolidation, merger, or sale or conveyance of our property as an entirety or substantially as an entirety, the holder of each outstanding warrant shall have the right to the kind and amount of shares of stock and other securities and property, including cash, receivable by a holder of the number of shares of our common stock and/or our preferred stock into which the warrant was exercisable immediately prior to such transaction. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>Exercise of Warrants </B></FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:34.5pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Each warrant will entitle the holder to purchase for cash such shares of our common stock and/or our preferred stock at such exercise price as shall be in each case be set forth in, or be determinable as set forth in, the prospectus supplement relating to the warrants offered thereby. Warrants may be exercised at any time up to the close of business on the expiration date set forth in the prospectus supplement relating to the warrants offered thereby. After the close of business on the expiration date, unexercised warrants will become void. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The warrants may be exercised as set forth in the prospectus supplement relating to the warrants offered. Upon receipt of payment and the warrant certificate properly completed and duly executed at the corporate trust office of the warrant agent or any other office indicated in the prospectus supplement, we will, as soon as practicable, forward the shares of our common stock and/or our preferred stock purchasable upon such exercise. If less than all of the warrants represented by such warrant certificate are exercised, a new warrant certificate will be issued for the remaining warrants.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>4</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977359 />&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>PLAN OF DISTRIBUTION</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may sell our securities from time to time in any manner permitted by the Securities Act of 1933, as amended, or the Securities Act, including any one or more of the following ways:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>through agents;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>to or through underwriters;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>to or through broker-dealers (acting as agent or principal);</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>in &#8220;at the market&#8221; offerings, within the meaning of Rule 415(a)(4) of the Securities Act, to or through a market maker or into an existing trading market, on an exchange or otherwise; and/or</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>directly to purchasers, through a specific bidding or auction process or otherwise.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The securities may be sold at a fixed price or prices, which may be changed, at market prices prevailing at the time of sale, at prices relating to the prevailing market prices or at negotiated prices. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Offers to purchase offered securities may be solicited by agents designated by us from time to time. Any agent involved in the offer or sale of the offered securities in respect of which this prospectus is delivered will be named, and any commissions payable by us will be set forth, in the applicable prospectus supplement. Unless otherwise set forth in the applicable prospectus supplement, any agent will be acting on a reasonable best efforts basis for the period of its appointment. Any agent may be deemed to be an underwriter, as that term is defined in the Securities Act, of the offered securities so offered and sold.</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We will set forth in a prospectus supplement the terms of the offering of our securities, including:</FONT></P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the name or names of any agents, underwriters or dealers;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the purchase price of our securities being offered and the proceeds we will receive from the sale;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any over-allotment options under which underwriters may purchase additional securities from us;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any agency fees or underwriting discounts and commissions and other items constituting agents&#8217; or underwriters&#8217; compensation;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the public offering price;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any discounts or concessions allowed or reallowed or paid to dealers; and</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>any securities exchanges on which such securities may be listed.</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>If offered securities are sold to the public by means of an underwritten offering, either through underwriting syndicates represented by managing underwriters or directly by the managing underwriters, we will execute an underwriting agreement with an underwriter or underwriters, and the names of the specific managing underwriter or underwriters, as well as any other underwriters, will be set forth in the applicable prospectus supplement. In addition, the terms of the transaction, including commissions, discounts and any other compensation of the underwriters and dealers, if any, will be set forth in the applicable prospectus supplement, which prospectus supplement will be used by the underwriters to make resales of the offered securities. If underwriters are utilized in the sale of the offered securities, the offered securities will be acquired by the underwriters for their own account and may be resold from time to time in one or more transactions, including:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>transactions on the NYSE MKT or any other organized market where the securities may be traded;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>in the over-the-counter market;</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>in negotiated transactions; or</FONT>&nbsp;</P>
<P style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>under delayed delivery contracts or other contractual commitments.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may grant to the underwriters options to purchase additional offered securities to cover over-allotments, if any, at the public offering price with additional underwriting discounts or commissions, as may be set forth in the applicable prospectus supplement. If we grant any over-allotment option, the terms of the over-allotment option will be set forth in the applicable prospectus supplement.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may authorize agents or underwriters to solicit offers by certain types of institutional investors to purchase securities from us at the public offering price set forth in the prospectus supplement pursuant to delayed delivery contracts providing for payment and delivery on a specified date in the future. We will describe the conditions to these contracts and the commissions we must pay for solicitation of these contracts in the prospectus supplement.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>5</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We may indemnify agents, underwriters and dealers against specified liabilities, including liabilities incurred under the Securities Act, or to contribution by us to payments they may be required to make in respect of such liabilities. Agents, underwriters or dealers, or their respective affiliates, may be customers of, engage in transactions with or perform services for us or our respective affiliates, in the ordinary course of business. </FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Unless otherwise specified in the applicable prospectus supplement, each class or series of securities will be a new issue with no established trading market, other than our common stock, which is traded on the NYSE MKT. We may elect to list any other class or series of securities on any exchange and, in the case of our common stock, on any additional exchange. However, unless otherwise specified in the applicable prospectus supplement, we will not be obligated to do so. It is possible that one or more underwriters may make a market in a class or series of securities, but the underwriters will not be obligated to do so and may discontinue any market making at any time without notice. We cannot give any assurance as to the liquidity of the trading market for any of the offered securities.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Any underwriter may engage in over-allotment, stabilizing transactions, short-covering transactions and penalty bids in accordance with Regulation M under the Securities Exchange Act of 1934, as amended. Over-allotment involves sales in excess of the offering size, which create a short position. Stabilizing transactions permit bids to purchase the underlying security so long as the stabilizing bids do not exceed a specified maximum price. Syndicate-covering or other short-covering transactions involve purchases of the securities, either through exercise of the over-allotment option or in the open market after the distribution is completed, to cover short positions. Penalty bids permit the underwriters to reclaim a selling concession from a dealer when the securities originally sold by the dealer are purchased in a stabilizing or covering transaction to cover short positions. Those activities may cause the price of the securities to be higher than it would otherwise be. If commenced, the underwriters may discontinue any of the activities at any time.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>To comply with the securities laws of certain states, if applicable, the securities offered by this prospectus will be offered and sold in those states only through registered or licensed brokers or dealers.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>In compliance with guidelines of the Financial Industry Regulatory Authority, or FINRA, the maximum consideration or discount to be received by any FINRA member or independent broker dealer may not exceed 8% of the aggregate amount of the securities offered pursuant to this prospectus and any applicable prospectus supplement.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977360 /><FONT style=font-size:10pt><B>LEGAL MATTERS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The validity of the securities being offered hereby will be passed on by Stradling Yocca Carlson &amp; Rauth, a Professional Corporation, Newport Beach, California.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977361 /><FONT style=font-size:10pt><B>EXPERTS</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The consolidated financial statements of VolitionRx Limited as of December 31, 2014 and 2013 and for each of the years in the two-year period ended December 31, 2014 have been incorporated by reference herein and in the registration statement in reliance upon the reports of Sadler, Gibb and Associates, LLC, our independent registered public accountant, incorporated by reference herein, and upon the authority of said firm as experts in accounting and auditing. The report of Sadler, Gibb and Associates, LLC dated March 18, 2015 notes that our losses and negative cash flow from operations raise substantial doubt that we will be able to continue as a going concern without further financing. </FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977362 /><FONT style=font-size:10pt><B>INCORPORATION OF CERTAIN INFORMATION BY REFERENCE</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>The SEC allows us to &#8220;incorporate&#8221; into this prospectus information that we file with the SEC in other documents. This means that we can disclose important information to you by referring to other documents that contain that information. Any information that we incorporate by reference into this prospectus is considered part of this prospectus.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>Information contained in this prospectus and information that we file with the SEC in the future and incorporate by reference in this prospectus automatically modifies and supersedes previously filed information, including information in previously filed documents or reports that have been incorporated by reference in this prospectus, to the extent the new information differs from or is inconsistent with the old information. Any statement so modified will be deemed to constitute a part of this prospectus only as so modified, and any statement so superseded will be deemed not to constitute a part of this prospectus.</FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>6</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We incorporate by reference, as of their respective dates of filing, the documents listed below that we have filed with the SEC and any additional documents that we may file in the future with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act, including any documents filed after the date of the initial registration statement of which this prospectus is a part until the offering of the security covered by this prospectus has been completed, other than, in each case, documents or information deemed to have been &#8220;furnished&#8221; and not &#8220;filed&#8221; in accordance with SEC rules:</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our Annual Report on Form 10-K for the year ended December 31, 2014, as filed with the SEC on March 18, 2015;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our Quarterly Reports on Form 10-Q for the fiscal quarter ended March 31, 2015, as filed with the SEC on May 12, 2015, and for the fiscal quarter ended June 30, 2015, as filed with the SEC on August 11, 2015;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>our Current Reports on Form 8-K as filed with the SEC on each of January 2, 2015, February 6, 2015 and August 17, 2015;</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:-18pt;margin-left:36pt'><KBD style='position:absolute;text-indent:0;font:10pt Symbol'>&#61623;</KBD><KBD style=margin-left:18pt></KBD><FONT style=font-size:10pt>the description of our common stock contained in our registration statement on Form 8-A as filed with the SEC on February 3, 2015, as updated or amended in any amendment or report filed for such purpose.</FONT>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We hereby undertake to provide without charge to each person, including any beneficial owner, to whom this prospectus is delivered, upon written or oral request, a copy of any or all documents that are incorporated by reference into this prospectus, but not delivered with the prospectus, other than exhibits to such documents unless such exhibits are specifically incorporated by reference into the documents that this prospectus incorporates. To request such materials, please contact Mr. Rodney Rootsaert, our Corporate Secretary at c/o Corporate Secretary, VolitionRx Limited, 1 Scotts Road, #24-05 Shaw Centre, Singapore, 228208, by email at notice@volitionrx.com, or by facsimile at +32 8172 5651. These documents are also available free of charge through the Investors section on our website at </FONT><FONT style='font-size:10pt;border-bottom:1px solid #000000'>http://www.volitionrx.com</FONT><FONT style=font-size:10pt> as soon as practicable after such materials have been electronically filed with, or furnished to, the SEC.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>You should rely only on the information contained in this prospectus, in any accompanying prospectus supplement, or in any document incorporated by reference herein or therein. We have not authorized anyone to provide you with any different information. We take no any responsibility for, and can provide no assurance as to the reliability of, any other information that others may provide to you. The information contained in this prospectus, in any applicable prospectus supplement, and in the documents incorporated by reference herein or therein is accurate only as of the date such information is presented. Our business, financial condition, results of operations and prospects may have changed since that date.</FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><A name=_Toc428977363 /><FONT style=font-size:10pt><B>WHERE YOU CAN FIND MORE INFORMATION</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We have filed a registration statement on Form S-3 with the SEC relating to the common stock, the preferred stock and the warrants offered by this prospectus. This prospectus does not contain all of the information set forth in the registration statement and the exhibits and schedules thereto. We have omitted parts of the registration statement, as permitted by the rules and regulations of the SEC. Statements contained in this prospectus as to the contents of any contract or other document referred to are not necessarily complete and in each instance reference is made to the copy of such contract or other document filed as an exhibit to the registration statement, each such statement being qualified in all respects by such reference. For further information with respect to us and the common stock, the preferred stock and the warrants offered hereby, reference is made to such registration statement, exhibits and schedules.</FONT></P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'>&nbsp;</P>
<P align=justify style='font:10pt Times New Roman;margin:0;text-indent:36pt'><FONT style=font-size:10pt>We are subject to the information and periodic reporting requirements of the Exchange Act, and in accordance therewith file periodic reports, current reports, proxy statements and other information with the SEC. Such periodic reports, current reports, proxy statements, other information and a copy of the registration statement on Form S-3 may be inspected by anyone without charge and copies of these materials may be obtained upon the payment of the fees prescribed by the SEC, at the Public Reference Room maintained by the SEC at 100 F Street, N.E., Washington, D.C. 20549. The public may obtain information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. The registration statement on Form S-3 and the periodic reports, current reports, proxy statements and other information filed by us are also available through the Internet web site maintained by the SEC at the following address: http://www.sec.gov. </FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0'>7</P>
<HR style='page-break-after:always;border:0;height:3pt;background-color:#909090;margin:8pt 0'><HR style='border:0;height:0;margin:14pt 0 0 0'><P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><IMG src=f424b5030718_424b56.jpg width=148 height=117 alt='Picture 5' title='Picture 5'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt><B>VOLITIONRX LIMITED</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt><B> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares of Common Stock</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'><FONT style=font-size:10pt><B>PROSPECTUS SUPPLEMENT</B></FONT></P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0;text-indent:3.75pt'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><I>Sole Book-Running Manager</I></FONT></P>
<P align=center style='font:18pt Times New Roman;margin:0'><B>Oppenheimer &amp; Co. </B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><I>Co-Manager</I></FONT></P>
<P align=center style='font:14pt Times New Roman;margin:0'><B>National Securities Corporation</B></P>
<P align=center style='font:10pt Times New Roman;margin:0'>&nbsp;</P>
<P align=center style='font:10pt Times New Roman;margin:0'><FONT style=font-size:10pt><B>March  &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  , 2018</B></FONT></P>
<HR style='border:0;height:0;margin:14pt 0 0 0'></DIV>
</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>f424b5030718_424b51.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 f424b5030718_424b51.jpg
M_]C_X0@&17AI9@  34T *@    @ # $   ,    !")@   $!  ,    !!J0
M  $"  ,    #    G@$&  ,    !  (   $2  ,    !  $   $5  ,    !
M  ,   $:  4    !    I $;  4    !    K $H  ,    !  (   $Q  (
M   F    M $R  (    4    VH=I  0    !    \    2@ "  (  @ 'H2
M   G$  >A(   "<0061O8F4@4&AO=&]S:&]P($5L96UE;G1S(#$R+C @5VEN
M9&]W<P R,#$X.C S.C X(#$Q.C4U.C0R      20   '    !# R,C&@ 0 #
M     0 !  "@ @ $     0   '"@ P $     0  !>0         !@$#  ,
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M/\(FZW]?VM@B/"-/T1T_U<G_T.[R:W'JCGR?Y_&GTPXD -N_G?8ZO:YS]O\
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M]ECD^E]'_C/YO_KR+?A9+\\W"IAK]>ES7#:' ,KL#K;'>U[]MC]C:U+T,_\
M8/V>/U[T-D;A_.;8^G]'Z2;7Y_M;!D.$:CY:W_U<G__9_^T.P%!H;W1O<VAO
M<" S+C  .$))300$       /' %:  ,;)4<< @   EDD #A"24T$)0
M$,@C+,G[S/)IN*D@1P%6;,(X0DE-!#H      '<    0     0      "W!R
M:6YT3W5T<'5T    !     !0<W138F]O; $     26YT965N=6T     26YT
M90    !#;')M    #W!R:6YT4VEX=&5E;D)I=&)O;VP     "W!R:6YT97).
M86UE5$585     $    X0DE-!#L      ;(    0     0      $G!R:6YT
M3W5T<'5T3W!T:6]N<P   !(     0W!T;F)O;VP      $-L8G)B;V]L
M  !29W--8F]O;       0W)N0V)O;VP      $-N=$-B;V]L      !,8FQS
M8F]O;       3F=T=F)O;VP      $5M;$1B;V]L      !);G1R8F]O;
M    0F-K9T]B:F,    !        4D="0P    ,     4F0@(&1O=6) ;^
M          !'<FX@9&]U8D!OX            $)L("!D;W5B0&_@
M    0G)D5%5N=$8C4FQT                0FQD(%5N=$8C4FQT
M        4G-L=%5N=$8C4'AL0&D            *=F5C=&]R1&%T86)O;VP!
M     %!G4'-E;G5M     %!G4',     4&=00P    !,969T56YT1B-2;'0
M              !4;W @56YT1B-2;'0               !38VP@56YT1B-0
M<F- 60       #A"24T#[0      $ #(     0 ! ,@    !  $X0DE-!"8
M      X             /X   #A"24T$#0      !    !XX0DE-!!D
M  0    >.$))30/S       )           ! #A"24TG$       "@ !
M      (X0DE- _4      $@ +V9F  $ ;&9F  8       $ +V9F  $ H9F:
M  8       $ ,@    $ 6@    8       $ -0    $ +0    8       $X
M0DE- _@      '   /____________________________\#Z     #_____
M________________________ ^@     ____________________________
M_P/H     /____________________________\#Z   .$))300(       0
M     0   D    )      #A"24T$'@      !      X0DE-!!H      T<
M   &              7D    <     D 1 !O &, =0!M &4 ;@!T #0    !
M                          $              '    7D
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   7D     %)G:'1L
M;VYG    <     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   %Y     !29VAT;&]N9P   '     #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!0       0    !.$))300,      :4     0    P
M  "@    )   %H    9X !@  ?_8_^T #$%D;V)E7T--  '_[@ .061O8F4
M9(     !_]L A  ," @("0@,"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,# P,
M#!$,# P,# P,# P,# P,# P,# P,# P,# P,# P, 0T+"PT.#1 .#A 4#@X.
M%!0.#@X.%!$,# P,#!$1# P,# P,$0P,# P,# P,# P,# P,# P,# P,# P,
M# P,# S_P  1" "@  P# 2(  A$! Q$!_]T !  !_\0!/P   04! 0$! 0$
M         P ! @0%!@<("0H+ 0 !!0$! 0$! 0         !  (#! 4&!P@)
M"@L0  $$ 0,"! (%!P8(!0,,,P$  A$#!"$2,05!46$3(G&!,@84D:&Q0B,D
M%5+!8C,T<H+10P<EDE/PX?%C<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-U
MX_-&)Y2DA;25Q-3D]*6UQ=7E]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$
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M?LV[T(&R(W>EM_T?YB>XM'57-:6!QNQRZ:S)]E_^$%GO?[/]&ST?^%2VU_\
M-?;)]/[-SZ;9B/\ N/ZGI?\ 6_63/X_M;)/I&_RC_P!)S?_0[J\3UAQ:6B+L
M?=N$?X/( V?O/U;_ .34MH_YJ[?T4?98Y/I?1_XS^;_Z\BWX62_/-PJ8:_7I
M<UPVAP#*[ ZVQWM>_;8_8VM2]#/_ &#]GC]>]#9&X?SFV/I_1^DFU^?[6P9#
MA&H^6M_]7)__V3A"24T$(0      >P    $!    & !! &0 ;P!B &4 ( !0
M &@ ;P!T &\ <P!H &\ <  @ $4 ; !E &T 90!N '0 <P   !T 00!D &\
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M6B 'S@ "  D !@ Q  !A8W-P35-&5     !)14,@<U)'0@
M    ]M8  0    #3+4A0("
M                         !%C<')T   !4    #-D97-C   !A    &QW
M='!T   !\    !1B:W!T   "!    !1R6%E:   "&    !1G6%E:   "+
M !1B6%E:   "0    !1D;6YD   "5    '!D;61D   "Q    (AV=65D   #
M3    (9V:65W   #U    "1L=6UI   #^    !1M96%S   $#    "1T96-H
M   $,     QR5%)#   $/   " QG5%)#   $/   " QB5%)#   $/   " QT
M97AT     $-O<'ER:6=H=" H8RD@,3DY."!(97=L971T+5!A8VMA<F0@0V]M
M<&%N>0  9&5S8P         2<U)'0B!)14,V,3DV-BTR+C$
M !)S4D="($E%0S8Q.38V+3(N,0
M                                6%E:(        /-1  $    !%LQ8
M65H@                     %A96B        !OH@  ./4   .06%E:(
M     &*9  "WA0  &-I865H@        )*    ^$  "VSV1E<V,
M%DE%0R!H='1P.B\O=W=W+FEE8RYC:               %DE%0R!H='1P.B\O
M=W=W+FEE8RYC:
M              !D97-C         "Y)14,@-C$Y-C8M,BXQ($1E9F%U;'0@
M4D="(&-O;&]U<B!S<&%C92 M('-21T(              "Y)14,@-C$Y-C8M
M,BXQ($1E9F%U;'0@4D="(&-O;&]U<B!S<&%C92 M('-21T(
M                9&5S8P         L4F5F97)E;F-E(%9I97=I;F<@0V]N
M9&ET:6]N(&EN($E%0S8Q.38V+3(N,0              +%)E9F5R96YC92!6
M:65W:6YG($-O;F1I=&EO;B!I;B!)14,V,3DV-BTR+C$
M                 '9I97<      !.D_@ 47RX $,\4  /MS  $$PL  UR>
M     5A96B       $P)5@!0    5Q_G;65A<P         !
M             H\    "<VEG(     !#4E0@8W5R=@        0     !0 *
M  \ %  9 !X (P H "T ,@ W #L 0 !% $H 3P!4 %D 7@!C &@ ;0!R '<
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M P,# P,# P,# P,# P,# P,# P,# P,# P,# P,# P/_P  1" 7D ' # 1$
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M+9">.FEQFX\W3Y^NW%245?4&+ I3P+]MD0MN6=AGAO7EEABAK0+X8(#4+'4
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MD4K%6LW^H/KM^;6_/M1;O"C:IUU"J^9'XAZ>O#Y5KTFN?$B7ZYCJ@MPSS14
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M-=0F23PG@D=KI$N7:4R7.J64MUL#?RQ^RL3VWT[VAOCJ^@S>&^,$W?6^-O\
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MD=7A_P LS>_S5WYU[W!E_GQL^BZ^[FQ7=U;M? ;)V]MG#839.*ZRI>H]FY3
MU.R\_@JW-0YVBFRE5FZF?()N3*^'(S9#&M51''C'8^6>39]WO>6Q+NMNML[R
M.P"NK@@TX4)I7B:DY-!0  8>?>$V_P!A]H]R%LO:J[DOK;Z*W9[J9+Q)9I&:
M9G5HYHXA&%9@J4C6J*#EB[-8WD,:]0\$ D=816TM1)I$926.GD^X1)@6#@!E
M5T*,#K":P\?DC8RMH:ZOD?YU/^K[>HDMP+6X$]I9:L4U^-2E1QTD^F*4X'%#
M1A67VE_* ^!??7;79_<O?/4>Y^U-^]H9O!9+-5^2[1[3VEB<%1X#:&,V9B]M
M[?P76N3V_3MCXAB_O5J,C#6UQJ*JI+UAH_!!2A_<.78+VYDN;F#ZIG QXAB&
M/F& ;  X?S.<D.2?O>>]OMKL?]6>1.8S86L*D&+]WV,U%9]?QW%G*S'62?BP
M,"BXZ4/Q;_E@_#'X?]RU'</QMZ[S76NX,CUUNSK3)8U.Q-\[QVUN+;^Y-TX7
M=T]?]CV)D\W505,%3@J-(9L974U-IEG6III)# :91L>R0[<&DAV[P2206^H+
MTR*8+,.'E\O+-0W[G_>*]UO=W8]KV_GC?_KHH[MY$'T5I$2[1LC"L%O"5  P
M.'<3Z4L:JPS> '0DGGB$:/"D_C>.)V$J,P(#)&)&'];:;W(]GECXEO)*RVY1
M6&6$OQ"HJ*>5*_GU!-U!>R-<265[H,25D_14]IX?$<]WH#]E.M?'^=QM#XH[
MKWG\44^8_P B^Q>D.DGR'=-%6XGIW*TDV]\WV748; 3[&[*RFSJO#YFKR.%V
MYAZ?<>(K<AA\945F/J]Q8^E\;460K)8XSYUGY8N;8+S!=F"+6PHJR,Q:F#1!
MJ.E2PU '3JIC5G/G[F-Y]X7Q[^X^[[9)?[M' AUR?1(J0^(X=(Y+S1'')+($
M/A"1&E\)I*,(24J3Z7Z#_D?[:[[^,>X_C5\W_D7V3W7A_DU\6/[A;'S/6&7R
M6'S^Y7[\V\8(<NU7LC9,5&LL:2F;)1YFF:A0-624&4>'^%5H&Y?M/;^"^7^J
M]W)<3L5!4QS1@+7C66,!O0!6%#G.1UDS[V<R??SW+VBYBM/=?EVU7:19R_4R
MQW6S!T0&JLBVMT^=="X$;E@3P/<-W/'*KU%4_P!B:93]UI=Y0THE9F-3'+$
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MAHL=MVJ$5'41Y"HJ*_)T])35&!W#&6_\SV/+*QR;D75':042N= %2=(-<D
MXH:@XTG,+V#]B_<#WKY0WVUY7: 3VT<)+7"0L5,TTFE(V=NP,BN[2@5UA4,9
M\02Q(7KK_A1'\9N[^P^J.H^M^F?D)0[W[?[2ZGZMP#[XHME8_!XNG[,[$Q^Q
M<MN/)R[3S.==6Q4&0J\E]H: "I%*M,L]'%,*RF2VGN)L'-5W!8[0TGC1/7*&
MAP.)-%%.(XUI2@R0)?<K^[T]^N1.0=[YQYAN+8V<-B96,9@+H$J*T,BDUKW
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MMR8SE'-F:[-U%3D3F,GX<C_$,9]W *!<;0R5L$O-KV9'-=H+=@ 5"R1.*4%
M#&S4J!4@L2"?+ &'OO\ ;7[<<O\ /JVOM=N+[A92V-LJ7,D4T<FLAV<M%,D?
MPD@*/#34M&);47:P^O.15KRU$T<*AV^Y@@@ED*Z&4C[=4<Z;_K]!]-_T_J40
MQQV[VC>&,DBJYX5& ?G_ *L]0VD5S86IW2ZW#Q[>$,TL/TX7Q% /:'6KKW4-
M5!.*>?6I+_,5^,'\I/)_-;N[>7S4^?W;&Q^]-WS[!S^6ZOZAVAD\ABME;5I>
MG\#M' 8O="[>VCO+Q9*HI,><OZZJAM09&A+4.IQD*_'_ )IV3E;=]XN7WD/&
MJ*K($=F T@!B0$8\5+$D@ $+6AJ>LWW9/<;[W]_[36-O]W/E"WO-JM'N.^;<
M+%9/J&E=Y;A3>7%J^GPY(T(*/&KJ6#J6TJ-?\G[JW^6OU]\U*X?!/Y,=X]U[
MIRGQ9[DAWUB.R>OJC$;?H,"G;/6SX[-P;JR&W-GRM6+,(H*>@&.R*M%-/,9L
M4T1BRI_[=\L\O;5<>-M@; +&NJC D::$T^=:U/# \P#]]/??O>[WR9LD'WH-
MBAL[8WCFW:*YVQSJ,#APYV^61GJ@4I4J4 HU213:!JUE,<:1Z)/&Z-)$P42*
ML,,K7IRZE2[R%% 9T"@DZN-)EM)O\9*R)4<0:^9^5/(#SZYJ,^W)K@D'BP_A
MC[ET'-6U_$U>%"<>750'\QO?/R>D[,Z,^/\ \,LY\?\ J/Y*]K;)[RK-H]]]
MT96D7+X[977M;LO,[_ZYZTP^1VUGX*W,9^LJL/E:S'R1U DQ>!KYS2EZ9*W'
M!OF':N89WBDVB[2W\5CH9HU;25TZ@*\2U0*L&%*XU$$9(^T=C[4[59R[Q[@1
M7-[:T\.VLX=:Z9Y!,1,\JR!Y$BC5W,9:"LC1MK94=']C_D3FZCXG_P MGN[N
M/<VTMRUO>59\(\!NW8&_\7LVFQ?;/:??&3VC68/LK:,%!0PST6Y]I9H'>V$@
MQE*M"*;&9<''1?[C]Q;<HFW\R6]HESOVX"Z%8P%,$4(\3B:-&PU$!B2,@ &H
MI1@2MRQM^];QS+8;&S20VMM/+'HC9O!B1Y-)D+U;1)18JDA@SQUD60F&2WR@
M5HF+R-$HBC\4\4,A<-)5QQUAEFO!$0X<S6T@ AM1 )TH)KC4\  QY_F,'_)U
M"+!MML4@GRFMLXX5/I7C\CTY4:.)YGD2S,@ ?4#JCU70:5X''^Q]N2LIA55.
M!_A\^K^!MB3F:T'ZK*-7Q\/+XL?LSTY^TW3O7__4W^/?NO=>]^Z]TG-SJKX\
M1O5"B#RV%0RF6)"T;1Z9:7R1B;4&*HAU .4?02@(0[E9W%Y:/'!<"V '<3&)
M*BH%*$BA\ZU^7R)CM)==QB=(3-I))"OHIVG)-#CU^7F./6F-MGXS4>7V=BJ[
M<7_"G+#8W=-3M_$5.[8MH=Z97.T./W*\7DS,F.SR=QXR2OIZ>:2I2.MCHJ)J
MJG6&3[82R*@B.YV'=H=OEE3FL^#5B4%LO"O"OC%JTP" ?6F17J GO?[>6]D-
MJN/8%9W%NB+<-O,Z"M$I(8CMI !H"1J0 $@FJ%A=A_);VW%MKJ'Y,8^?Y*P_
M+[*)\N-Y2Y;Y XS(P[EV]O2C;I?8<>U/X'O*FRV66N6/ -BA7TRR0KC<F<AB
MH$JZ6@@RV2'/)EG<V-E*L^[C="_!A#X8' @:M3EM(H""QTG%33K$'[U_-%CS
M!SY;W=ARRW*]H^V6B_0-+J,1 D\1M(BA($KEG5A&AD4B6BEZ=6^Y"C%1!+']
MI]T4D0M1:XQ87*QU/EE*_P":?1,"CK(NG5&2X56D&V<"-:M0-^*GG7T_U?Y1
MB_!;BQ3]YP6/^,1$F(>-76>'%JHM5K\2L/*A/6OO\I/Y>G9G:WRUWYC,-\6_
MCSO[J'Y!MD>T-T_,/L+;?7V\.S.@.Q,#T#@MA]+[&VELK=6Y:>MSN+Q^\=B8
MK.97'5=#-A,[1YN7"UU%3T])D*O+11S5L=US/NCQPE*TUR2%%9D(!1%"LR @
M:$;\0;648#2Q;,GD_P!V>7=I]O[.^W/F.:WW6TF^GDV2**X1/H&?Q9+N2]B@
M,):?QYH$$)6Y@:#ZA6[H556_RJOCS\X>DODI\D=S=^?%OXC_ !EZKW#U=L/9
M44'QEQ>#VUM[L?>77V^MP9C:6^-G;7V[F<G+'2RXO<.;I]PUVY*2AKZAH<"E
M-3J:?)!5W)/+NX;?</\ 7)&@%%I&H4,P+$-0.W'5YTQIQ4'HG^\;S;[=<R<E
M\NVWM=O=[O=TMS=23?6)*KP^+#;@Q%[B&)#1XB56(NJDRG5H:/J^FJ\L\<3Q
M!#J:+];HGD=PZH4UV]2M:R_GW(8F\*;P0*GS_HC&>!K7TZQ75[JP@9XH?%N6
M UKK"T&<UH4/F*"GV]4[_P X+='P"7X\1[2^>^;S=+AJVJW5GNF,1U[D-TGM
MC,=F[=V;D\149/8^#V\J8UJZC2N:GI:O=>K;Z5E32KDBJ2H&C3W-L.4YMM!Y
MAN? C8U("2N:A6 >D9& "_$::\<Z>LSON56OWJ+7G.XWC[NRF3<W@\*_UIM@
MB@LFE1P&EOB4<22)$3';A;@!:K4!J4O?RBMS?R6MO?)S!9'K'/?)W;7R,J<C
M1;=Z.S7RNS.)P>/_ (_O# ;BV?G,-L*3H\Q[:J*W)T]<F,:EWHY:2>?%#" Y
M3S*0-R!MO(-IN'_(3W!KJ9J:T>&6$A.-0TA*YK0#!_AJ:CK(;[YVT??DYI]O
M9H_=F2&3;[-7E(M4VH^&Q=!J<1%)3ZL8PX6C-* @##<>Q<DS>=ZN6-I(GD@:
M:-)F5XF*R0+&SBW"^B0H=)=&^C:@,@KH5A"HOSX\/S/'KE'9?4;?LZ0;X>_6
MV?VD5T5R!_JR.G^E2SN[K:1E +7OJ0-Z.!P./=9&[ H.!_A\^G1!9I<F>W^)
ME4'XN'EQQU-]L]/]?__5W^/?NO=>]^Z]TEMX)CY<'6PY7U8V6GG6OC$D\+O3
M>$E]$U.Z,I4V:X<&P('-O=)8Y9(F$,/CMY+K$>:_Q&@_F/7I?LTUS%O]D;&3
M1<>(?#&@.&8*V,@J*#/<"#2GSZU@OY>'\M?^7#\O?CZG;.0_E[]E=2XK![FG
MVGUQF.X>Y^^X-^=X=>4NU<9G=J=]Y.CQ%?MK'PG/_P 4?R-AX)L8KTM4,?6F
MC2(+%</MGL$FUR3W>SE6DUE2UQ*.RI*OB4#((IGAP.03T&]T/O5?>J]H^=K/
ME;E'W4BNC!%#-<>%R]LVFWNI4;QK76]K-([VTE8S)J!) TQH6;3<S_+YV5T7
MU;T[D>GNC.G=O='3]3;_ -P;4[AZNP6XJ_?";;[;K</B]TSNG9^:"9'<M'7;
M=K]N9+"9G*PP9";"5&(AR%#B*VEJ,-CY V+8EV[:ULWM?HA&<#Q/%XC5QJ2:
MAE-2<"@\J#"#W1YFYHYSYU;>O<;<?JMTND6;5X$,8DA):.)E2T5+>$$H_P"D
M@4JU2RU;4QY\C+H,$<B1@U,X1O* Z.&1C'&?[*W<*+D&_P!+7(]B!I4MH?%)
M[5%/,>7KQ%>'Y^O0!W"\MD=+,W?T[.: >$9-51PK2B^M21_#6I'1+>POG/\
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MB41HL00"Q.OJI*.G9HT$LLK-%&K.T,:22QLM+Y98PSA7ET1%D4E=6LBRDA7
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MPULFJ@"CC4@#.!DX&2...C#;MNYEWZ5;3DV-I9G#45%1G;2"S!5DH:]I.,D
MC@>L&R>S^MMTILK^ZV^-K[D/9.RJG?VP:G#[DQ>1IM\[!Q_\,6MWML:GI:JH
M^\PJ?QO!R/D*'73*N0H \@:HB#*3<%K>-S0>=!3..-1Q'IQI7'6[C8=WM(YC
MO53<Q]DE5"E6%<,%- =0:OXJ@U]>A1=;DV_M1,O_ "3?V\C @$>M>BIU\3;'
MC'D#USIDTO?_ )M:?^LA/M+_ **Y^?5[3ML$3T)ZF^[=.=?_UM_9OQ_K_P#$
M>]CK5*D'TZ;J[QB*)9'TDS(\2^)Y_)41 RPC[>+UOH91*50@^FY(4'WMLJ3T
MU.U947U/^?JJ+^83V_\ S#=AY[J?8O\ +_Z&V5W#6;HP'9F9[,J-^4DM#C-J
MXW9^7VMCMN46(W?6[CVOAXLCE:?,9B>FQDV3;(SK2/4TT#4]+6M$$>;+B2SM
M8);>,2N'8JK5%33@&#* 2"2*D?,BM1D][&<O^R>Z[JTWO;OTFPV480Q216UQ
M=M*U>]3#!%,PT "C.OA.>S\+'JKWJG>'_"B[IWJ79G5>QOA+\9*K;'7VUHMI
M;!Q^>W=M#[O![4P=,4VGM"@F7N R,N*QR)C:"3+3359AAIVR&2K*T2U50#[+
M?O<XCP4V)/ISP?ZN#@34577J  I3)84%2QR9ZYH]N/[N;<K^WY@VSW3N9[Q&
M , V#?8_$9(Z,=<EOX2R2$%W!'A*S40JM ML7\K'L_Y;]N]6=S[G^9.W]L;4
M[-Q'R%WCLO 8+8\6VI-F8#:&T]D[9Q-=@L)F=J9?/TF7FIMQQYX9>L.?R<E+
ME37XIZBG;'MC,>.-I>[ENWGW&,13,HK&K!@* #X@S G&<FA!&. Q8]]^7^0-
MCY^'^MW-+>;>UG;Z)IEFCDDUZY#JBE2(QC(T#PEK'I:KU+M915/5)=]*(06*
MU#2Z&-D9E$2Q![," WJC<$ J5(-P+;M5:V*QMD_AI_EZ@&.UN[K<5"V/A"O]
MKXP:@]=!(_GC.>M?[YK;T[X[$^2E7B_A1_+9^/WR:[H^-T_49WY\IN\X-DU3
M]99I7RG:F#ZRVFV_IMJU-;F,-3UNWMWXROVYN#(Q8>7*7FQM-62P%XJYNL]_
M>$1[&BSE!1RPC4+4$A=3D$T[352: TH.'6<'M5RC[8ML*_Z]GN!+R[MFX,P%
MO'M5U=>)''X8,[BQ,CHK.&B(,2-*8RZLX%.AQ_EZ=G=AYKY$=DX/YD_"'J[X
MX?.W/=-XW>M7W;L*EVYG6^1W56-W7'M?<\,6^=KPY=: ;5\>QZ>KV]E-Z5M4
MZ5V/JZ>BI:)855?R1%N,<0DWM1$2#I8*"&8-I(U)4DCMJI8T!!  8= 3[Q'+
MO+.P;78/[2<QMS5RW+</!"K0R6!MYQ$'8^!=,)],@\33,T,:.8W0R22QR4N/
M:6  >5!&[R7A0R2)XZB962*7[N+UIK+",E 39K$:2WN0$N;2YF9+9M;H!J-"
M*"M!AJ YKPZQE7]\3:KG<$\&%5H4U(V%&3J6C9XTICJB/^<SLO8%7'T)VS\C
M^C.T_E)\1=ES]JTG;76'4VY]]8G-[3W%D=OT&Z]B_(3.;7VEE,%BJW#;3QNW
M=SX3(5F9RU+)3+GD:G-1>2FJ ESO<0Q6H=HFDBB#-(%+'3VEO$( I15# DL*
M5R<4.7_W8+[>.9+F;8/;*\MK'>+P1I;2W'TZ))^J(WM5EO>$D\K1.L:*^HQ$
M(H+$J4+X8?/G&?+CK'X&_#;HOI/NR/L[X\;G^'0[?[XW5AZ7%];]0XGH;#KE
MNXYJ/L+8HS=9#5;VP. W/L#&K5P8RCS-+FJW'5U=3TU5+2UP9Y;W62^MBB!F
M"!06*!0FFM<@>="JDTU G/J*?>?[N_/GM3?;MS/[AO% =P$X@B$L#27$C2J5
M(CCG:H0R"60*&2,HAC#U&G:;QNJ.69I9WDFGJZ@R1^,P0JU/.T#S013J)K2
MKZFDD4 !8V\:K>2K!S)%W>E?]7^JGY=8-[>"\4RMY.X\_P"(T_D/7[,=*- !
M?_"_^VU$^W=)#D^O7HS12GH3_AZR>]].=?_7W^/?NO=1:L7C5")"))8T;QJK
M6#&UW4JY*@_6RG_:K)J(]U[HD?S"ZN^0?9_6]1'\7ODOG.BNRZ#'YH[;AJMC
M]5[_ .MM[92.>GJ5IM\4&]-O9:O@HYJ>*6ACKL-EJ."DGJ4J):.MFBBHG(]\
MV*_WN!1MEQ]-/"2R,461:D4HRM2H^0./BR%/4M>R_-/(G*?/%K?^XVQC?]K+
MJ);?ZJ[M)  &.N.:T=75E-":AM2@HN@OK%%O5'Q:_P"%%FR.G>J=F;7^6?QM
MZUVEM3KC:&UL)UUO7 ;"W!G.OL/MW 0TV!V+DLU1]69^/(5&*Q\=/1U=<F;K
MO)4Q2E*VJ $SQ=#8>ZUM?+M\=^GAD\#%;U'$T^$^G\1^WK,/<O<C[AMUO%Q?
MV_M7/-=EV(E3F'>0I+.0&56G0 &OF@)J"0!0"X_^7%T)\BNCM@=DU'RR[EVM
MWC\@NXNT<EVCV/N78>V,?MW:&+JJ79> ZKVGA*&2BQF'^XE3;^V,1++(N)QT
M>N1T%+/)%+DZZ6MJV+>=L$E_OEWX\\H"D>'&F% H1H-#0=O <,Y/6&?O-SER
MSS%SHB\A\NMR_M*0HL2M>RWK$AI"P)F[Z:F-*EO,:O(6!5/WVN,R)-'!%,#X
M8'I2TT3AHI TY*-&JJQD+K(I&GZL+HQ[%X'TY*&K9KQ'^''40W,$D=Y'<+>Z
MR#41>"!JP<:SPKZ_+TQU0=\GNH_E'5_)WM9_Y:?SWZ;ZT[]WA@M@;C^2GQ.W
MM5[(W9F*27:6UCA*/O5,/GZ3=F4P]3-AJ[9NVGH\1MS'4=52QXVIGK&G6G66
M*]VAYNN-RG'*$RV\FA1*&,3ZAFF)%.FO:!ITBBBK8ZS,]L_<'V%M^5D@^\_R
M'-N]G$7;:;N'<KVVT3,R+)$R[=X#RJH\61GFFE8,[:8P7KT9WX)_%;Y5]==@
M9OO_ .>'R$Q7R1^068V')U)M$;1VN-D["ZGV/DM[3;JW?28+^[T."Q6:KMR?
MPK:,^6R-3LZBK::3%Q8U*ZOIZ0RD0\F6O.2AOZP35\,5%!#04-" $H:MVDL5
MJ-(&?**??;WE]M-SVS:=I]H^6OW)M[7DY(:]GNI):QKX99KF%GC6']4)$)F!
M,KN55C5K1-VI(V(JEI)YZ"L:*):2>F$DT[R1^J....-D-R0%YD4&_J)74")C
M:;C)<(^U2A#6LH*H0RYH*R$ >9J*''41;;M.V[IN$,VY0^/&Q'B#Q6BTK0FN
MM36E:5TBM*TZUKL!TG_PIBR^'PU15?+[XT[;S51BJ*MJ]N[@VWU.<O@9J['Q
M??83/3[4ZLR>)-51R7A/\.JZJG8F0P530K'KC2_V+W85?J(]XCT/FAMX*C@:
M'L()KDD5J:T-,=9_'W9_NRH[\6,'MO=W%[:C277=]_5=04(777=JI!H2 \:M
MW5"J!09*'I_^>YL3?_1&XOE#\P?CGN#H[%_)/X[?WWVMLZKV-LK.;IQ.6[UV
M[B*[!4NXAL79<EYQ4 KC8MQ0R95E7$I39'[XXZK9CM.?8Y/&YDOX[F+L[1'$
MAPPIE$6N:8+#\^'01YSYX^Z]S-RCO,?M-RY=[9NGTLVF62XO)T50C55EGNG6
MFC6NH1MDU8J!J&S#21^&,4Y,$;4U((?M%,#2P1)%^R *41QH@]051%=AI-Q;
M0)5CJ+1?2@_R=81A0L\'V_\ /O3_ !CTK_P4#_;"WNJGM'5F:I-/4]9/>^J]
M?__0W^/?NO=>]^Z]TG=QL$IH79V10\H&E/(9)7@988-(9&)D:R*$D1F8A5=6
M8>V+F*SDBU7K:%7@:,>.#\-3P] 3Y#/34_[O\%_KEUL01&.\=U/(J10TP-6.
MJR^Z?YO'\NCHG?\ F>L.S_D[MF@W;@X\G2[LVWMG;'8?89P]7C\E7;=RV W)
MD^M\%F*3'5^/GQ\_\2H*^MIZNB55:J1(G!(>O.=O;_;W_=UU=*)3Y!+AZ>NH
MJI ;!4@Y%. J"<A>2OND?>#YSCCYQY-V=WVT!&$DD]C &&A6#J+JYBE>.C*P
ME1&C;-&8*U+!.M>Q-C=J;9QN]^L]Z[6W]L[-0U2X?=^R,Y1[LVIE8\=E*C#5
M$>-W+BO+15<E-64E;352PSAX)4:*:,..#+;#M<T\MSMTOBJRBM P'$YU$FN?
M3J!KRTW3:+R6UWZ PW"RO$4:BN"A- RCX3Q-"!Z5J.E3.9Y?+&CF-V61?NQ;
M5$-#%BJ<+<@%07.D$W.H#21#$%6W!!H/3_9^7'I%!%(FZ1W,EB%0&ID,]<4/
MX!DY(! %:$GRZUN^W5_FX=0_-[YB[S^#7PXZ@WGUWV+D^F\-D]_=@1[>V_F=
MYYW8?2&'BI<NVZ=Y[YP&2S<,#9=\0T] W\%IUQS04M+1YU=RU^2BK?=SYOM]
MXN%Y.MTN=2J9&;PU-$% =4K*30G3@D"A:@)8MGYRE9_=/YZ]M]IVWW_Y\N=I
MFL6NFMK2';=QFCB>>0DK_B=N\8,@!EU$5 <(S-'% J&=^!';W\W7>OREJ-M_
M/SH?973?5@Z+[3RNWZGK#"[8R6VMT=EXOL/8^.P\NZMWX3=6[Y,=54V.K,]_
M \;+44"Y.GDKZL)D?X<LM$=\I7_.ETH3F")8X5+'M\(UR*UT,QQY<//CQZBO
MWWY<^[;L.Q[:?9WF.;?)6NRK":UO;<)&L+Z63ZB**NHGO#:B"!0(*AKILZ:F
M/'J8W-T<R.PBCDT%87,(,+1R:KR^/D:2OZ]5E((TACAOKHQ(^@KIK@FH)X9I
M2F3C)I3K%C=+3<KRTF.Q/X=Y&I:$=A#OPT$RD(H*DY:N:"F>M<K^>UM3I^JI
M>E-[?+/<'?\ AOBYL^D[4@HZ;X]938O]]-U_)/+5NSI>J,!1;;[,2? UJ4^U
M8>R,E)F,PM/3TL5)+2QU)J:Z*EJ8KYRVRW:WB66[;2CL7"Q\68:H\%J' D-0
M,9X8ZSR^Y[SG[KV#7_\ K#K;_P!9$CC:[,RV_P"E9PNRSD&[B$;+]2]J#' S
M,S /I*H2M1?17Q<^,OQ5_F6?#?H+<_5'S?W=\D-L?)# Y.HI<]-UKE^DMR[$
MQM+EX^J/DEL/(;%7"YZ7%T^4IML[ORU#6Y&OIL)CZ;/X*O:NR&+"U02VO:K/
M:]R2W$DLLH-#J154A0X#A@=1%0I /PC4I)*U.1GN][G>Z'NK[!;[ONX;M8WG
M+GTH$2I!X-S!N'B6INK><E5=W1'EAUU\*4^!<6ZI'+X:;U.. %5676%'*U-2
M(X8H8@D5;6U,D-6R:3+KJ8TC\K-,0S1<10VLT^J*6:_8/\G^K\^N1-PM+F#[
M?^?>'2CB:Y8?TO\ [W[T!^FIZ21/65U]"?\ ">L_OW2CK__1W^/?NO=>]^Z]
MTD=[*\F"JXH:<5=1+#/%%2^*68S^:G:&2,)&&%K-ZRRL-&JREK>_/)%%;2RW
M(K$JU<9R*\,=W'^$$_+I5M-QM]MS#M\E\_AGQ?TV[NU@IJ1IQ6G#40 <DBE>
MM-O'_+C^7#\.L3M_X]_.7^6KN+>7R=V;2[FH>W>X]V]7; [0E[]W13[OR6/W
M!\B-M=P]XUN&W+N+%[WRL&6S.*K9*+12">6C5XZ:D+O",^\^V]G8R1;EM[&Y
MK(:MXKK)5V[P\@!8,<@D&E" :4ITCV+V:^\M[BV[>YW(_.4<>V0B-8;>(P6[
MVJPQ1B*U,-LYBMWBA>,/%VM^.5=3$F^K^5=M#=&WNB^S-P4W5.\OCIU=VK\B
M>R>S>E?CQOZ+.8S=?4/7^3QF(VYF<'ENO<_$(-G+GMU8O<F^J7;.'J'Q]+'G
MS]OPS'W*G* L8]N6XMXO"A9FTQ'4"AQ4FOPU(+:!VKJH,#K"[WZ5-VYWC;9=
M[%S=0V]NMY=K!XJW$@5L*\A!E$(I ;C2&F,/B-ESU9[7TP_AA#QU#E2TOAI8
MH*B:4B-E,2I/=")+E&#%5L3J8(6/LZW*Z18G8=V*?;\N'4-R0O+>0P7Y%Y0^
M8\(<"*G21_AIZXKUJ_?-/ISXL?*WY>?(_8GSW_F1[AZ>VMUY6=22=%]!XCMW
MJGK/9^!VID.JES&X>R<M2[DH\AB:O/5V;S.7IHS5TD6X,?0ICY9I_P"$9S#1
MO$.Z;%L&]7D@W]RD,6B2.+Q:*" :MVY<MJ:@-2 *$=ZGKH3[;^YWNC[/>WUI
MO7L1RDLE[>QW%MNM^S>,\D'C*4B1;A2ULD92+Q#"=$D@!5D,$U7;X,;M^(/P
M+^2TO5O5W\T; =B?$RJ^.6<K\YL'N;OCIG,;7Z][:/;-%#L'*;&W#AC0X\R9
M>A;?M3G,5MV)13U,<%9N+6^1VX8S?9KCD.T>+;[:<:%']G),[:22V%;M7N[B
M0O#!?XEZ#'O?M7NU[[\OP<UWO+3V>YF9DDN+6T<^/&MO$#XL;4>L9\-$DD.E
MP62"HAF4;!?2G<W7'>W7F![/ZGW;B^R=EYJLW'B\-O7!U!GPNXLIM7>61V5N
MA\)F((8:>LI4R>(K84R5#(V/K0@GHO+22T[&0D&VV,/U.UBJN2I/<1I%#6KD
M@Y;%!7@03YX3[[9;MM>Z2;1>Q-<7FWQQRLATPL X*H3^$-0$LE2RYU*#T3/Y
ML?,NG^*O9/0^$W-W)T;TOU[N6A[1[#[/W%W7M?.9)LGU_P!/TVW*>OVATY7[
M<W!BI(]ZU]5N"GBQF#;#Y9*JB&0K4$=5CH,5F WN.]WFA7(5$.HLSNN52FJE
M0"6-:Z15CY>8ZFKVQ]K-VYY,DG*^U374KM%%(D,B]K3^+X;2M(X58%*=TWZ<
M<9^,T(?JK?XC_+'^9Q\B\IL;YIYGL_KSK;XZ]F_)O8/473GPUFZXV=N[<'87
M7>8[,/6W;.6J]]T$&'W?0UNS,,FY=XCSQR3UM3MW)5STN*VWYHJ@/;%<76YW
M$]S+IA6BA(AW$J6*U)P:BA/$DD,=*KQG7W@]N?9[D7;$]O>3K*2;>[*W:YW/
M<&DND4.R"18UAF>2 !I&",T78HDA4R2RDZ=G^E@"S5=5X=%M40F>3RS3Q7,T
M4;2/&)!'')+.8T:1@NMBH",EI(LQIC$?S_P=8-3R^!:2H,T+?X?]7[.G>FL%
M"_D@O_MV(]O2,"QIY=,V,>FU#>I/4GVWTJZ__]+?X]^Z]U$K-'C0NJ$":/UO
M(T)A#7226.9;%6"%@"&%[VOS8^Z]T23YD]N?)7HKK7)]C=&_'?!_)5=N8G/9
M+?&T:/M27KOLRJQM+/#_  I=C;/@V9N2/<]4E/\ <R24/WU#/+%'+'0T61K9
M:6F))S#=M9[3-+&GC2!3HBJ5,K?P!@K!2?4XIZF@ZEGV7Y4Y'YTYXM>7N?M]
M'+UG<,%^L:TEO(XSI8UE2&:&1$J%76I.DL&-$5CU1WU-_.V^<%?TGUODW_E/
M?(CNVLEZUVW53]O;7D[*PN![6J8-OP15?8>W,7M7JNII*.'<!\F0QU+B)I:2
MFAJH_#/+3E'$;6',_N@VV!8MC=H6!I+]3;KVDUJ(]&IAP(IQP1PZS,YG^Z!]
MVG9-VN;$^]ULEZCOH@_JU>LJT8^'%+,=P,<<AHRL),H5I(=1(ZMJ_EG]D?(G
MN3K#LSLOY%]3[^Z%EW[W/NS<74W4?9V<JMQ[RV=UO'M_"T6XJ.;*9VGH<ZV-
MJM\C>&1P='F:&+^'8^IIZ'$JNW(L(ON3^5II[O8TN[Z+PIBQ5HR:E3123J
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M*Y'V]4=XTH)'TUP!0G5\JCA]O3-42DH60V<S%">/4.2!8BP^GM08K:X/A2Y
M%?,4_92O35M-=;MJ6TE^F\(Y.D25XC\5*</GUZ1IVG2.EDT+ KF:+0C?O&%E
M0:Y/]K ^G'^P]M>-:+ T7$XI\7PU%?Y?GTW]6E[<-8+'K=!0W&JGA-0C5X5
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MC<VU]N=6C%9K'P15%=!_$XLGN#<2RXJCD>FCEJI*ZHQVW\Z6S[@]HXD 05+
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MV)M]/\?Z^TS)2!9*\21TL^D:WB#AZH2:+3AY\:DGIP]L=4Z__]+?V;\?Z_\
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M;<&+Q5'F:2.FDM0K49RC^TM409SSR!RIMTS;EO%PT$99M9120&-3VHE10:6
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M6D;A6GSX]8,>[?.$?-W.]UO?MQLPVVW"PN;5;KQE@B$(B"+)/'&674A8$(I
M.D@ *.F/YS_S"_CO_+_Z\Q>].[*W*Y2IW#6U6#V7UWLCQ9+L7?5=1N%W1/B<
M%E),?C/!C8W^XK:W)9&"FC4+&LOW=124U1KF'F[:]C:NZO@FBT!+,:' 4# 4
M DDD#RXT!''LK[!^YGOCS#,_+%M1[2%'D>22)8HE_#JD,B59J@*D:._XB BL
MRB?M+Y0;"S^QOC-V((=U[<ZX^1N VAN#:>\-R8^AH,+@,WV;MZER77&P>UZF
MAJY/X-F-PS9 8[&U%1#)BZC+Q_P9IZ?/9/;]+D'=NOMLWZT%S8<5R<-CCDEM
M(%3]N>)J1U'-_P M;FDNX6VXS"2>SEGC*A57$4OAT32Q#Z!Q&"$&H JK:37T
MTU'6R9!J2JCJM!EI7$,M/+'2O2SM0SP+XFU"TT,L3@CTR1.ALR-[/5_3" <*
MUZ!5Q=+>[9):KQ74#\Z&GR&,C]HKTZTJ%7!_YLA?]M*Q]HS)JE=?G7I19C1M
M\<?H3U.]VZ=Z_]7?X]^Z]U[W[KW3-G8S-CY(%52TQ\:E^54N"OZ0R$LU]" $
M^IAP1Q[M&;D2JUJ^A@>- :#UH?3C_L=;%ZVWL+J)/$D4U1*Z=9_AU$,%QYD?
M+CT'NVMIX#9&"V[M3:N!P6U=L[9QV+P6W-I[?P\>.H,-M;$8J#!XC#XREIP$
MABHZ>GI*151%6.FC5%$8  > W KALU^+MQ^5:&A/Y^6>DALA<;?-<7.V:I92
MS-_C IK<ZB3IH/6B@BI&*BJ=.&V]JX?;M?NG*X#;.$P>4WSN,[LWCD<=1Q4V
M3W'GX=M8W:-#N'<,Y -15IB,3C<7>0LPIZ.G0%41(DH(YUDD>[D$BE0!V@5H
M *=OIPKP/'SZLF[7>]P.+B3Z.6%0@6BR]@)([@%'$L0#5J&A..E?6"=Z"2.)
MI'GF#P+/&JHT32QL%<>E].EB &\;V)!*Z;D)T*A'H*#.*_Y>K6MRULBM7ZE@
MWF/#!IG/R\OSX]:<W\Q'J'^6=O/Y_?(VI^?OS7[BZXW:F+ZGS/5^#Z?IMP;[
MVOM?J?+=9T^+DV#N+';?VCNVHV_G%S='N/=M3CFFI*.7'[BQF4ID-9DLFZPC
MS0^VON<SWVYOMC,!0I#]2I0@]ND(Q1@P9RVH B0=M:GKJW]WK?\ [PH]K[2S
M]CN4[;<DB>?ZV2XN(H)3(&%)=5Q=6B/$(S';KH1WC>W=6DTK&.C!_P FKJ[^
M6OUM\U<BWP7^27=G=^XLI\6^W_[[8WL3K[(X3 4^WCVSUM+CL]'N[+[>VE4/
M6QRB*GI\=_#\B##+-*9<28O#E1-R':V)E,NW;P]XW<65K81 BHII;2M/.M:G
MAP\XW^^1N'WAIN4=FC]W^7+;;(?K6,#V]U;2$L8'\42+%<W-2*+IH5 R"7J"
M-I;(O&89"ZLI53HE4L0CF-E5G5>=/]?<E26\S./IDU,W'(&/3)_P=<ZYMQL]
MOCFGFD[5'>NEN%:4J ?,\1PX]5@?S >L/E=FLCU=W_\ !/'=?9GO;J#!]M[4
MK=J]LUKT6QNR^INSZ"@W9O+9- $B26/.S[HV?L^IQTQRF)C"P5"S9*&!WCF"
M_,\/,5K']59VZLT52$:1*&H&*BK5)TTK0>K  ]3G]WSFCV4EN'VWW*N94V[=
M&$-M/ EQXEA=I)5[EE5/UHO">571UE %?"B=^%>/P[Z3_F^[NP/QM^/'RMV?
MTUT-\2?BU5_'BJ-3M++;3SW<'=L?QSQZY_J?'XK)8C-[WHEI8MU;8VYD=R?<
MTV"J'I';[2;1]S21D6Q7N[70AAW6V6 1L--) SR'20 -.I  0I:H&,+2II,'
MN_=_=-Y7LM\O.3KB;FS==SA<*9(MRV^#;F:X1S,5987N&9#+%"FJ1%S).&.C
M5LAP.%DJ(R(I83$*A:D/5&4)4!6@C8,K1MSY#Z9 53QJ$L;B3)0QA4KP],?X
M>L*9#&FTQW$QUP,S:5X47)&02Q%#2I KGS!Z?H X'K?7]2#I"W!/!L/\/=7*
MD"@ITK8JQ#QX0@4'^6ISU(]M]:Z__];?X]^Z]U$K-'C0.R &:/T/&TQF"W>2
M*.%;EF*!B %-K7MQ<>Z]T2'YG3_,BFZOR^6^(;=+Y?L7$8S*Y!NJ^UMGYS,S
M=BSTN3I:O'[=PO8^$W;@Z;;%?-CER)QSY7%Y"@EK#!#55N/IR]1[(=\/,$:Q
M7'+X5I(V+%6"E2 N :LI%3@$$9XD#/4G>T(Y+//=@/<%IHMG,R"ZF@?3+#"Q
M*M(H,<NO34%E6-WT@E$9A0T9]-]W?\*.L)U!UIM^#X@=/[VH,5UKM/"8[/\
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MSSSM$UZRM&;"2(1$0.2P>6ZN"@>H&D:"U*D$*.MC3+5R8^ 5%26%*CB26:T
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M<;>A@[-09DE4R:O#4%F"';SHIHVEG2FAT:*>(O3>> ,3,HG2.6*7_*(C$C*
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M44"-HFAEED=I!2XG.0K5XZ>DFC22GGCE6HB=WC+P24TB,5EB:-ETL59RKAM
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M3D F@)HM/A ZR:Y]^\?M]_[8R^V'+7*L=EN-Y<F\W&\6^8R7:R+V#PWMU\%
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M0/:O9.:_;S9[JY]SUY/9_J"]N;/QU,2SR@,$-];ZB6UDR!2"H6-@/#8N:O\
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M'96'P&XMDXG<69RFV<Y78G"032SXS)5FVY8\MKS-)!3TSPO4;BVZ$+WF:ZL
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M:"8G"X[-P5F4GHL?C,QEZ&4.5>7]JV26YMMNF:1_#0LA6GAAM+"KUHU=5:!
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M2S QETD59&-(H+/?Y>G\L7XU?!3YB;RRG5O:?<F6WSD?CWN_:XV3W;C=DO\
MZ0NO,[OG9^YI>Q.G]U;0I<66Q^W<E0+@MSXFNI9LA1U.0Q4M7'C:*KPT^>.N
M1>6>4-IF6XV&=Y'S4LDBUH12FH#X36H.HFH.*YQ8]_\ [RGN/]X/DG;]@]S;
M*WCAM;V;PFA>/6!X;(1((:%ED4JT3 H!ID4:S4I>L].8H_M:8M2PNRF-D^WG
M(F,;,7T5ER=! D&GFZBP(N#*4DDC2&5XO'P,5TX!'I3CPK\_6AZPW_=T=C:2
M6-@GTD8J5DKXM2:U[&)(IQR?EU1+_-@[CV'UKV-\<:7.?RU#_,KWGF]I]ZMM
MK;NJLW+_ */]J8#);#IMX;C.QDVQNR"L-975>&@.<.-B:DL*9:A!7O', .8[
MU+:-&AV;ZIB)!I\4D)0K4@%'K4D"OE3CGK-'[NW),G,.P[E#N7/@Y3BC-L?&
M-HK^.SBXTH66YMRNE59_#U$/\6GL!ZK%V3\AL1OGO?XL]>XO^0'AOB1G=\?*
MKX]4N&[ES/7>?VL-J_W-[4QG:V?S6.KML=?[+JY*K$87;^4SZ0'/QTK)CY&R
M5/78U*RAJ0C9<Q.9A$VR?0ZR LI.JC ZL?I*00%/X@".-0"#-7,?ME9\I>V_
M,.^VONX>;5CLI3)M\=K],-#,(@SL;ZZ5D,DL:]T!(8KH9)&1UW#*&19JNIO$
MBAT9HW*RF59%14=5DF5#H*I&MD4K="6;7=$F\(?HT<_PK7\U!_PGY'Y=<SK>
MFY[,UXQRLLGKP!/R7APSGY<>E/&H'-_KR1_K\^TH/:!Z=+@^I0/.@ZR>_=>Z
M_]7?X]^Z]U[W[KW26W>DTF(DB@7R2RB2-(-;I]R3"S&#5$0PU*&NZJVC_.:;
M(2$MW<R6L7BQFE.)]!ZTS_('[.E^TSVUON]M+= T#_&/]#[3W:/Q_P"E/'U'
M$:7'773'R%Z]V70? +8?\GKK;#_*K#QYC8^%_F+XG&[N78FV\JNY)MT4WR0Q
M':E=M]ZJ@RE-C'3-8RKIM\0SX_+"EIZ'$0UM+3;.IX6:^WZ"]-DT C0X672E
M&.HG4K%#)PHQ((*@A: C2O2OFU?;R[Y5BY]N/>&=9+]#79&V.60BD6GZ60PW
M7TRZ@A ,L2POAA+*7DE949O!?(;=7S5_FA=UQ_#KY14.$^3'Q3W+\+>O\+G.
MN6JZO,=T]A8G:'4&UZ#(9C'S';T>U:"7:6X,YN#>D&XQM^AQ8II/OO)D\/%6
MKMK26WYGNKZ[LI+A)$2--1$9U4(J?#+ *:L:EB@%"*5 Z=YUWOD>V]F>1N0>
M7-TLK_<>7[Z7>;FYBDFBC,$Q:58TBNH87:5-2((P&GDE+5BHDCG<-H&ECIH9
M8T!%-2T]/]JCK)4:*0RF">LGDT'R2Q:) IC(0JY2236I>7['<H;N%HD'A$D^
MKE*_:!6F:YHWSQUS W*Z>TGO[][<23#4U%D #+K.FF***5H*5 QU0M\^?CE_
M,GQ79.]-S?"C"=9]Q]2]N=V?&GOS<VT-_9C;>!W3U]WGT%DL'639_;<AKMGI
M+M7(0=;[%I\[3Y+<&8R$\S9)**'%PN]0H:YAV_F^6)VY>W%4\0J)8_ B+ (P
M8D,Y50IHH-"SZCB@U=9B>Q6Z_=<YLV4;3[T;K<<N3W"W%N;J*WOKV.>*2/PT
MB>.V626.:W+3/$84AB(4+,9 JKT8#X+;7^<.ZN_X^\?YC-9TOU;VS4]";KZ]
MZ&^.'3^Y<#4-2;8F[(P=;\@^P=YXF.HSE3D:S[S$]=PTU=BMU5>-QM-61TE1
M34]?6F:IURA:<UPQ^)O5VLBK4^&L4:Z:L:DLM:DA4':Q&*@"I C+WHW#V9Y=
MVZRY&]E]RFO+7ZJ1VNYH)T\8^&/"2**=4:-(C)/J\2-&9V^)D5";A_MQ$\;R
M-H F58H].JSKJ#2ZU-_4/[/X_/%_8QGN;8$K)Q(XY\^ H!Y>OI7J AN-S]*J
MW!\-V=E+8;6HK0:0*#A7U%.JK_Y@NS?YH>^-R=08;^7)VCU[U'BXL3V3D>Y-
MP=FT?7]?@*ZKBDVO3]8X3')N#;.ZLB*F6*;<%0C8S'Q4(6&<5=2DYHXI@?NN
MU7^Y.IV+<%M&[M3-")!Y!11@?GP%,<>LC?9+<_87EN>XW#W@V:7>86:/PHH;
MB\MV_P!$\5M4$L0T_P!F*,VH5!5:%B"-[%^)?\\#?O:?3M/\SOE[\<=U?'?8
MW;_6':>_MJ[2V5M[*YS/GJ??./[,VWAZ:';NPMEU"+-E\10!ZA=P1K$!K>FK
MT#4%24)RCO\ :SQ2<T;U'?0.X"1BV$7>.X=T8!/ ?$0,>9-#*/N=[W_<CEY&
MWBP]J>2[G9=W>U>/ZJ7<=TN442#0:QW$TT>06 HC$E@.T=PV**5C4RRRAPB2
MQ+.:1PJS+!)&?M]*:(W5&9)F#R*69M7JL-*R3(;:XL_ @-:"@-&%#PR&-:TH
M*8 ]/,X01O*9+:6UNJPR&H0Q4J"M1W-W#%#D U/EYOL"*LTA'!902.3R6N3?
MVGB5X[=8G_#PZK&MLMP_AI1SEC4FN?0X'Y=3/>^E/7__UM_CW[KW7O?NO=)K
M=,DD6/UT]FKE%0U# 8#,U1.M(YDCCT^I6\7D_00Q%U%[Z3;ZVUL8WEO#2,BA
M/<:>?!02>'^HTZ=MI-K>[BVS=_[*\;P^+#@"YRO#"^9 ^?6F9\.ODU\+?B7\
MT\Q\A/DA\A.Y)_D=VATCWKU)\T,9W!@7WJFR/D?LSMG8?^_#ZGJ>D]N?:R8&
MN&'W1/A$I<ED8*'%P82FFDQ;3TM%40VG.NU1;^;CQ'-RK,LNO4Y5XVTT4^'0
MK0,$ )4*%"XIUU+]Q/8C[SGN5R9RYL'+VTVW[KM_IIMF2WDVV#Q[*YM7FBEF
M$MTDB3&-XI9A.JS.]P99%9F#-L&_RP=_8CN7IOL?>O76'SF+^+_^GK?>$^(M
M+FEIZ&F@Z5VA@\/L_-C:&%>LJLMC=OGL"AWT=O8?/1T-3C,4*#'TN,H,33XZ
MD@DZRWR#QI?W%$71U0FK:< 4) <'!?705!I3 X#G3[[<AG:?<%-MYD=9KNTA
MB-T!J[+IPS20LZE0\D:-&DLD>J!G4^$\BCQ&&_YN_%/!_-+XX[F^/.:W-DME
M8#>&YNNJ[,[BPV)AS>7IL9L;L[$[^S5%BH*VIIXZ>KK:7$R4%)D)!.E)-/'5
M&DK!":6;>[(=ZMGVS<@8HY@H:A#'2&5L$#!-" <T.:'@3CV/]S+C[O'N-:\_
M[%;)(]FCO$LCN4,CPS1KK 65V53('*C07 TAXR=:ZT?R/_E'?R:OB#F,+AOD
M=\W/D'UGN'.R8O)8_;>,W#L#<N\9HLE%71XS<M-L'8>P,GG*?$U59A\IIR=1
M0/1BIIF@>:(100>X?Y@]KN0.7[7]Y[[N!B2:J*"CN^HU).F,NU *C451!P#:
MB0>B'M5]Z7[[?WB#<O[5;1!?.\LHB4)8V\*LDE"%N+LP0F4AU)BE?7X?=H95
M)0_7\GOX=? OK7MG/?)?X)?+/<GR%VK7=,;MZOWIL_>G]UZ?=6$DW;OC"Y;:
MF>R&%H<3MS.X1;['S%.L6<P2KD//]Q13+%3.L@E]N]BY(LI/&Y6NFE=C5BRN
M*]RJ**ZJ5TFI(;5JK44\X'^^']X?W^]Q-JVCV;^\#LMOMEWM]ZTJO ]NQ.JT
M,1U-::X)@RJNEHIAX9#*X9F!78-RL$60QZ05D;(75S"BU"JYEE#PQPQABL<C
M.2BJLK!;D$FXL90O8+R1BED305J0%-1ISAO3/^'K!NUW:WY>W86\3!48(!4,
M:FI)'!F' 9!K2H''K7>RO_"<3XH9G:&S^L\9W=\B<;UOL/>7<>^(::.JZZGW
M=/NSLS&[*V=3XC%;MGVXF,I\%A<=L84HQ:X6:I>6>&4Y"-(&AJ(UW;VWV/<D
M2WW2X=8U+N %S60(":J>%(QVT/K49!S/Y>^_G[N^V_B[EL$%M->3PVMN2R1J
MH@MFNI$70T;#47NF(<.M "K(U5*)Z'_A,9\,Z<M%4]Z?*^6*JM3.LFX.DZAJ
M?RQN\-1'$VR)$=@R@:7C90"6=2JGV&V]E>5I%\?897DEB-37 X'CXA4?+C7.
M,]#R?^]3^\Q+MS6E[;V-E'<_IEQ#!,6P2!I\-Z'%00!3UZ-+_*$^$_8?PEW'
M\MML9?";TVET_N??^V\9U!A]^=V;;[ESF]*O:55N"EW%W.(]EX#;U!MZ/=&.
MJ-N*<56TLN45\>PK9O$E("-.2^6-UV*66UN21''I:C-&_F1JJE/B'D1JX5X=
M09]Z3WK3W2WC8-UW>_CNK^2(([1V;VP%8E/@M7Q-;(^NLBRF(MK*8<]7@T\R
M2321ISHC34W/ZKV*V(_']?8U-PC3M:_B45/V'\J?SZQ>:WFBN&D9*(PP:@U/
MGBM1U-]WZOU__]??X]^Z]U[W[KW2.WE+44]'1U,#%?!5EI/5 D9C,+*YE,JL
MUE%V C%RP745CUD-ON.T[>5&[&B2D*/CX_[0$_ZO2O1AMFU;/N]T+;=4#G)B
MS(#KX]NAE!) (.LD:=1 +Z0=?KHKY"_ 'Y4=.;7[9_F4]@_RH]Y?(BJ?=.S:
MK!)B^LFAZQV_M?/SXY^L:2O[CS6=J\S]ID(JJMJ,EBJD[>KX9H*G$'(XN2#.
MY4(-S7RN7\*L)\AW$TR<5=:BAX]VDCA@U.0-_P M>Z?+FY#EGDW;]R%G*%:@
M+*)!(BMJ,:@Y9 N"%F1ZJP5T\-+K.@OD1TO\B<5O',]'=A;2[/VULK=AV1N3
M<VQ<S#N+:U+O$;+PN]JK!X[<%*6IZXQ4&;H'FGHF:-)FEII=%5!.@/\ ;-UV
MK<7D7;F#,M"U"Q K\R IK\B<UK3J".8]LW_8]Z.T[Y:O;2A009"H>M6&8^*C
M!IJ.10CM*U&7(U+P44;0+YGEJ'A0F.4QQ 022.9/%'*UR%TQ@1L7D*1BQ?4#
MJ"H4U'^JO1&JB"_A^N/B%FHI^'3@G\)H<8R1]O6I#\F_F1_+4^,'\P/YJ8;Y
M2?"[<OR.[ W;NOHK.0[RKMD=/;UQN&IJ/I#;V+AV1MW ]E;@2GHJ7&ESN$;B
MIUH*ZNJ,C5X^M@^TP.*K\E$7,V[[1LF_7#[VIF,@C _34BH#'%&-!I89 !8_
M%\*D],N0/8K[RONA[0;)N?)W,"6VTVDEU]+;UCA,9U %RZ:9)7>0.K+,"L**
M#"U)7C0#^K/YN/\ + Z3^4%'\BNC_AGVCT'MRE^/.\.E:[;77>RNI-J/O?*;
MHWMAM[Q3';6UMSP8+#M@X,":&++8QZJLKFRS4]=)BZ?%8O\ B:3;N=N09;@
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MF>VZW.YK#X7<<_:NT*S8.%V3G8MV;BIEGW!3+G?XW39O54?[]S'G%QT!7/\
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M0=NH,\<JM*7\( DA>MN6AEADK9XX8!3I!&/2)H3JDE G2.2D<"HA*(RA4D1
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M#E.W,[F:#;M5E*JAQ5+N[.XSM>-H-RPT4-!2;DQ?W%;'A<Q3Y*A;)9,0-5U
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M/&M*@8/GDGG/]\R\]T=P]X8[CWCVR+;=_%A:":"&:&6,H%D\%E:W>2(%DH6
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MH;Z*&>YK+$Y1;=HH D@5TFDE+>.BU11K#8)#/AAVK\U?DUUI\2/A_E?@5O\
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M5V[_ !"DJ4S=%/59"B(I5B>N#VR>T>R[HRW]Q.^F8G2-))< \02P*G*XT9'
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MB5X5-34-5&1&5AT*.55XU!AN\T\]-'%$BTS2O4*QF0Q1U?I>V@O( 5*QAW#
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M+,6N*ZB2Q)-!YFI^9-?/KIDNP_WH$6^VG+VV;>MO';I MC"LO**K#:*H%O$
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MJ(/\!%/Y=-;E;F[@,D=)PHJJ'LJ:4^(^M>J6_P"9+E/Y@^U^]OC%N_\ E_\
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M3Z&4$A3S]#?ZCV97OZ4  ]"?\&/RZ))P(K>VB3@S?ED9_P!7S^73I3/J8_\
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MF16IV]F\+DJRJKZ"NH*FCKZH5<$ZR1>-I]Q#LTLC7,::M>D%83I&K"X5OA!
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MN"*+0Z8ROY_;G^74&W,[W5@UG&O;)596K_9@\32@U9Q12/4'AU2)\J?D!_*
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MJ503:YTD7]CJ.:/QG\%M14 TI3S]3_L]84273[;>VLKGQ_U"*T"4[3FF:_8
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MI[@W5MIL-UCN.O;$9#=\V2BICF8<15QR0SR1XF/'"A-3'NZ6UO+*9(=Y3:4
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MC%;$%2$""C+7!#FH%,T8U '6>&R[Y]S.VWAN8^8^0;C=+(16D<</[VW6W87
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M><DS]79ULBXHLCMXU56<SDT$];3>7*U"L:F>$WY@N19/'#RMJA.HH[7*]PU
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MM12TF[\ T%50XC'TR1H!JRE9/7R4!CM]OS_9SQVF_7<<@<5+I'$*U:I! ID
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MPVXZHY&@R%/4TM5#1O$**FEKEG:(=E+3R[DVXM, "SQ&-@!323WR' [0NHD
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MS1Z8UED.SQ1Q")XT4S%%BG 9I)Y/):<1QM42NO[D@15&N5M8Y%Y#K83!.:P
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MT .*,9'U "B"N1IXTIUSO^\S[@;7[@^YS[GLO**\GV=C900+;+=>.J31F0R
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MMK")M/"T.-& DLU54-B_X/B_-Y3EC1U#97^*5PEY,@NK.R^FO91=3AF#2 :
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MVW<508O(9O(4AEFJ:Z$-&_,6_P#,^T;O+=\N6!W&24+XI66.)DT=H_M%8,
MI[56A<@UZS(Y"]O/8+[P?M[#M?NY[D+R-OFU^)']%)LU_N<,MFQ,D-PL]JUK
M;QRN\LB&/Q)92D:2-I&>A9^"V0^1ORG^3]3\YNX/B57_  SVSB_C7F.CMF;1
MWS2TF2[8[2J=\]KTF[MTYK/Y*M3!9O"XC 56T(_X1A<_M*&>J;.U.5IJE(*A
MDJ#/E3FKF7>XDM=]VY;81 T;Q8W8ZVJ=11%Q&."9%68@G5@+>^NW^VO*?(FT
M>U/M9SC)S2MON-Q=7<_T%S86\2"W2")8K6[\3]68ZC+/'<,[QQ6\<D49B!:X
MG(4QDHX(3% Z35<:5%/4*DJ5$$KNM="JE@Q<P%RHC-[BUF74K"QK"RGN9);C
M)*X^+%!C -#4XSPX]8NV\,^U-']',8_!;Q-04$N23VT-2A&"&!XC\NJ#OD)_
MPGH^'GR$[CB[0P.Y-U] ;=KMN9'$;HV%T/A]BX/!YO=V*J\?BL-NFC7<-%E:
M;%.E+25]/E\=04B0U<[T]6R4M?'D9LM&N_>V_*V^W@E+F-@H!$89:F@S4F@I
MW!@!1C1N();/KVG_ +P[WQ]KN6#RYM4$5XBR$QRW;1RM'&S.7C[84E92?#,6
MJ4^$%=*,AB6"9T'_ ,)Y/A;\=>Z.M>ZX.S_D9O[/]7[QPN]]K;?WGNW8]'MP
M[PVS4_QS:>8JTV+M_$9&9L;D:>FR,=.*_P"VE,'CKH*FA:H@D7\N^W6V\LW'
MU-M(\OB44:J"E*FN*5_V.@![R_?E]SO>?9+G8.;%M8HE4DB*( G40"*E&Q04
M-3BM:XZOAQ+1QB"&!Y:I&C!DR#E)!5U#54XJ97GABCA9FE6233 %"AN8H5,2
ML/+YF2'3_"*_R'^KSZQ'O+KQ%MXQPD;\OA_;_P 5THJ5_)J?_%E_Y)D/N[KI
M10?0'^0Z=GCT79_TB_X3U,]M=>Z__]/?X]^Z]U[W[KW2;W1D!B\8]8RK*L'E
ME:F*RZJE8Z:1FB26*^C_ %3,4>ZAD"%F%D\YUE;8'293I#4KIQ6M//'ETLV_
M:9-YO8[)7T*S ,: T!QP++Q) XCCD@5(UF-G_#?YO_S(-A[#^9)_FR[_ .E,
M#W-B<ANC ],?'*GW!D-D=4[+S&[<CD<;UGDNQNN-P=?)F-Q[3BF;!YS)9#;4
M.1@R5%-15;S_ &@N ;[E;W)NIGE@WHQ0LQ,<0M[?L4FJJ"9!J(!TZF4EJ5^S
M.7:_?_[O_*.R;?RCN/LS'N<]D1!=7+\RW44E_*D?ARW.DV,C6JW!7Q4MXI6C
MA+:%\05+6T?RYNVNU^PNO^XMA=U[[VQW)V7\;/D#V/T/N#NS9O\ =_%8;L]*
M3'X;L[&9:NV7MJCI*+;F6Q=%N:EVIF\#3RUOVF2PU;Y*QY)"/8QVN.X@N9-O
MW"0330A=4BT )85H57"LO!@":,"*XJ<7/>;EVSV7FR/<-BM9(+#<[6&Z@MI*
MJUNLNK](2/)))/$-(,%R^@W$)28QQE] %SYF]'=E_(SH+>G4/6G?^[/C1NG=
M-5M-\;W#L6CKZC=VS8=O;RQ^Z\F^&;"9? U=Z^FH9L94^/*P?Y/4S:A,MZ>5
M9O%G!-8NL2?J-2C!B"*&N!4#(!'$>O11[<<R[9RSS';[CO\ RX-WM(BWB6QO
M3 )0RLH!=8Y"-+,K4"FI%.J#=]_"'N'=?979FW\M_/BW7UQF.D^INJI=W;&V
M]V+OFIW9@=F]9]"[,Q6\^^^XMG8?LO!-M:;*Y:9\_D8ZB?)P309"CR57E9_X
MM+21PAN^U[K'??H7!AU(H*ZU-2L8#.Q\0! Q!D-30%J E10YN<G^\'M38V,%
MA<>R*[Q=;A=3Q6SMOES&6>:YEDAMX8ULB)# C+;!15G:(,14E.G[^3AA^O,S
M\P<_O#97\TG._/V;:GQJ[&VAE=E=H;2[ZZNWWLNGW_VWM#=&+WAL3:G<>3RD
M.7Q,PPC8_<5?CG@.-G&$BD2:/)Q-&(O;B2:XD9VF:3P]0 :O;5^(#$X(&2!3
M -2&4](/OHQ\Q\H<L[#L_,'MG%R&;V[DE6>+=[?=/'"PMI206Z'241U9#))W
M*6,8IKIL\U3K)%'&TH21)P53PF<M+"#-3H(4LTFEE\A"&]E))T@^Y3N+>R:8
MM=KJK0KEAGS/:?3UQ^?7/6[M;^.$R1W%&R:^&IUC-%I7MI6M10GHC_R'[N^2
MW67>73.R.GOBQN;Y#]5[EV?VUF.SJO:.:V=M'/\ 7]?M*JVSC]@5F-W7V-DL
M-M><Y(Y?)I/@*W-4>3J($DR-$\D.-K:6<CO;[>]LE2>*O@'4'H(R5 IIPQ&H
M-Z5!%*_+J7>5>1_:SFSE:^_KKS FSWL(C-K'):WTZ71=B)E+VBNT#1J 0[(Z
M2$^& #619O67S:^.W878M;TG1]@4&Q._\5F9]M9KXW]H2/L3MO';H. _OKGJ
M:FVY6*XSU#3TE0\]/N';LF1P5>@-1CLE64JQ5<BJUYBVK<PT-J0;B$UD5F*M
MD8.E@ 0?5-0J#FA'1+O'M-SK:<JONMAMKG8PC/%N$;++!-^H8W0@MXD!#:25
METS"IU1* 0#GT]1!+&\:S)/35-+]["P0PO'23'RTD2HBBZJE[,2#R!;Z^U]J
M[,5>/ABGKZ<.@"+^!=X3;H4"RHBZNXGA4<"*9IY&G3U2J?6S+8W**VH&\2M:
M,6']!_L?Z^U3B@ K\R/GY],6\UU('2Y'!VH<<*FG#Y=3/;?2CK__U-_CW[KW
M7O?NO=)O=$\5)COOIIHJ=**1IVDEIWJCXO"T53'!3PJTC2/$SK&(^;D$ZEU(
MR2]M7NX#$JZO,CY?R_U>O N16>X[DW[MVTT>?L/PT(.:'456E16I( XDXZ^?
MW\HNU/Y'/>/>G8O8M'@?GYM9\SN[?IW+N#H^IZ-_N'VIN+-;QRVXLUV[2Q=X
M9;-;A*9,5[ST<30T:+#]H/X53UBM&V,VYR>ULNXE[C<IO'8G7IM)RI)<@G42
M0"2<G':-5 -1Z[D<F<K_ -X!M?(^T6FV';UM[2***V\3]U^+!%%;1QI%IB0(
MX10,_JL69AXC=I&U+_)U[Y^//=GQ<S=%\3.E-[="]!=,]N[NZBZ\VEO_ '$V
MZMQ9*FFPF)[8W-F)JBIS&?FH(FSFZ,I24U#-F*H+!30M"T,)6CII]Y0:R^C\
M:R.NU((1B"I[3GM)+<3Y\<>G7)_[R/)/N![>^X;;+[C72P[I<D7,Y5(95D>8
MN1I\ ^&HHI. M#7M4$5M<R\TL&/$J0.TD4P B21_7)(#3B.1HDDM&^LB5_&P
MCCU2'3HUJ(;R6)HV!/EC!S\OE]O4'7!W&"6-K./ZM_(:EBS3&6QQ\OY'K6+_
M )CWQ][3^3/<_P D>D-D_,GX0;;ZHWE!UCVM\J,+V5ELB_R6Z9Z6Z>P6#DK=
MK9/#?Q"14Z]PS30]A11+5;=C;+;@JH9JVBILO49#+ #F)+R2"2T0Q1K*06#,
M"Y514)6I$:UI)J<)D4U4)!SF]F.=-JY V*UW7<^6[]MVOXY[/9I8IG:VFOI2
MPDDT+ 5DF6(M;T9IHZ%1X9E"LAGOY>';?Q*[A^6&2VC\.-W=$TG0'Q=^+>X^
MO.H-E[#S';>W>SFH>V]_[0W;VSO7>75_:6Q<1#E*2HS.WL9$,[AMVU\U-4F2
MMS+Y&KW9 ,*IY!NUN6")I9;<LJH#I8%C4UP*C'Q9SEC5A4$?>+]J??;D3E^P
MW#W1LY=MW#>;N67ZAI;"\CDT1*8E M9Y5B94E8K&ZQJ4(6)0L+!;U9(W:"!U
MJ=>FZZ_MY[2>(22J6BIV4D<:=#$ _FY(4R!?7%A;R#ZX%=1[:%CF@J, X^WC
MPZQ'6SN5M9EW >+=(I/B5"U%3I[%.G'H,GSZH7_G T/=>7[!^-NUMD?-[9GP
M>ZVWGA.TL5VIV#O'N&FZBJ*S$+O[KG*XQMB8*FKZ')9G.XZ"FGEIVAAI$@IC
M586LSM!29ZJ2N F^1\[W\:0;2XM[6KAW+6X+ Z=.G658%:<:'!H3QZS?^Z_O
M_MUM6T;I=\W\B-SM=A(S:1I?7=H;5E\8,S>%#)$PEU?!*'&I Z1:@K=%X^(O
MQ&_D9?'7'X7;N4[T^-_RX[LWQFMJ];X[/]@[IV/W%)FMY=E;HP.P-MX?8/Q_
MQTF2QE+1R[@CI*R#(S8[(5^/2?(??Y\XZ*:523;MFVK9IFN[1D^JD 2;]19.
M!P0I9DI4D_IK49JU!TO]W?=O[T_N)''M?-&WW6V<H[?*]S;V0CMPD2:6#(]Z
MEO#=LWA4!#OWN!2(.5!LU_EV]5?*OJS?ORNQ?=.WL+UM\?'[/K\5\3>KL1O?
M*;TAQG7F$W)G&BW?C,;D\YN9=K8C)86?;./Q6S\5E,;B,0N+EIL9M3;\9EER
MTAVMRMTYEC0* P50"^%4G)#%A5@5% 0%T]J**U@CW<YA]LKJ#:=LY)>67=?I
MHWO99 ]#</#&'C0M;0*PCE65M;>(T@D!>>:@*VHT9E\K"4W<1L3PH^M0Y7]/
M'TM[.9]&BJ<*_P#/H_R]0?8+<KMP^L_M/$DKPX:C3X<=./M+T_U__]7?X]^Z
M]U[W[KW28W6BG&AO'Y9ED5:9=0&JIE(B@BTNK(?(Y5/6MA>_! /NCVD=U3QF
MTJIJ30G'#@.E>W;@;+=+>)VTQSL4<T)H-)(.,X-.!7YDC!U4.A.S_P#A0SUO
MTMUKL/KOX0="XSKG:^S\"FQ<;ON?:V#W3LCKU<?3Y39_7N2P^?[1Q671,!A5
MI=O#^-PG,@4:#-35N7%;531#=<V\UVMT;&WL$:(M3474$9) IJX"@6M:XR2<
MGHHWMI_=U\P7MM;[K[E7D5U)''XB+LN]L%F,8JU1;%3K<.S%9?#$E%CC$)4+
M=%_+5[(^;/8VQ>[,I\]^NZ#K#N+%]\5V!VWM+;5!B8-AXOKB#IS9.3Q2;'SF
M*K\JN:HZG*UF:J*K)?QG*>#)'(XS[NG% N,H9"V*UEMU:YG4(\@%5!J!YX.I
MJY_U>0PY]W=CY&V3F4[/[9[JV[;3&BLMP]O-;N^HOQCG5)%QIIA=0HVGBQL3
MR$02+S12&GE1W]2LQ;4\3PHJ1DE'8EO2KQN+@>FX4J=W=X$@-344^RORX'J'
M;>ULXKU9+6#Q7!J:R,@Q7C4\./ BG&HIUKU?S"/Y=7SO^5>].V-@=;=U=%XG
MXP_(??/3^X.T]Q[LP6ZL=\@MC;8ZZPN*V]_HGV-)21U6.R&W,=GL;6]CX;'I
MD\*:S.YK+4<TU+1U-=5Y8#WZ\S;M'):<K7266HHTM8EE=U1E(C'B%5"EE+54
MJQ+'NIQS ]L_=WVF]MMIFW7F;:;B7=4MY(;1UO)1;"28L1-(B0NXD$#?3&OB
MQ^&$K%X@!0]G2?QY3H7Y8;&VIM/ ]&]<]&=4?%#L3KOXV[/VEV3E4[;RF/W7
MV-L7<7<6:W1T_F-O&*JQU+6XK;E,VXJ7=4U13U<IJ,N,G5[G@7 GVT[=S8D<
M2;S=B>.,O0"*&,@$YKX?'\(!!J<DUKVPES7SYM>^<NP7FY&0W%W=LTCL&*DI
M%I3054%2=4A9"NA1H6,1A#XME]3(NEEF<-$L4;U,15 !"5)G9WD].D_VP?[-
M]/JM[$J*&0^'VFM*\?Y'J*+E&CAFN936T*U"X%<YS\?SR.M>'^==OK^7EU]O
M3XQYC^8)TUW;WM1U>W^\,;UMM7J?-Q[?VY09">LV54[LSV[:FEW%M?--5P"&
MAIL*E/D7HC!/7&IIGF%%)#%'.E]RE;P+_6.U:0 O30\@SC572RG.*<13AUGO
M]T#:/?\ YB@W*+[NVXP[7<A83.T\=M,2-4HB""\AECH#K)HJDFE3IH.JCND.
MT_Y.':'RA^(^W?A7\%?DMM?OZ#Y2]%YC;E5NK=V[<YLB/;F-W[2/V+N#>E.>
MQ<Y6+1[<V\V3W93-0TJC[[%48R+2X4Y2DJ0ERE><@7NX_P#(4L7MKF,JY<R2
M2 BI%")'(% 2:J*^1Q7K)/WFMOOO\G>UN[#WEYDM+G:[BVFB=$M=L65BPH!&
M;6TC*LQ(CJ7':[:1XFFF[E21P>5X98FB@AI**>&D:-XR35^4RY"5UIX6\T\B
M2"5)&U (C-'&SL#D/#(R0!D^(C)Q\O\ /UQSWS]UW,$<FY1>-('?NU.OY=AT
MT%,"GGQ. %?!QZ-6JR*0;6LI/I%O]:WMJ3(U<.E*2Q,PBA%%55H,G_#GJ3[:
MZ>Z__];?X]^Z]U[W[KW3)G6"4GE^T^\,7ED6+[C[>[+$6 N>&O:Q#<6^O]/;
ML7B9,9^T4^(>E?+I7:.WB&".7PI)1I4Z=53D^>!@$UQT0[?/\Q/X2[#Z9R/?
M.6^3G4U;TMAMQ4.S9-];)W%_I!QV7WMD,?%F*+:-/3]:0Y*IJ,H])+!D9Z.F
MI)YHJ+S54T"TD4TJE4_-VPV:.\TBD@@<7[236GP'RJ2H->).%ZD/D/VB]WN:
M^;5Y2L^7Y);R96=)#<6T=8PS!I661XHD04H&,JJSNJJU634-/QG^2'1_RNV!
M0=P]"=@XWL?8-9D<OM^'.P8K,8;*XK/XB58<QM[<&!W%0X[)XVN4>&::AR-#
M3S+%]O-XC#40.7[0B]U7D/=&Z@@\#D^8-&'V$ ^9\N@CSERQS1[><Q3\J<Z2
M-%=.$"VY2,Z"0S5\2%I(W%#3XNTZ@3JJ Q?,?XM;!^:?QWWM\=-_[@W9@MG;
MXJMLMG,ML>KQV)W12KMG>E!O6C&+KLY19"FC8U.-B5M=(Y92R*\+,)HS"YA'
M@O%-&=,@ (# '!!&2&\Z>71A[=<\;K[-;_;<T6<2330,Q3Q*Z*NK*:JA+'M8
M@9&>M?7OG^4%_*[VGV::?Y*?/#-=1[TS'6W5F)V9LK-=I=)];;BQW6G6W3N&
MZ>VI5Y;#=B4-75UM343;7R%2^5HZ*AHFLV/:D4T'DGA;G+EWE7>3$W,US](H
M*B(LQ>NE E"$*-A5K4T'X1D5.=7M]]\+[S.S6%Y?>S^V^&UUXOCM#;07&MY;
MF2Y8)X]M*D?=/0@AF-2S$JY13'?RO/B5_+=^//S K]Q_##YA57R!W?N#XX=J
MT>X=GS;QZ^[7CQNVAV;L&:OW9%O'J_$X^FQ?@K8*.E-%E9)),K]WYZ "'%50
M4[Y8Y;Y/VA$.QWJSLY>H4.:T*T)JS%2?5CD#& >HY^\=[S_>:]Q/;C;(_?RV
MEBM8KUY8GEM+:V+220/K[H((C.0@ [*F($++W%.MAZI<Q^%:6G2I!D>9@S*K
MQZ(W:.2!9U(+EP$ +( "3JXL9-IJB)N!0* !YU_9PQUA#:V,;6DES92%*U*C
M374VKX268:1QS0Y %*&HJ2^?&\OF)!V[TGU!\&]L=*X_O;LWKGY$9!OD#W#3
M15V+Z2ZJV2NS*;?%3!32TK2//F]QYC:,<,2-D8WGHJ=ZS$U5''45>,">YW_,
M%O#X.SV"2N=5)7F"A:4SHIDZJ 5U>A%#49&^UT7M8^UW-_[OQ7$MK#X>FT@9
MP9W9FTJ9(F4K&L0D9T#V[%2"DP<!27[HW<?\W;XI[NVM6_S =Z=*_*'H'M+L
M_J[IRKRG4*;)VQOOIO?G:G9T.P]D[ZCP-%M#:E+E-O39[)8W&;DI34UN2ION
MJ?)4A2*AR4<I?L]SS?=S'^M%FL$:,A219HI*MD4"(J$+PU:]1H5TU[AT)/<2
M'[K/.?)%U8^V.TS<LWEE#/,S23[A?1;@#X0\!DFDD-I)'WR12"1HW*R138:%
M^KVZ:G@29##0RS2>*75)-4 2*/NF1KRR,79'TIXFY!C5;VTJ/<@W,A2U-6TC
MR-*^0QZ_;\^L4+>XO]NVN*TVV(SPAF 8NJ8!-#1ZD\33)I4YSE3TJJ$!3Z :
M3]>#J+%>?Z7M?VD5V=!JZ42"1I_%D%"5&*@_X.I7OW7NO__7W]'_ +/^O_Q'
MNR^?5U\^NBMS_L.?>P<=)635)CI,;LIXZW$U5+(U1&DL%2DLM+3?>RQ0?9N]
M0PHPKO-=%91%%&SN2%47-QXM'$OBRY"D']A&.!X_9T8;?)%:;W87KD%XI"8U
M-0';0PIJ! 2E=6HD 4SZ'6IZ]_E(?)'M'OWX]O\ -_=_Q][.^*'Q&VMO['[)
MZ]VMMS>+;U^26Z]R5SK/VQWY%NAVD&X-[2B@W=OZ5]RY6DKLK3U$,]#*,OEZ
MIX@W/:+>>^AD:59%5F" +(&))J6?5BK8)H2,&HJ6)S*W#[P.U^W_ +;WNU^W
M_CP[IOKTW"Z81&.&$"L=K;Q&.0%+1C+$CHD$A4AE8PI$B7-_#;KKN'9F/[IW
M5WSA^NL)VCW%W=GNQ\[BNI]]9[?^Q*+$P;%VYU5L#&8_-[FVYM:O^ZH=O;5Q
M5-DFJ\=(*JM6IR5*]#2Y"/"XN7K2*!8_%B*U8*25UTI0$?'FNDBOEJ)*@*0J
MXL\^KL&Y\Q6YV5Y%ABL[?Q(Y8]+M*0QFDU*Y70TI?PU7*H KZG#2.<'*J\L"
MNI<2TS^>$I3-4?;2P4TK^9O!^\0XU1%80S-KT%71G1E HJDTKQ/$YSPZ"!K8
M7*7$K%K?AX8 'D<ZJ,W\OLZTY_GOVE_*9ZN^>WR;V[\S_CEW)\G.QL[6=5[L
M&[^LMT[ZVG2=;-4]'8#;E=U!D-OT6]-J4.0$.,PV,WD=Q8^&=:G^\G\+EC@D
MP@67'?GNZY0M-Y>?F^V:\+J@0"22/0U*<8V4$E=!K3-<TT]=;_8#9OOR;G[2
M[??>Q/,<6T[*\]U%#;RV>T34HVN5E>ZAGN3KE:9'BE&/#0AY05TF;_DX=H_R
MU.Q_FM7)\%?C5W=T=NC&_%GN9]\9OL;L.LSVWZW MVQUM'C,-#M#);BW=*E8
M9C%/!7C(X]5BAGB,66:4RXHW]MK[DF>X*\NVC1,>.J25@.X4 U.X-<U)H>'&
MF(N^^MLOWN]HY,V*7[R_,4&\P?62"W2&UVZW*L('+:_HH("M$*A*A]8JS$$+
M79WW%!5-BI!25M/2S+>03U5,D\!,5Y6=HFY!0*74KR"H(^GN9;A&D)#2^$E/
MX _#/J#\^/\ FZYU;=<;%8W27E]&6CJ: ,X(-#6F#7'$$4I7K6'PO\BSYM9J
M+8F;["_G =ZT?8."$&Y8*,4G;G:&'V+OF;9TNU\W7[+SNX>Q\5,PIJ+(9#')
MDQB<>M4M2TXQ^/-0*2*(]VY*O[VZ!',+]IJ!],>PT.03*--!BHI@TX$]= =E
M^^/[&;!L[;8/:ZUNS*K)*_[TFA\9-2D"0#;G+#M5BKN5\3OH2!T/72_\F3O[
MKCN_HGM;L[^8_P!A_)[:?3'8>)WOB^G^_.O-W[^V]F<GAL%7X?';AV]/N'M"
MLAQ6>HZ>OJZS;N;-'/)CJY*>K$,O@\9$NT<F7=F USN37J*!16B*!31@2/U#
MW4/:0,'*TZ!ON#][;VUYFY4N^6>1N0(>4;C=$,,MU#N;7CSH727PV5MNB(1G
MC1I5#@2J-#57'6P13QQF2 ^1Y6$=86>6!XI2\LPMJC8H8P27T@QG4J@ZA;U#
MJUM391>&N:4!/V4X9/H/Y=82RR+9VTMB>,[,P_VY)X@'A7&13..G>FC6*\8_
ML@D_7ZLY/Y]T^J%Q*5]*?YO0=4M+46=J(1ZD_MSZGJ7[MT_U_]#?V;\>]CK8
MZ@Y(*:60/))$&#)Y(G5602J86D(<Z2$5B]F! M>Q('OPH>/3ENFJ0>?5>GRX
M^+7;G?\ VQ\8M][%^3^_^B-M]$[]&^NQ>OMJQ;BK]N=_X>+?.V=PTVQ=TQ8'
M<F$,-+'2X6MQT[U&,KX6BRLK2PRJC12H]TL+N\6(6KE&5M6,AJ4HIR,8SCJ9
MO;WF[EGE?;-XM-UVA=RGW&V%O:S-.T+6,I#:KI5\.2.9M)95CD=!FJD'JG[;
MG\DSY[Y' [>CW-_.5[\H-S5^W\/D-Y0;<?O3<.*I\Y5T41S&$VSN>I[.P\L]
M#22KHHJR;$TCUBAJN6CI9YIUD 4G)_,0(87<@!)&&P"<^4M/,$"F:YX'K(RS
M^]Y[%[==6G+][[9VLMQ;L7N(VOW#SC0%!\;]VGP-1!.A&)0  !A6EL/\M+XE
M=K?#?87=NP^XN]:[Y$;BWOWY7]HXWM3<7\0_OSG,)-T_L[8"4^]XLG4Y&<5=
M+-@9*>D#YG)$8U:#_*801C: :[+M%YMS2/=3&X:0*-3?$<+Q.IOL'R_(#&'W
MTY_Y<]W>=TYEY(V1-AV^"&**."*;QHED3Q/$C4-;VI!U$LSF/2[ZBI-2QL7R
MJPO',K_N//$ZI$-(EJU2&22:G@60$:GC5U( !TZK%3Z@>JS+"<<"<?GPZA44
ML-VCN82'N:BB?#D T.LU4?GCUZUU^Z=V_P YOJ_Y<_*^H^#_ ,3^I-Z]%;SW
MCUWFJ;/]DSX:ACW=OO"=#;3QNX>PJ.JW9V#M>I=98_X;M^2/&WQ+# Z*:F3*
M-GLC5Q!>[KS-9;_=MROMJ7VN--=9UA*TXM^I0&I)':?PU \SGKR/RI]S[>^1
M+&^]XN?9]AW@O,DMO'M.Z7ICB4D1 R6\+6Y!4:@!24,Q$A"Z%0>?A#O;^9_O
MCYFT%1\]/C'U1T]L?$_&GNY-B[OZWP>V]Q2U6[-P]F=;UF2VY7]AX+<&ZWQ(
MJH::JK&Q;U^.7,M3BI^VR3805-$?<H[OSA?N4WK;%LT6IJL\4E26%?A)/;CA
M2M?/CT!_O!\J?=@Y5Y;VE_8?G&7FFYENF\42[;?V'AKX#D%3=QQA@6JIU YR
ME%J6N[G]<42PF-+R+&3(WZ2UPAC#BS-JL0OY_K[&4H99W>.+QVH*KJT4'K7@
M:T/V<>L6XW=5:2<:&(-.!IZ<.J^?G-\Z]O?#?:>V4/5?8O?O9W9^3W+M/J?I
M?I6+'YSM#?.;V[M>NW/N3,_W0EBEF&'QHQZQY;*TE!D'I/N(7-)(LA4DNX7\
MM@AG7;C([5T1K+J+8)R.( IQ[CYT-#U+'M3[6R\^[D!<[U'M=K$5:>ZGAI%"
MI=5&EA(NN0AJJC&)"10RJ2IZ)1\5OYPF\>W.W=B=2_)OX!=]_#K_ $N[M79/
M7/8'8:YS)]59S>#8K-Y>#8VY]X]A[?V8*'(Y-*&6@VU04461?)U$JCQT07QR
MD6U<\W=Y/)!?;?)8Z -+,^M7/<2I)C32>TE::JFH% ,RG[I?=IV;E_87WWE?
MFVUYH&WH9YH(8!;RVZUBB$R)'=7'C*3*!*3IT+I8AB]5O*QDYD$#(B14R4CT
M_P!NJ1Q)15%#(R+#$*>,QFXUI)&)R(2@"AP^H#VUNA=1ZE\Z$YKQQ^WU^8IU
MAM;N-QM9+\G,+.O^\$@^G"E"*&AJ*FG2@IW#L77Z,ES]?U!RI^O^M[I]*('+
M>O\ Q?KT96UP+JT68>I'[,>@ZE^[=.=?_]'?X]^Z]U&JBWC55,2^218]4K!=
M)?A'C4@AG#:2%-K_ -;^_=>Z+?W/\G>B/CX^VU[E[BZIZMDW/+FJ?:G^D+L3
M;6R*W==3@S'2[C.)Q^Y)*6*>:&HFIXR8&D8&0#TJY!9FO[&Q >^=44UH6-!4
M9X\/RKT,.3N2]]YSO'M-BMY;EXM)9(HVD:CD@$JAUA014L 0*4-"14LFP_YH
M'P'WKU]LK?Y^670^RJ3=^S]J;RKMK=E]Q]5[6WGM#^]RI6G;&]</_$IUI,]1
M3))05F/4'[>NIIJ7RJZL0%VY_P!D:2C:"P ()D((_+3QH.'$<.EZ^RG-^U1W
M.VOLEP[":9&90SJ2)"*@JY4*#\+ZM+"A6H!Z'CXP?*'8WRAH^X,GUUF]IYZ@
MZI[AW+U56;AV!NG%;]V1GJBGVM@M_P""R^%W?CXXEJZAL'GL4N:I?!$N-RWW
M^)5\C'01Y6L$>W[M8;HKFVHP4#50DC(P : >8K2M#4>71/SIR;OW*LD<&Z,]
MFTD".JO%WHM64LR,=5-2L$K36E'H RCHRV3GK8J+[BGJE24!D1W@>6))F1HA
M--! R,Z@L+KK4"VLL-/M;!&CJ\8&GYY- ?E_EZ"(W#;K2QUW\]*5'BZ&XU'X
M%!I0<>(I^T:PGS<V/OWL;Y?]X4';'\XK/_R]L9MREZOK>B.HJ_.UFS\-NOI/
M='7M',_:5)58+?6R:#(Y,[[HM^XBNH,E3UV:HHL92RU++BZW QM!.\VTS[]/
M+%OG[EA"J0/"68S49J@EF5E%5)-!4< ::>NA?M!SSR#L?MU9M;^R9YVO9)9H
M9=V&^7=L"1I<)]#]-/'"(XI8@&[1+5W(+"1%$G^6+U'B-@?.B&OQG\UW"?S%
M,G'\5^]<+5;:;<V[-Y;DZ[QU7V_UA7G/C)MN3>.*IJ2H,,4,E)DLG09$R/%]
MDF7I8JV7$BWDBSF27Q;C?ANAHU%\ *11AQ8.P!;[%!I@>0!WWF^=+#?^4=IM
M]E]L#R3$MZS-(;^242DP."H26UMRX2@.H:RM:$@,.MCJNO:$O )$%1" Q>,!
M$8%96(?@W4Z;'ZWL.3[DT6YE+^#)X;%>.G57Y4/#[?2OEUA+<VMO/-']2/&8
M,3&N5TG2:FH.<&E#CJK3YX;$^3DV\NH^W/A#N'JRL^5NP-G]VT*=&=N9W XK
M:W<W0^](-OGLZ@I,96Q-E9<AB]SXKKV6CRM)E,3CZ>618<A7K!6?;S!?>X>?
M(Z-LU\CF($JKPPA&J,*3\8:H6G<!_%BH,Y^UNY^T^\7K<E>^B2VNSWWAJ9X6
MEDEMV#']2ENCZH?#:02J(9I0&K'&S@4(?L'+_P V;MWLKH/!_P Q+9O0WQ>^
M->)^3/3FXLC-L*OV]F=Z=C=C;#W-7]F=0[&QVZMO93L'"XG%5F^L%MG'963<
M$FW*FNJ)J+#8?(OE,DM)5$&U2^XER\C<WM&(:K0*L0JRZM-&C+D+\([RE>U1
MW$@RWSQRO]U[E?8]QVS[N^XW6\3K:N[F2.[B2-9'B24Z;V.UEE8J9&41)+I7
MQII8U2-638UI%"/,KS3R.',<OFG:H!)8B-(V>QTQ*OB#!!K(+.SRF0^Y&E!^
MG&GTK_@ZPGDN"UJL,^/U''^'T'Y<>G:F8M++J32RW75JO=5:RBP_I[M(*1K0
MU'^QT9O:00L)X_B8 'CP'VGJ=[8ZKU__TM_CW[KW7O?NO= ;\C>K^KNZ>H=X
M]6]T;2Q6]^LMYXJHQ6[=NYI<E]C5X\)]Y',M1B'BJ*6IIYHHJBAKX)HIJ.I2
M&JIY8ZF&%PCNVVFJ1;ME)#I .O.,Y08H,@FE#0@U Z&'(.^<R\N\WV&[<IN8
MKR&4,DJF/5&RY0A)599 6HK1D$.A96!4D'21I_D!_P )W]F4LFUH_B!\H>W8
M=KP4.!.]I-W;BVU6]H_PIAMJIW]]C3=B[<CIZG*RP'+5%&<#AE@641QXBB=9
M88\?;W=O:L;OXC!ZZSW!;C.*5(U GR(K@>@8D]=FN6K#^]2W.UT;=SA:VU@]
M#],UART?B%-)E^D,A8$**AF&"PR2QV3_ .3-VW\7>UOC9OM?AOT3D.A.C]H]
MU;LVIA]O;EKH,IOO=V>39VW=S[@WOO?)O7Y2=JN67*QX:C$N8RA&-QM 364P
MTXJ@G/8+[EB\@+<OU"JN:AP:8R0U?,G@3B@] .77WI.6O=C8?=.]B]X66\W6
M6VMW=HS L3DAU"I]/IC3M0$@(@U%B :EFM@SSU4./62-!!.LB)8JE2K1M)H\
M;*>!JU$!KV4V+:E!4B6Q6*0LK-53\CGU'D>L=K2]W>VA_P 1VSZE@&I$+F.(
MB@J")&!'$<.-*@$$AAIG_.3N+^5%L#Y_?+C;_P T_BCW=\AM[9'*].[FQ>^N
MO]R;GV)18;#YGX\;;@JMCKMS [ZP+U]'31X]LJ,W*IEGK<ED*"6AACQE)692
M .:1MS;[=2[AM3[A)I0E%G^GT"A_$K@O@K@^9:H!%6Z_>QJ_>IW#V4VB#VJY
MMM=DMXY;M9=NGL;.Y>-5E-)/K'LI_%621ID\ $")8HV1G$Q6(U_\FKM'^6OV
M3\U<BOP7^-O=G2&XL7\6^W_[[9+L3L'(YO 5&WAVSUM%CL#'M'+[AW;4)6R2
MF*HI\C_$,<!#%-$8LL9?-BA5R'=6(E,6W;.]FW<&9KD2@"HII74U?.M:'AQ\
MH2^^1M_WAH>4=FD]W^8[;<X?K6$"6]K;1D,('\4R-%;6U":KIH&!R2$H =I+
M*Q(U.Z:Z<3/?[8U0<PQ3"%SYFC1T:30FMO&'6]N607=1ONT%G?*L-S)X>@DC
MM+=W#R(_F<#/'KGO;2>!<,;9/U&]#EO.@K4#_4.M>CY$?R5NZ^POD!M[L?X^
M_P POY)= ;"@ZYW#A):7+]J=\]O[^V-FJRMVZD^V=A;DS6]J7(R;?W",2^5W
M&E?G#-'E<?1R*M?3U,$>! >[\B;KN4@DV7<Y(452M"NK).=.N5=(:@JN>X5K
M2@&;/MY][+VZY>Y-;DGW+]OK/F&[EDUK*MW^[R0%(B,JV]C(CR1!I5CEU*?#
MDTD!M;S<NJ/Y,G?^Q^W^J>PNY_YI7R>^0?7W7?9FQ^R,IU;N*DWRN(WAFNM]
MPP[_ -AQY:3?&]]UT8IJ+<&+QE?,%PDTS)"RPS4;D5D&]BY7YJY?N ^][G)=
MQ2$*D>E$ <=P/;))7URM,<034)O<?[U7M9OO(&X<J<G>VMIRO=Q1.SWZ7[7\
MDD4O8T83]WQ/'VZAK6?@QJ#\#[!M)XYWG>,QBGJHZ:HAEC6XFE2$0R3W!8G6
MN@ NP/I_2?UO*TVJ.$'C_F.?]7'K" _3[]M,=W;FE78UXX/"GP_X/,?8'V"Y
M=F#:HPBH#8+ZE)#<?7W5Z! "*'KR03PW1$AJNA:</\F>I?MKI5U__]/?X]^Z
M]U[W[KW2.WQK;!U$2IY1,K1F&Z#SR-84]/>16 \DFF.Y'%[\$ ^]R>$+.=Y6
MTA5J#2M,^GG]E.C#9-P^BW^RB9>V9RIDJ1X0",VO2!5N%*57U)([3JO?'_M7
M_A0OUQT;UUL7KCX*?'^AZ\VWL_ 4O7U+ONKV]@]W;.V$M%3Y;:'75?A\[VMB
M<E%'M_"+2[>5L]3',?Y$@S4U;E_O*N?'W9?<?F6T@DLDLU:-'?.M0%%6I5:5
M( JO$L*Y-:GKH!=>UWW&Y;N3>=P]T)K01QF6:!=BW>4RS::2$3+&40R.7E+*
MK1AB/#B\$C1<[_+6[#^;?9&QNZZGY\;"H^N.X\#WUD,-MW:FW\;A*78^'Z\3
MIS9>3QT6R,WA*W)QYRBGRU;FIJC)_P 9RGAR/\0QIJJ?[%<;13/RN\DVV?7R
MQK$\Q-54DJ *4(+,Q->)]"2. H,4/?7:/;CESGA]J]G[Z3=.79+.W:*\ECFB
MDDN9/$:=6BN(XIDTU4+6*.,H%9=52[6-UFBG%*QYD-0L4%XW93(^M@#* 5CO
MRJF0JK,1&&5G4^SJZD/@/Z'C_+J%XIOH;;Z5?B>H'YFN>(_:1GJA_P"2N?\
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MD=^YUE5QH5O"2Q$O40R.TE5"TPB$THE8NOG^X$8IJ)96C6Q$CH7.CZP<$7C
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MHL:@WL%2Y&DW%M(E>%6^D4A>(%#7@:#RX''6#G[KW".6"3;I?!M@?@\,,.'
M.[:J#\S7S]5/3@!%%[W4,I^GI/Z1[8K50>J!I0[1S-J8'C0#S^74CWKJ_7__
MUM_CW[KW7O?NO=)S<[UPQDJ8Z,R5DR30T^DH&69X3I9?(0+@7-RRCCE@.?;5
MQ)+#:32PQ^(54FFK3C[>E^V&T3<(9[^3PX48%QI+:QG%5!*T.:@'TH>M.2E^
M2GR?^5U3\:OY;_Q/[_[&V)O#,#-;O^3O8,_1D/3N?^%NS^OJ*@I,!\7,)_H3
MVYU^:.'90Q_\ K,K245'2[BW%]AC%R.%PN2;"TT)_OWF23:9;/;;5HY%DE\8
MLZ:D <CPQVQ\"HU. =3KI! +*.DES[,<H>PW*=S[V^X_)D-Q#O,,$6T[<F[2
MF'< \2S?O+QX[F]T?41222012$);PB19$DF591?#_*SS=#N+J[N+ [8^1.[?
ME9U/UO\ (C>NS.I^X>P.RL%VQONOQ6.VE@:W>>%W)OK%Q4M;5PTV[JK<;8'^
M+P^9L,^/J*%I=NU.!J)Y6Y;W3<(]K07"$(^%8RI(3@%E.A1\+:@K4&H"H[2O
M6%'O!8S;7S7;W5LB[:;RU@FGL([=TCA\76\>F2:69V+0^$[@/V.[(Q\19$0W
M'RI^-76/RZZCR'1_;T>8K.M=R[FV/FMU8C"5\N(J<W2=?;]QO98V]69: BHA
MH<I48>+'Y)J(I5?:SS+23TE08ZN YW2W:ZVR:UI4.JU-?P@@C%1Y@<#7H(\E
M<];M[8<Q6^[<M-]/?.9!#+1)-+R(X8Z)8Y8SVLU PTU(]*=4 =3?RJOB1V7\
MX_D!U36?R^MGX/X@='[-38TW;,/R0^060[%SO?V9VSM/L?';:CPL>]J6K7'2
M;5W8%C6/!5]+YZ*:-<RM1++C$A_;^2K>+<KV&6Q6\ C&?&:-N\DFH\330*:#
M%?BS0T.<O,?WQ/>#DKVRV&?E_P!PFGWO<+BX%U8G8MO2."U*D1D32;<\4S/(
MK4*2B14>C1Q@DN=+XB?$'X>_#_\ F([EV7T;LK"=?;^WI\7M^[UVYM_9N_\
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MK=FC?)QFS://;(P'=NTMC[FVW)-N3#8;)XZJQ-3E:@U7\&KJ6"JAFH),9+3
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MZ12F+Q=.K&O10%&!S45P:!?,T'RZU:^O?Y.?S/WYU[LO>U-_.[[]SE-O#8>
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M"%&IHG236"H#&O#3I'Q:BQIIN,W/_$J?%-IC-<Z3Q,L7E-&E9$[DU<3RT_\
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M5U4$-Q3&VOZC\F6X;BVWP/=4_3C%7;%%!-,U!QGTIT"?;OD/G3W/WR/EWE"
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M+:-RD>J.% B+$L:BP>K!2G IDEJ/'&9*6.$HDDLJ,S%PT[QA=-BWJ<?IXO\
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M FDO[/<[>%W:4&*2V0^)6-U=F24Q2*T>N&@DH6!9%5F/97NYIG7]X3,LZQ-
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MKM9CC>&( 2:0J,Z,K1AV17JS@#M>NRG4Q+(@7SBGJ"Z32ZE1QIU,[W\I"'2
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M[5=@. H/3()(%/6G&@Z>H "\C:?4+IJO]5#&W'O3? H_/^73LD$:R_4#XF4
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M623(/XZ%'O6.8J^HC%(RZ*L208UTE<F(NL84M:0HVAB I33WD=F\;F,R.6[
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M&"C&MOA8UKI_!3/Q#@<Q?NX\B7',^T[E#O?/L?+-I#X3+<-:@O-,3((8:)+
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M2Y(R?+1(%IQ!I4&N149ZG[;L']YGNEM)%)S!;1[3/%%%"OTO+U,# U"U:Z^
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M)]L9O#_Q&OJH(,ED\4,!%6O)C*/$14L2JON1<W$G]1K](G!'BTC@-1W>&?\
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MI& P(2/6'D8(&:@7(4YJ<FFZ>[8VUVWM^MR&)ILA@LM@,F^S-\['W/+"F_\
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M!B,.85.F0T--+TTY!%:T7M7JBI ?*MV>6#[DV5X5>*5O/% ;B0QFS,EQZ0S
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MJCO;1KJ(((_%%<@OHQ]M1_A'VCCT;[==;=97T#[F"R%J!1J&HT)I502OK6A
M-#I;X3J1;3_E9_*KO;L/X\="?(?XP==?'+X5=!UFZ^R>^JGHWNC;F-Q'RV[N
MR585W%OS%XCK2+&5>(IMPU<6O#8JFPV+EV[MRLS.*H:_&M)C<91Q-=<H[Q>[
MC%9FR6*)&<DK*OZK$FCD:AY952H*J66HP%Z [S]XWV9]M.2-QW/D?F2;?=\O
MK2WBBGGL+N [! @1C;)'/!-'>-&089I$GDCN94BN&CD9'>2]K^7!U-6=3;-[
MYEJ/CE-\3\1V9\BMR[XVCT2M9T[7X;:NUL-UEM+JG 5^VJKI#,YK$+39BFVV
MN?K*0M3/19*OKJ%$KJ6GI<OD94L;.[M SO;B $+4 I2FD &B$J*T)(%*$D&O
M6&WN]S:>9.;K<7>YOO+M96R?7R"4-,:.YBT2HLOZ&OPQ))36JJ0%RBFG^1?R
M"Z;^-75>XNX>]-T?W.ZOVI)A8MR;A.'W9GUHAN'.4^U<=&V&V;0Y#(5'EK*^
MG@58*5[,X9K*I8-;M)LJ6KR;RU(U&<2<#C\&37_5Z]!KE3V[YO\ <K?[;DCE
M*P^MN;LE43QX(=7:S,-4TL2"B@GND6OV]:J7S?[H_E6_,#LF?MSJ_P#FG]G_
M !2[$W+3=3Q]DY'K[H7Y&#:>_*?J'.9'=>P]W;DVUA-N[<>OW/05-5CQA-RY
M#*ROC(,?C1!2L[1,L1[Q/[+[G#2*0Q2H02P-\%.DDU8 **U(T.S4&  Q('75
M#V<]D/O4<B;9/RU=^V=OO\"1RR0"?>MFB-M]6L<4FB::[G00S0QR)-%31(\P
MR%HLIV_Y..9^'E)WYO#;/7?S![G^?GRUSG0E?'V!WMV_L7=NVO\ 1KU;U5V7
M1IC>O=KKW%#%NG%09FOWC2S56,I:_*4==4X:7(U\F.J5HZ>I%'(B\EK(S[0[
M23#)+-.:#42%5916,58XK2JX X=8Q_>RY,][.6MIV=?<[DVVY7VPW<YAAMKW
M;IOU9(4UM,-OE(D<)"H1V@C8(2A+$5ZV)-Q/7C'2'%H\V6?T4,2%4O5^)XD+
MR2*\:K=@2TD;HOU*\7$D:[MI],&(U^(XX'AQSQ'E7[.L*+1^79]VMH=\D)@\
M0: %EP0"&KX>EF&FN&9145# TZUS*WO+^?P</U=N*D^#'QDRWR(RE?WS1UV6
MK,1M&OP&S>D(\1U9DZ.BQ'95%VK]AC9\_N>JRR289\VTV8I\!25Z4*KBY:J6
M-]YW;G:#2;.!&?4W;6, * N@U9OQ$L./X:GC4YLVW(_W/=QYJ7:=UYTN;#:E
M@MB9_P!W;C,QF;QQ<(8TMQ)6(+ :Z:'Q65?@(65@OD3_ ,*$!V?TABN\/BYT
M=U]T]GN_^@=N]I[VZGHMK[QW[A>N-Q]P83$;YGQF!QF_=[.M*<7-5QY;(?W?
MD&/Q[5=>U3COMOXA2M[-N'.NX,1OUHD<2T(*NC$9H2 C$FM0#4$ $D4(KT8^
MX'MY]S'9N6-XN?:WGVXW_<K2T,D-M)M>YV2&0@T#2W$$:$X)5=:U8 =]=#;%
M>,D-5+,LU["<FE@9)HI*:.GO2,\LDKN9WDD1V\EU C\=D-S++*EQJC@J"> !
MJ/L/\O7K &S#\P;:NX7J:&BEE5,C\)(X*5 ]14&HZ4\*Z2X'Z2S,#_BS7/ME
MC55KQH/\'1Q(02*_%0?LZD>Z=-]?_];?V;\>]CK8Z@Y(*:60/))$&#)Y(G56
M02J86D(<Z2$5B]F! M>Q('OPH>/3ENFJ0>?5=GR_^+G<WR [8^+^].NOD[O_
M *+P'2>^ZK>'8O7FU'SLN![_ ,*VZ=OYV#9.X&P^Y\"M/'3T>&KJ3R56.KZ=
MUR3F>"5%:&4/\T6%M=QV_P!9N1VY5<FHA:;Q!2I2BL"H  )-#^9ZFGVWYXY+
MY,L]UM^9=ICW*7<K?Z>SD>62,V<^ES]5H2*59J5(\-W44X$>>NPOQ+R> GQV
M![8_X4CTFT^T-K5D&"['VD>]MQUDVQNP]MM/C]U[5AERG<F'J0]%DJ6MQ<L=
M3AZ4F&GE\E#25"SH\6MR1&KL8N;]'R^G(\_A*^.. )X@'R/6;7*7OQRI'8SW
M"_=W6:TDB5E4[Q+-^\%/?XB3G:F:U$Y"2 JQTJ50'BPNV_DY;(I-B=5?)?$T
MGR\V]\TZ23Y35]7!WGB*K<V4R693_9<^MXCAMRUV:K,G1-7X]S)#)_!,WE:4
MPO3M/6090Y'&T(WY/V9MKNYD7>/WL[(NMO \.A-"._6P:@HN.!!K3@,2/O6\
MVVG,WN3#N8Y6_J?;Q6=N(=K\=I_ "^("XD\"W8B6NH!H4K76-2NK&QCOCI/J
MWOW8T_5W<&T<'V#USF<[LS+9_9&YHZB3;V;EVANZAWK@8\S!%*@JZ=,ICJ&=
M\=.LE-6:/LZN)Z2><>Q=N,6R?3L=YC#(:5J7(-#4 JM:BM*@BA%00:T, [)O
M7/>P[Q#S%R9N;6$T8?2R0Q.ZJT3QN5=P2C:7)#J Z'N4JP##7"^4WS#_ ),'
MPX[[[#^/N_/Y>.W]V;SZY.WOXI7;/^/70];M[R9?KO'9S&8_!R[NJ\;52K%B
MJ^@@,DE*4IQJAC?[6)3[C/?=S]F]ED*SHHG8::+;S!17N&0-/G@$4JU!4T'7
M0KVW]COOE^\W*%OSY9\S3[G:71*P+-=012*8&$4A4&X5N(TG4PP!J(J:#S_*
M\^77\N/Y%?+S(;>^%GP[F^/N]-L_'#M>NSN\'V;UWU/'7[=/9G7]-7;539_6
M63KJ?+&:NGHZLUF8BCDQ7VO@Q_[&5JBQKR1O').YRB/80 PU5(C= 02"/(:O
MS^&N//J+_O'>ROOQ[=\J;9>>]-PTL$MZR0(UU%<E62!R]1'*YCJI7(H9!W2=
MP7K8>R,=7-%%&BK*+@U%._B"U(LRF!G;](-^2+W%Q8@V]CJ[@NZLUDVFN!@&
MGS[N/I3K"2_N(-,EJ+7ZH$41?$,=&SYTR*<:XIU05_-C^8'7GQ#^0_P4W]VE
MG_DE%L1,AWS)E.J_CSV!/U_A-XUV P6V&VYFNRX*/,8E-PPXG*F@HL?M^L5*
M*>+(5,];DJ>DII\#N$';QS3N_*5O%)NBN%<R#L,1KA:,0 >!( 7 -:DBFALU
M?NV^QG-?O-RWNNR<IVENE_"EJ4-RRN$,DLGZ499PBK(JLQE()4J(_#K()H49
MUI_PHE^,'=/8O5G4G5_3'R%H-^]O=H=3=88:??-#LC'X7&4W9/9&.V)DMPY.
M7:F9SK*<1#75F1%+]A_E?VHIUGHXIQ64Q1M?N-:\WW<6W1ZP\;:EJ@H20%R0
M!0TJ:&M<\"20(>??N%^^O)G).Y\S<Q-;BTVR&6YGT& NL:U _P!$4T-%J=6H
MC4P0D9V(,7]V&GDF*NK2,87@*O3Q4=,[00IYG]3M+_GO[7CN8]1TAI)7N-)M
ME7Y?S('6#-]/'):1"R%%@=E?SJ5J#\7"F%-!DBM3Y*"!=+MZKD*1:UN#(7!O
M_K'WIC5!_J\AU1XRT_U(X%57\Q4_ZL=2O;76^O_7W])"!I!^C&W^\>[*.)'E
MTV\OA,OS-.H56--+(RABT(=T5?HS*ATA_P Z;VO;WMF(!(].MW-K]852N:_Z
MO,=58?S'?YG/0G\O=>L*7N3;_9.YQW/#OV#;5+L+'8;)TU"G7M3AJ/<%5FH\
MY7XV..%9L[0I(ZRR/9FM&5U/&%.:-[V#E_;VEY@1I$FU*JKJ[F7BO81Q_;6@
M%:D')'V&]BN:O=O=9;/E:>&WDL/"DD\;%8Y=0!##45(-"M%H<EB-.=3SJCO_
M /D,;<ZNV7MSMWX&?*'/=C;9Q8P.?WG@-^;GI*/=VX=I3S4]-NI]KXGMC^'X
MJHST=*<A4X7&0ST&,J)ZBEH:FHHZ9*]X*MG]I[G;9KU[9S+W$G7<BJECH8_J
M 589:JU!U DT)ZZAW_*']Y+R[:V5MMO-%L=ID95AA:SV.L3!274EK9I72-@R
M1,6_45?%HA8J-H+^27OSXG[^^.O;%5\,.A=W?'SIK$]_YO&IM3?._<EO[<6X
M-U_Z)=F9#/;NJ*K(9K<8QP_RF+#_ ,,BS=0A_AXR"A!D ON8N1M[Y6W/:GMN
M6(C%'%Q#&4D\*U\2HX\-+'%"0*]<U/OA<F^[O+/O"C^]^YQ[GO4EA:%GBCM4
M14I((EK:!%8A!1BT2G7K6KZ-;7!5Z)#!(L:*U2R3&G5I602SK \BH$*RAB "
MX!C<<:M)T^Y#M)&:,$F@&/Y^O$>F,_MZQ:^K\6^CLY/@8@$U\J'[/\(^WK7S
M^1/>G\X_;WRE^1NW_A+\-/COO+I2'<^SY1V5O6AVYL;>?8>ZI^GMHTN8SM=G
M\MV#M7^.BG*_W6BR\./#T_V,>.$DAQ862/>8Y]WLKZ=MHMEE!  8MI+&@- 6
M8"FHZ2:8-?2G69O(/MI]V_=^4+2?W:YMFV*XG67]&.RO;P'ODT5%JLAB+( X
M+LM5TOI(:K"Y_+^PW\SW?7RSW+W=\Z>F.E.AMD8+HC<'5&W\9U)NC'561[1S
M>;WSM[=&R:O=M!L[=FZZ#)4VTZ/'[F_@M1EOX;-BO[R5T6+IZF/*Y66);RG?
M;M>HWU<4<0C!'8:E@2#DZFKI(P.VFHT!%3T"OO!VWW?-DV+:-E]G>9+G?I$O
M)I'\:TN[:.&D02D:W,,)5YC361XE1"H<KH3Q+K*A8UAA$;)22K.YIP\FHRR6
MD!2/R$ LXUJ%)XOJ_ ]BRYM5EE:5H3<F@) 8I3'J/RZQ9:XW'<+66YBD^FQI
M+:4DJJ,/(TIPX@5^WJI7^8;V-_,'V)VCT2/Y?OQBZB[N["JMI=XIOC?79V(Q
M CZ_VH,UL9Z7:^-WGE-T;5CQ4NY*G[6JFQ!R4AR@PJ5:4K+C&D@!>[WO,VW1
MA]@V=9F.K4#=1B@Q0U<@9SBOY'RR2]CN5/9??=ONE]W^99=GA71X,D=C=3^*
MQ:7Q!HMUD(T K5BO%J5%:-7UEN_?YY61[)^-.TOF-\5_C%UWT7O?Y4_'/%;J
MWMA(.M-RU>V(\+V]B-\0UE+49SL'=>*QE;4-BA0X7)5]!%4IE9Z"#;]0-TU&
M"AG+]HWKG?=)&@W_ &M+*W!7]0312FM3BB.=.!0$BA)"CN*]3ES9[9?=+V_D
M;<+WV9YSN=^WF."5I+5[#<+-0F$!#7$$?BT9]3)$Y98U>61? CD(V;H"D51)
M(6T3F""$0  &.$1K4&%YC<S&)I++)P 'M;46)DF12UN 1P_R4'6 E]+]':)"
MIJ/$>G'S^VM*_MQG@.GZ+ZM_P9A_L-5_^)]U/PC[!_@Z==>[7Z@=9O=>M=?_
MT-_20 Z2?HIO_O'NRGB!Y]-O%XK+\C7INKQ'+2F*6!*B"H,D<\;AV#0^!G=-
M"QR:@]A&P('#'2=6E3ME)! ].MW-T;,J_P#J_P !Z(1\U?D%@OB3M"'Y";AZ
M"[/[>PVU=M;SQFZ-Z]78'JS<^YNO-@Y#*X1\]]]B]XY_#Y-L1F)8*&LR4N$6
M>FIHL:M?FE@@H8W4IW:]@M=HN;J[MS<QQ(2P#$$+49H"*CU(K09(I7J9/:OD
MV?W2YAM>6MH:,7TDB"T5W\ /.X=559R516-!H60_J-^G&4<J>J5=@_\ "F_X
MT)U[M:#MWH[OZL[3.Q\-3]G'KW:NP<EU[_?ML:HWU-M.+.;LFKI=N&MCK#BF
MK89*LT"H95DGE5'BVU]V^78]G^A6V>@+ H7HO=Y!S6@J0#J-0!DC/63F\?W<
M_N/M^X_ON 6K*TK@CQG\1(@31I$\01EB*G3"SC7VI1"";:/Y6_R8_P!F\ZR[
MI[[H]E[IVSL[=7R(W3%UWN7?.P-I[)WGV+M6BZ[VJ*G.YZMV-/48O.KB<N^3
MV3BLM!*T\.+V_08K)//E<;7551*7+V[V.\[.+K:X&BA8L1K)+$FE3G\(8%5
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M"H^W/V4_P=8-NL%[8I/MI_&YKGB2:_%3_BSTYT@C\DC1#TE5U-=N9+^OAO\
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M[GR\;>X3ZM0\BM%7PO$HQ&G6*:?(Z@>I<YDAC<K'J:*G58VUJ/6C%+6-_P#
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MOA*]J[>6&U.E2E5++(RU$TJ^;R"<TI(AA:94)6Q*,8B/48RI?]PR>YWNPR1
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MHO&M)?J?%M26E#.TLK2M-KTH5TRL=+*,%&5;&JDP_90)%3C1]YYHHS%45WJ
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M7VGO>>^1-WDM;:XWV:*D@@MD\$PI)-IU2.M6D"L53P4/BNI>?0L4;N@H4/\
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MX ]K +^X/Z<DCL!C )-.%3^T UJ2!4#I_IU*WN;\&W%K@N6!_P!L?=7-0/\
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6[KW7O?NO=>]^Z]U[W[KW7O?NO=?_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>f424b5030718_424b52.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 f424b5030718_424b52.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !0 &4# 2(  A$! Q$!_\0
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CA/O12^"='OM'@U1;Z(1FXU"26/# [D.,'BBKA?EU%+<__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>f424b5030718_424b53.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 f424b5030718_424b53.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" &4 90# 2(  A$! Q$!_\0
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MN9R:<D_M)))7\MMS]6/ ?_!9#X4^+_C5_P (=J$FH>%UNHVFT[5-95;6SU%
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MH **** "BBB@ HHHH *#THHH K7]E'J-E-;SHLD,ZF.1&&5=3P0:^#/VM?\
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M:R'/ 9>IP0#D5F_MOS^'_ W[0GB/X9Z/IMUHLNG:PSV-S DTAOE8!H%!)*[
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M9JUL;<@+N)/RM@MQZ8KA[7PIKC7'BZ'09+#4M/-FEYJLR11/##E@2T6>A4G
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M (Y>*+^WTC4O[0N;?1=0O3%]LLD>)K"5V'[M7!R^U>,=,'UK[.^%NM:+X/\
M EYI^I>)+9+@6,4UM$MZTD\JRCYXQC^+/+ U\/C'B<KRUX*AO-OF:6KCT7R/
MB,\X7^H>SKXN:<Y7]U7LK>?=G&>$=-TWQAXMUNQU&QAU2XMY(!+=ON,D8"G$
M2*IQY?N?3ZTSXZ:7'HEE:0:/I4,EU-* L,< C)7O\HZUYS\/_B=/X"\?>)+^
MV^S:E8R:B5<QEE9$4?*C?3]<FM/Q5^T2OB7XBZ*T*S9L6#3/&I<(&QQGIGZU
M_<G@K1H95P7%X-\U>JG*V]Y=%;HNY_/GB+1G+/\ V<XVIP44WZJ[U."U?Q%G
M5[F+^RV2ZWQP06'E%))WR S8Z]QCZ5^O?P._;=T#PS_P3!L?^%>ZEJ-K=^%;
MJ#1]<DN8<7.DNX+.V.>,C /OZU^<7CG3M'_:0TRZU:VT^XTWQ;H8:X6YMW$<
M]U%&O0^I& W_  $XZUH_L/?MOW7[*WA#XE>'X=#7Q5X)\96T:W>K7D"QM9W,
MA$0E?=]Y1D\>HS7XCQSQ?GN,QL\+F]-X>7)\"=[7O:2MW=T?L^!\/<GS'P\Q
M-;(:CEBH\S<EI+;6/R6JV;9]2:A\6O$7QHT:SU:YU:ZUBX*F&%KV5I B[L_*
M6_#FOTP_8N^&VI?##X"Z39:K-'->S*;E]AW*F_D 5^1^CZJOCC0H;OP[+)IV
MFY \QL&-3@9VCH3WXK[5_P"")W[0_P 5/C3IGCBP\;37FJ^'=!ND@T/5;F!8
MWF7D%,KPP4 ?3-?EGAW4B\SJ5*]Y3:LF^G>_W'\L>"_"U7&_VCGE:HN?#\L7
M&4GSVD[;==5W[GWN%P].IG:DSQ]*_;D?L@]C\M<M\9-%T?Q%\+->L?$$\=MH
MMW9217DLC;5CC*G+$^U</\5?VUO _P (/&']BZQ?R1W4>T3,B%D@W=-QKYK_
M ."BG[3FI?&+PI<>#/ >I6D5JX$E[<2+O%[C#K$A[*>Y[_3KX]3B++*53V=2
MO%.Z3UU3?<^?K\79-AIM5\1%.,N5ZWL^Q^?_ (]30M)^*UNTVLWGBOPOH^J2
M0'RYV$US$O\ JGY&%4=._3-??W_!([7O%C>*M:T^2.^7PS';AV25V:&&8X*[
M.VXJ><>G->7_ /!-?]C!OCWXYN?&?BK3K630;5FBN+1X@D=W<J1A=@X**1G/
M<U^G&A^'['PY:BWL+.VM(5_@AB"+^0K[_-LU@Z;PE.TUI[SWT['M8;"4Z=L1
M)<DFI>Y%KD2EK=VWEUOYEV+I3Z:O6G5\R;!1110 4444 %%%% !1110 4444
M %-;@TZFOR* (IB%C8MPH'-?SK?\%)QX;;]LCQ]/_;5R=.GU"XEM-8EM3+$9
MMN'M@/XL-D;NU?T53P^?$R'[K@@_2OP7_P""JO[ GBKX(_'W6&M/#FN>)/#6
MN:@=5T:^D<_V78M(Q::WF/126/#,0 ._>OD.,,/.KAX.,;I.[/W;P%S7#8+-
MJ_MJG)*<+1OUUU^:Z(^+O"WAS7-/N;3^U+B\TO39'*P7VWSX[3:P$DH(Y&#W
M[>M3VR6OB[QD]IK>NV<+6"R7MKK,D322:D028PW?YL=ZJS^+-3^&>AS6?_"1
M62SS3SZ;J>E,_GBWC1SO9)5!1T)&,HQ)QGI5>+QW:?"Z2'QCX=\/-;V5XO\
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M9MT217N;G<N>5/#H".C X->,ZW\4-'U7X;F)81'X@):5[D9Q)(3NR1]T<]@
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MK#RY#.C$@J^>X'7'K7Q=X3_:-\2>'/&6EZMXDUC5);.^O&%Y!]E93& ,,X.
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M^%:=66KU5M?LV3['AJK1QGM:-79:7MVZW/U8^&WQ<T#XKV<EQH5_'>1PMM<
M%60^X/-=17D?[+O[.,WP'LKQ[S5'U;4-0*F67&%..^/>O7*_HS(:V-JX*$\P
M@HU'>Z6WD?#8N-&-5J@VX]+A1117L',%%%% !1110 4444 %%%% !36;;3J;
M(<&@ WTR1N:^</\ @HI^WU'^P[X:\/R0Z7;ZIJGB2XEBMDNKD6UNBQ)O<LY[
MG( '<FODWQ__ ,'+7@O0O!5G+I_A34+S6)K-C=Q+.NRSN.1MS_$N><UY>*SK
M!X>3IUIVDC[/)_#_ #[-,/#%X&@YTY-I.ZZ;WN]#ZS_X*(_MT?#O]DWX6WEA
MXNNKZXU+7=/N#::?IUHUU<%57'FL!PD:L1\S$#/3.*_+#_@G-^W'XLUCX>^+
MH_$C!M#=5$6J7*&%75@=R$X()]2,5\I_%K]JW4OVE/%>I>*M>C\5:WJ.L6,\
M%TRW[XL3YF[<B+]V!5(^7H3R:^G_ /@G?=ZUXK_9CU[P?:K'K'AU9V$E_:P>
M9(\17<RA2 <KW-?B/B1C:>88;VLH*R:BGU2O_6A^W5N!:'#7#]2%3WZT^5R;
MV6_P_P!:GLG_  L6Z^%_B/3?%V@:!<:EI=W)]BL;FSF0QQF4[LJ"<OUZFO;_
M !?X;M?BG\&(M%\0SW"Z]<2!H%>98XK=FP23SP1GJ*^ U^/.N?#FPCL+7_3]
M)TN_9-+GFPK0Q*<$.G)P!W[5]':CXJUKPUX/\(ZYJB6JV&O7\4LMZDQ>>VB/
MWOD[+CO7XOC<LJTW"<';>S[VV_0_-Y03C=HZ#0?@1X1^$5AK&@^,'M=0U9HU
M_LZ^:<&-'.2WS$?,03]:WI]>L?V4OAU+9I+9^(=-URU2*XN(K?<MB9'PH)/J
M2!FO)?\ @H/XAL#I>FZSX3OIM0M]/G6Y^PBYW)/\AW2,P'W0/6OB5?VW/'7[
M1%C#X)T&[3_A+M2UB&TLHH )+26%6R Q/^UCGTKV,LX=Q>84?;\_NW]Z[M:Q
MZ^6Y'5QL)3I6]W65^A]Q?MI^#_ _Q!^%+-X8T6S@OK"W5'V_,+N0L,KN P,\
MYYK@O"NB^&_'G@KP?IOB+QE'H>L$II.HV=K"Q2&.!2%<\G>>@R,]*]K^#&FQ
M_L]?"J;P_P#$C3[2Y\17%L!+!OW16[L.'45Y3\1/ %MX#^(FF^)((]/O9K$Q
MSZ2\97R5')VRCID\C)J<'BJL*,L%%MKFW[M:*QXM:@K\JL_/N?%W[?/@S3_A
MS\0)H;2]DO+6:7:DD%MM$B XW$<$,>O-=?\ #CQ!Y?P7\/PWESK%KJ#(SH9Q
MB)H5&$"@XYSU.37OVM?&OX7_ +4[:E=>*-.A&N7A"6A 5+9')P2/7\*\KU'P
M)<_%CPEJEA>:]'Y?@N=K#0=.*%6N8=Q.Y2,?+]:^UP^93]C3P]>#C*&[?7IH
M?F.=< QQCKM25ZOPZ7Y6MV?-?[1?C.]86S3V\<323!//,G[QP#G*^BGIGI5[
MX6B[^+?Q._LOPYJ(L[^"Q*23*_[EUX!&Y?O _2NQU#Q,WQ:\6:1H/B>UA&E^
M'(##!+&JJ-H/.3CDC)ZUPWCY;'X _$.WU?PWJ$<<FYO+VMGY?[K#T-?T7P3X
M?_7<)#'YI'EI)_#LVNY]EP)P3_8%?#YM2J.,J3U:>_>ZZI]CK[KPMXF^$?CF
MPO+6UM-/U32\+;.H+PE2"DDC;O7=DG&>.E;OC/\ 9S\/Z?H-IJ5YXET>#7;Q
M'O;A7GS%=,/F\M,8QNZ9XZUYW=?MGW7Q$\1Z4=3M?L<,;$.\9WO+_LX_NG&<
M5T!\.:3IVIZ9XTEA37+)79Y=.E?RTD4YQT[@\D5]=F?!>4X7+J^,R&+G-1?+
M=MM7W=N]C^ELEXZAG-7V,YJ<)27,]%MLG\S#USXY6_PJ^(</C#PWIUOHEQJ!
M6 :)&'6,PA>9-QX(W XQGG-:7Q"_;=U;XD>#9%T_1;'^TI%?[:Z.9)((UR#E
M64+R.<@M7B_QNUBUUWQ9;-;W,DBM&9/)*G%ERQ6$$]@.?3FN3T[5%$\D#;88
MY'S(ZC#-GL?45\WD,LUIY,L$JLH1G?F4M[/>W8_&^.O%+$93Q1BZ3I1G1@DJ
M2C:UTE[S?77<Z#5_[-BU9FT_[1'9MY<D?E2!B6*C>22!SUZ#CWZU]O?\$S?^
M"G?Q9_95^'OBSP_X9N%UR;6I89-+&M7'FPZ6L0D,S ,0-S#RU"YYYP,XKX1A
MN)A>1VUK&J[92V\?\M<XP,>W]:]^^$O@/4/ VI0W^N-)';JF\0(=C2!U/.1Z
M<?G7)GF(PN6X%TJ;:J6]WKM;?Y'\IYWG]2=:OF.(G:M4NU;9R?EZ;'J'[?\
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M^QMXFUQO@A:RZMJ$=EHLB&*.7S%61,YX(!SM'8].<4_PS\3/A7H7CC4-,O\
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MOL[B)Y+I0X6%0Q&T_*3CI7BOB+5?%GP<'DW*WUHUY$Q$OF,K8.1]X=^^*?\
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MP3-?VRO<-=2#@;CC"CWR17QK\5_B!HNKZK:ZLMG'IMFL)@>QBOV7S-JKOW$
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M]>)OBK^TIJ?Q+N-/U#0?#6JW=O'#8W,(GCN%B7"%F'W6)Z8XR:W_ -H+_@H
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M+#Q=U%M76VFASX/$?6*$*]K<R3L]U?4****YSH"BBB@ HHHH **** "BBB@
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M#"\%2]M[2M/W;[+_ (.Q_3V<?2'@\%&AE^';J<MN:=KIZ:Z?%\['XS_L]?\
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M=K/)YQOIMGR(O'5F].E?G3^W;^WAXL_;1^).G^(/$5YH,VDKIXM5L=/TMLB
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "FL,L*** %ZFD*XS114@)U!I4ZT45H4&WYJ<.**
:*SB2%%%%4 4444 %%%% !1110 4444 ?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>f424b5030718_424b54.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 f424b5030718_424b54.jpg
M_]C_X  02D9)1@ ! 0$ W #<  #_VP!#  (! 0(! 0(" @(" @(" P4# P,#
M P8$! ,%!P8'!P<&!P<("0L)" @*" <'"@T*"@L,# P,!PD.#PT,#@L,# S_
MVP!# 0(" @,# P8# P8," <(# P,# P,# P,# P,# P,# P,# P,# P,# P,
M# P,# P,# P,# P,# P,# P,# P,# S_P  1" (6 M@# 2(  A$! Q$!_\0
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M-:5G&SLK?W>M9JM@YJU#J6Q?2OTRHXO1GQL;[HOFT5W+<]:E3CBJ$&K>:_\
MGFK*7G'W3FB4HQ7NFL8SGN6#2,N121^]22."1]*XZE25]#IC241UHBL_S=NE
M6I(E<Y(JG;\S#'6KH/%<DFV[LT]!0,"F"%4?=TIXA9OX6Q39H6\H@@K67-%Z
M&O(X+F";6?*7^\%ZUBZCXED5\X.!6HND,XS\W3\ZI:CX=+1_RK;DIKH9^V\Q
M?#VO)=3A2?FS@9KI# KPEF9<>E<);:'+:WJLA;AJZJ-IGMMN<MWKEJT;OW=#
M6GB(I:L2YNH;67K^&:;=W0NH/W?I]363JNFW$I8_-P:DT3S(7VR ]*J>'48W
MOJ$,0I2\C)UV"2.0M\W)/:J>E:XR2E6R%Z<UU&KV:SQ#Y1S7)ZW8?98F95QZ
MD"L_:)JS1HJ=GS)ES5HH[R#<N.F.M-\.6J#<I^4>]>=W/CR;3-1\IVRN<<&O
M2O"2C5M)25>X[5$H-*[-(RN9OB;2E^9EZ?SKR[Q3#(;G:%;.:]6\1^9'\OH>
M>*XV32/MUSG;GG(JJ<FG9DSIJ12T))8=, 9>,>G2N6\3Z:TL[.N>3FO0-1C6
MRME7;MQQQ7':S-MQCZ'VKMC:^IRR36C*?A/16>0,_P W?@<UT-WI=O.C;E5=
MWK6=X4U!6N]I_"M37U-JI8?A6WMK.Q)GVNDPV4S-&,<U#JL_EM\O)-0_VYM?
M;GZ"I;:W74B*JI%OWD!6ANF9^F[Z5N6EROV=@>-W-1V^@1Q)R:+ZR\J/Y>@'
M:J<GRW0$5TYBPRGVQ5S3'D,BE0=O?VK&AO/W^UL\&NAT:9?E/R[<]Z4:JV Z
M?21]I@"N/I[5K:3:-I]VLD?S8.36/ITV2OHU=+IY#0]OK6NZ-O;2V/<?@UXP
M^TVZPL_S=.37J$$HDC!KYC\#:ZVCZDK;OEW#H>E?07A'6EU'3XVW?-TZU\CF
MF'Y9\ZZGJT97CJ;U% Z45Y)J%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]>M1KKDNSY_%X6\['T5:>+K?Q!;)$V,GU-.GMH[>#<@KQW2/%$NG:DJ[L!6
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M+2C'S?-6I;Z+)!W[YK.-5O4#J+*56=6X]S78>&M3:+'S?7GI7G]B?)VYKH]
MU'9*H.WY3Z]:4ZBDK,J+LSVOPKJOVB%?F[<YKH <BO/?!NKXD7GY6]:[VTD\
MR*OG<33Y9'=T):***Y@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@#Y-T9!;2*W\/:K'B[7TMM(95ZX(J
M.+:5^7[M<UX\D9(F'J/RK[>A%.IS,^=Q$K4[1.*U1UO;MF(!YSTK(OH8UD^;
MH*MO=[2PS\PK'U&ZVEF.:C%5E>QU8.C=*QD^*+AHHCM^[UKF5O'8?>K8U6X\
M]&)^E8*2>9<-&H[]:^;Q%1RT1]O@*2C"[1.-0:.,[NO:LC6=68CK].*W+CPW
M)-:AJYO6],>(MG\ZQQ$9*.IZ>!E3<S#U"]8JVYJKZ;;?:$_O8JMK]T8E;^ZM
M,T/5U%NR[ORKR956V?6>Q2H\R1F^/M+^V1PK#(4DA;(^;&3TKVK]FKX]1O;2
M6=Y*L<EK#L6#&T[5!(8;LEC[9SS7@/C35Y [<G;7*V/CV^TS4(&C:0- X:*1
M.)(L'^$U^6\9<%SQ4WC<$O?>Z[^:\S[;)\TIO#+"8KX>C['UU^UE\++3XW>%
MXUT^9%UW2T6=,-A&! RI^N>O.#7R6OAG6/ 7B2&/4+6:WD6412AX\JP)P?8^
MOX5[)X"_:-DT".)9KB&ZQ"(P94#3X[D-U^7DX.<]*T+K]I#2;V%HI[53-C(E
ME7='(F?F)ZD$KT(YS7Q.5YSF&7TI9?B*+E3=U9W35^M[/3J>Q'+8.2J49K2V
MM]SUKX5S70_9:OEN;AC):Q2@[N2HP0J_J, 5\*^&?%TT8VLS=.,]37N?[-7@
MWXA0W/B#Q)-J$NKZ(#(QM8;^0GRP581F)N.%Y..H.*[.Z^*?P]\4R+:ZMH*_
M9TD6)9)+=!]G/ )W=1S].E>YA<UPW#5=TL/)8B-2,92E'3E>MUUO;Y$YQD,:
ME5NE44NNBV;MHSP?1+R:^4%LC/KWJUJ$IM8^WX5Z?XW_ &=HYY6O/!%]#J5C
M(0! 7_>*?8_XUX7XMU*]T+5IK&^AEM;J%RLD4@PRGZ5^H91Q!@<QAS8:>O5=
M5ZH_/\;@\10F^:.A/?:V5/WFS]:AT^_:2<,K'@U@76I_:NGRGIUJ[X?O-K%=
MWY&OJ*,N5:'S.,BI'91^)F$(6J<VL22.<;NM0(%E9=ORY_6KOV",VY;Y=V.*
M]"-5M6N?/^QM+G2(3<M)(N#][DUV7@/6#8+AF^7^=<#+N2;"C(SS71>'#(P4
M$G\:ZO9M0/-JRC*IJ>@)=_;+Y&7(&>?>O6/AUKOE6B1R-QC&*\AT15@C5CSG
M]*ZOP]JS(Z[6/M71@\1?W6>+F6#LKGKMY8_;$\U/N^U8.KZV/#<$MQ(K,MNA
M<A1\W'I4GAWX@6MC'#:W+,TUQD1Q@9+&K=U8VVO27$)"K@889!!S_G]*\W'\
M08*EB7ET*T5B))\L7WMI\_(ZLKR;&3PZQM6E+V*:O+ROK;\KC_"GQGM?$$%O
M \<@\Y Q)89!)(%=38^%EO)//7YE[5\O>)M?O/@MXU%M)!MM1(2EWY97S%)S
MUP1GC'T%?1/P0^+FE^(M/2..Z:1WC5V4C++N[].G(Y]Z_*>$^/<;''U,#GLE
M%]&THV:Z?/H?J/%W N$6!IYAD<7*+W2N[IK?Y%+XV1V]MX(OFN&\M8<%#G&U
MNG!KR^7Q;=:=XMT72[5;TZ3#IYNI9BC*))'<A%]S@$Y^GO7H'[17B*UU9(-'
ML;Q?M%S,&<JNY2H(R#V/7FOG/QQK>K:%XTMM#CU2UMU>78MT[)$(%+X_=@#
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M\+W?F1<C& *W@:Y7PE>;EP%[5T371V\?SKCJ_$=!8J-Y=A^]5&ZU3RB?F_\
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M **** "BBB@ HILK[!UQ3@V1^M !149?,JX-24 %%%% !1110 4444 %%%%
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M35DE9>B/PG'5I59>TJ/5ZMFEI4+,XX[8K<MK8G:H7@53T*S;?_.MQ5\MU7W
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M;4;;4+6;1[I5M[2,,&1F');/8 D#'>OC#X\:^+_5ELX9@\\@99%B.[S&WDX
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M4LGB1O [6=G:K#;W=]=-=W%Y'C[^0<HPX&!R<&OB+XI_L^>!WGNFM;@>>TS
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MF'+2J8&'/K[UM[/]#]7\+^),'E5:K];EI)+1WMIKTZ_(_)?P7KFG:_J.C_\
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M\L=M<ZA]FV74.\M&DT@_B'W V><<U]3^)/V>9_#E[!:V<-QY<('WVW=@!^
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M6D$EJT>)(\$$=_\ ]==4:W-LSGE&+5XJZ?4N>-?)U^R9%9EFAX50>& Z#_\
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M3]5MX88]\TES#BWF?MT'RGGI[5SG[2_@G3?C5X36]U"SM]>M]-O)=/DEL)I
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MQOEN(M:M_.D-]H^GM+;1N5_O%G(S_$%Y'8U\V_$'4;KPYK<T=PVV\B7R;C<
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M]@>N*I^-]#UK6?@+>>#4FTFW:;3-:6;;)BWTW[7*\J0+Z1H7V<#^$<#I6?\
M&#XB:7:27M[>#2=#@U+3=/TNWM["3S8)FM]0@NG=BJ@JJI$R1AOF^<YQ4U*T
M8V3_ *["A1YM8ZGT$GBS3K_X/WGA.ZUBWN/$%K>>5%;QSH]TB#^(1YW\8SCT
MYKR'XB^%(=54PVNHV>J:A !YUO;WJR2VYS@L44[EP< YZ$BL4?%+2]0U6UNH
M7MDTU?&/_"71ZI&1]M\G[0\WDA H;S&#>2<G;Y>?I7/VOB+2V\+^%-#NM5L]
M-7P[:ZE VJVTH>ZOC<VDUNN5"AE#&422[B<M$NWUKSZF'I55RM^?]?Y&L7*F
M^9&5XF^%FF>(C;^3=17OB :==:ILL=162!(;>2&-C(P;Y6S,I!/& U<!;_";
M6GB;4K[5+."QN+F/2K.XGNHYEN+F4\1*5; (!!)[!@:]EM_&?AV/Q#:_VM:^
M&VM;7P-=^&)+)-093>2RO:E</"BM'%B%R#DLK,<U++\;=+?2)]+FU/[9:6?B
M#2M8TQ-2N+>>\MX[? G26ZC@C$K$8\LNI8!<%CD8\^65T'JW^*/6P^>5Z2M&
MQ\]G]G3Q98:M<"Z6VMX['+W.S4(S]GP^S]X-_P GS_+SSFG:7\)_$VF0W$KR
M"SCNGW1W$E\B0W"@?\LW+8?WP3CO7LTGQ7\/V6O0V=GJ1CCC\9S^+I;BSDCM
MI-05FG41-,\;@.%E1AN4KF/'O6G>_'_PO8^&FTK3]66STN\BUJ2Y4ZE U^MY
M?2*4/VMK8G[/M!+Q0+'\['DBN=9/0=ES'=+/J[=N5/[SR31/A%XPL=76.[>U
MTG[5(A"W6HQ1.X8?(VPL,JV.#T-2_$Z>^\!6J:=87PNK&.7;/=PRB2/S H9P
M"A.WE@,,<X />N]UGXJ>&=<\*SZ8U_H37FI>$_#NC3R2_O/)DTU=LOSE>CE=
MPP.=W/2L/XF?'KPSJ/BG5-2MWT[4EUZ[MI50Q<YAM%@(=0,?,5 SZ &NO#X?
M#T7[KNSQ\96JU=9H^>=?\97#7<K+<3Q7$W">6^%SZ'U[UV'PRL+[[ MK)<2J
MVH%_,0,=N!]X8_.O-?%5];7WQ/N;BU@2UMYIF<0)RL:@G@=>@_E7NWAZWL+'
MPU;ZQ(ZQQVD<ADYX4A<G\ZZZS7L]19=1<ZJ78X/]H'7O[?\ $2V_GW'V738T
M@B"RMM5MHS\N>W]*XF/59M#TJ032&-EQRK'KG@Y]ZZ[P)X@CU74;J.Y_L]EO
MBX(E#,VY@2N#]3C/;-<7\5?!VJ:7,TDUK,(820$5MP7CY>@Y&<<UX>*P\E&\
M#VJ.9PE7M4;WZ[6,^+XB7^G7\D-K/>>8\;85)3@-UR>W;-4]6\=W.KQ.M^TT
MDP 56*_O,]3EL]^#STQ7+QWDUG</.WFM)L)<[,8/IGW./RID5U++<JH#[I,G
M .YB2!^5>/&-2&G3L>_+%4:L5)6374]A^!%]?ZS\0- TNQ+K)-?I]X] 2I+-
M[#!/TK](O&GQ@;3M#\/W4UXTUY A90B")8)%.R)=WNHW$^YKYU_8:_9:C^$/
MP1NOB5XJM)&OM:0QZ/ Q&%B!7>Y[Y(R!CL/>F?$OXDS>*7;S&^6$ B/&%']W
M '<?,?ICTKUJ7PKFZ'QU9\]5J*ZGD'[5NAV^M>+'UC3>$F(:]4G(:7DM(OHI
MR!CKQGFM[X+V4GASP;;G:R?:22WJP/ _E6AX3\ 7GQ2\3V]BUO-]ENI5CFF\
MHLL2$_,QQ_+VKZ"US]EK3_#6K&UTO6VBT2S"B&]NHQ%(X'\6TG@CIZ'^?FXK
MB+!X>;]O46G1:L^QRO@C-<PH<N&H/WGN]%IYL^5_CS^S;;>/M,74M*D%OJF\
MFX1I!Y=T#RKCCY3Q@CG->2>%_P!AKQEXQU#R[>S62+/^L7.":^X]4UCX<_"F
M:2:>\F\37D)Z9#(&' ]%X]JX'XB?MO:C+:R6NAQV>B6Q'#0H#)C_ 'CP/P%?
M)X[CYR?+@J?S?^1^DY#X*1II5,VKZ?RP_*[7Y+YG!^%?^">OAGP'I2W7C37;
M>UDA7)BW;"Y[C&<G\,5%'\>O#_P+U3[/X)L85,8VBXFCVJ??'4_B:\H^)7QO
M>YO)+BXOI;NZD)+22.6/ZUY%K7Q%%]>%@VYLY"+R6KY'$UL;CY<^+FWY;+[C
M]=RVGE.0TW1RRE&%UJ[)R_\  G=GNOQE_:"UKXC3FZUC5)IESO5,[8Q_NJ.
M*\CN-;U7XG:\NGZ/"]U)Z X51ZL<UYOX[^(EPT,C32;1C"HI^9J]J_9UUBQT
M+PQ8+(JQ->HLDSJ,N[-@]>O']*<L*J%'VLE<\/&<03Q%=83#OWI=>R_KH1WG
M[#_Q UG26NHY-%FX^2V%WM;/OD8S[5YQ8?LA>--:\07EOK5JVCQVAVM)(/,4
MMD +E<CGD@GCBONOPW"(5MUA6:Z7:I3<W(R.#BJOB[Q+J?AOQ'?7\.K:5X7F
M@*O=IYQQ?I@$,$.4SD8*D'GZT\/FU.&E1=/2S_%GEX?*7BI-XB;:3V[_ .2/
ME?2OV5T^"E_/J/VR.^AOHPD5P65VC(Y9-JG@_7K5>[ATN[F\S[5';.I_Y;_+
MD\]*]8^('Q,TZRU::UT6&^>^OI3+=I>[&A#-@YC"J 0<]Q7G?Q,^"%UXHU^W
MNK-OFOX]S01)O6)QP<#L#U]LUU1Q'M(WJ/7[CP\3E]"G5FL*FXW^:?7?<M>#
MM*T69GFN;ZUNY%/RQID _4?UKT;7KR&^TS2KS2;JWL=/LXO(EA68Q[2 #+(>
M<G)8\#MVKR[1OV6-<\/B.;[1<'SN62 *TBC'/&>OX5/>G1O"L:V.J1W^Z/.8
M95,<GN3D=Z5*NJ,_:Q:;UTWT>CT-,/6J4I.C1I-M]7I]S-+X-Q07/Q.OM6OY
M9&9M^QL%MP)(!/X5Z\_CY=1TJXTN25I?*7? 7Y(3^[GVKP^#6_[=F6VT33YK
M2!N&;<?F_K7HGP\\,S/KMC:7$N][IO)+MV)4\"O"S*I2J3]HS]0X HYK3A*A
M-+D=V[=&^E^IQ?BG4<FXA[R@]1WK[@_95^']_P#$V+P?X5T^"2XO+Q8+.)%_
MAW ;B?15Y)/8"OC_ %KP']O^(VGZ3&_F-/>) 2.P+X;\AG\J_3+]FW0I/A(+
M;7-)BBTN^1,0R1IMDB0C'7W%?IOAW@Y2C6KQ\DOS/QGQXS&$9X;"5'K[TG^2
M/I_QW^W#XE_8^^-6E?#.V\*^'M.\!Z'+INDKK.IRW,:7S3[59EFC1H865F "
M2D%R>"*EB_X*M^+-<>XT71/ &GZGXT\,:=K=_P"*-+%^T:Z=]BD$-LJ,5Y-Q
M(PV[L?*#UKQ/Q+I.C?$CQVOB3Q!H]KJ^L&>"YEGFGG\NZD@(,3RPAQ%*R$#:
M9$8C QT%/\*V<OAOQ3\4O$.K0Z+KVJ?%J9(]:1=.\NWDLHE*16Y5F9B<%F9P
M02QR, #'Z3'*Z32<DF[+OJS^<7BENGH='XY_X*3_ !>^*7PETQ]%3PGX;\4:
M7X^\.:;JEK$]Y;SK:WTV%BEAFC#HKE70L,AE!*G(Q7;67_!7'Q=>?$V\C@\!
M6]YX5L==N/#DKPI=?:HIH58&X,A3R?*\Q<;-V\*<^U5?V5/ ?P/\;^&?$'@K
MQ!X/M+&'4YK;4;J\N=3NFDN'LB6@9KB24R)Y.24PX5<G &:^E=-_8&^$/_";
M_P#"5V_A:&2_N2;@-]ON'M))'CV&<0>9Y1E9"?WFW<<DYK@Q3PM&;ISI[;:=
M_G_PQM3E*:YHL^8M#_X*?_&WQ-:>'9K;P'\.X5\8^"K[QKIOF:I='[-!9,HF
MBEPGS,X==NW 7OFO>/B-^W-?>&_V,_ OQ(TGP_:W&M_$(Z7;:?I]U<F.UM[F
M^V!?-D SY:%CD@9.*]$TO]D'X<Z/;Z/#;^&;../0-#N/#E@!))_HUA<;?.@'
MS?=;8N2>>.M7O$/[,W@?Q5\%+7X=WWA^UN/!]C;16EO8%W"VZ18\O8X.]63
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MT>L1JK2+N_E2:3J6P#:W KR./6IE<?-CW!K>TSQ1/%WSCO4>Q:7D,];MM58
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MMWE)_P!4OR@G.<E=WR]>:]!\(>+KOXP_"F34O%%CI[7-O=2:;##;6_EM+("
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M?;9'PI@L/@O[4S?WG:]GLC[2T[]OJS32VA;3=%D@DX-LUE$\)^J%=N*=%/\
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MK_%'5;[39K."98BQLW(D=%.>23R?:O5-&_;"TC^S9OL.GK%#IY*R[G4, ,]
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M[SPKKENMO)9@RPRP.2K #E6K(^'/A[^V=5\2>*?%##6O#_V;[59WTZX*D_\
M+(X."U>377[2NB_"R[AN/"NDZ78ZA>2.'FY#R1[NASR"14XR2G446[=-M!X>
MFY*]C]"O'T>/"\\T6I+I.W!-U@,$ //!X_G7F-U^W'\/;?Q8VCPW37VL0XB2
M01[4D/?#9]1S7D=_\7)/CE\*M)T*PF>W\0:ENCBLT9G$I09)+<[5/8FN>\*_
ML,>)/"/CK3O$6O/Y,,DPDGMX?GFE=@02&P< 9!(XR#VQS\OCJE6,DJ;[WLKV
M::LGVNKZGW'#^6Y74H5:F8SLUK%7M??[]>A]'Z9K/B3QAXFNM0FU*SM] FA
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MEH6I:39K)J'D0Z>3G9*3YH]UQT_&H]9N[>]1A;3[MO0L-N/KZUS2P\H:H?\
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MW5M?C]Y=H#(Q &5?;M(7'/.[ XXX-+<ZA8>+]#6X;4='AO(Y/LZWL60QMRP
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MU2)V51DYP,5[&$S%6Y9[CE)/5GQ!\4_'T/PH\+SZM?174UO;L RP0F23D@<
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M0[0652<X&.:_+?0?^"G/Q"E^/4.J7GB"\NI+:;?#\YVJ>#C;[X_&OT!^&_\
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M+*X&Y)H'#JP^HK6KQ6FG9GR\DT[,****!!1110 4444 %%%% !1110 4444
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M,\MG)EN0X8DJ0,X([]?6OTS_ &@?VD_"_P $/V3;7X9^';K^S]-TM(K">>%
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MXBT&7^R+'4;*XL(?L:&W@\G:J!V$>%<LP#[CSQWVC'K/_!7/_@H/J/A+7?\
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MW;BN&_:%\2?!GQGX=M9-8^(EA#=6LS6\2Q'[0UW&<Y.!T!/<^M=9_P %@_\
M@FO:_LA^$=9UOP?H=WJKZD^^QOHHC++F1P'M@J@_*J&1L]L 5^0GBZ_U9)O]
M.ADM9E8HT+IL9/;;7/6S"%&<:OO2<ENW=*_==RZ-%U:;B]+.^FY^B_P$\7?"
M']B;QYKEUC4O$&I1VDEXC+"(X+""2/8)<DYD8^8H4#@%LYXKT6'XM_#G]LCP
M'_:2W5SX:D8SK92R*")YHDWF-AUR5Z'UP*_-#X<Z[XXU*T%I;MJ%]9O$+=+>
M16D5T)XC /5<X.T<<5]L?L"_LN?$B7Q%IMYJVAZA8:>L4AL;+[(RQW.<%@NT
M<9[D^U;5L9A<U7L,73NK?=Z'5AE7PC^L0FXOO^ECS'POI/AO]HI]<L]+FU2'
M7M%S.J7J_)=0APF5(Z$9!P>U>_?LY_L^ZXG[.GQ&LM,TN\D74+ 6BZFL;>7Y
MHD1VB5O4J,8'//O7MG[.?[)]O_PD6M>)?$.@VGAEKG4YBEN/W<K6XP C9Y"[
M@3FO2?C3^V1I^@Z9;^$=!C6RTW2AB.*./RPYR?F.!W-?C?%F887(\^HU<#2M
M"*3=MF_GY?B?N/">7XGB#(*U"M+GJR;LW]E+\[O\#\E/VG_V9;SPK:M;0Z;>
M-?1[/,D((53T8<\GGCI7,_LQ?LP^(/%'Q$M8EMVC:&5&;=T7)&,_6OTR^(_Q
M&\,_M+ZE8:KXI\.V]QJNDKY!N8R8I)U]6(^\<8&3SQ6Q\/O[+\!BXL_"N@6V
MCV*D33SR)YGDNW()F885NX&<U]I_K?D"HK%5*S3WY;:W[7V/C,OX#S[$8B>'
MA13<=Y7T_KR'?'NSUCP3^R=9^$5BN&U:XNA=:A%; M';!$"H#C^(\FOFKX61
M>--%UB);"&Z6XGDV*"I4MWQGZ9/X5[C\9/$>B_#'Q"^I:SK.Z:ZM_-2"WEW2
MS]02#G'7U-?/?C#XE>(/B]XVNH_"[>(KZW9=L=I:PR32A>@RJ G))'/O7Y_C
M,#B>)\QGF%2/LZ3V;V26Q^WY#P[_ &'EL<"JB<GJ].KW\CWZRUB\U2"ZDUO5
M+5)K&%9;B6=R\,>[E58KGGOCTKH_AQ:R_%;PNT::I->QS/\ /,IVQQ,#D!3T
M_ 5\Z? 7XP+\(?&%Q=:DLUWJBR1X#Q,TUM(AQD%NC#Z=J^G?AM\=M1^-]SY<
M3Q+8V$7GPR2SC&Y<C8!],''3CBOSW.L'5P6+=*#3I+3FVCMJ?0XC)[8&=:$+
MR5M6TW]QH:O\-?\ A$-,CNI(Y+R95+E,X+[>WXUX;\:+27QQHRZ3IL%K91V=
MDVIZE9J%#QR+RYD/]X!E'XXKU#X[?'M;B[MVM;I"T*A=H[GUQ[UQ'PNUBX^(
M/CKQ7J%B]@;Z?1)897GC+0EI&56#*I'WU#?BGM7)E.9588F.*H1YG3=U?9D8
M'+_JD;8E\KJ+1>?H<'^SQ\6ICXANK&^^VW26L"0VI56<H%."&/4#D<D]L5]2
M:[J=K\)/@K)J<K 7VMQ%Y"/O1(>0O/YUXGX3T>;PPNB:>L1_MJWF8FXARFV%
M@0T1_O+T//3.*P?VC/B%.^FW.F75WF0/Q"7^X/3%>CQ#FCQ*?LZ:IJ3V6O\
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MV1L!B6W<8'Z9K\I?^"F/_!12XOOC))HNB7IOO#^AWCB&V=WDAFZ!F);D@G)
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MSCA\J2,2+(BK$2&5YMD>[# 'D*#@$FN%^*OA#Q3\#K/1Y?%FA2:/X@#JIMQ
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M"T-L^+A3$0Y?##D''W>]=%\+_%7@G]G;P%HNBZ]H$WB+5VA$%O9Z5$UQ)<2
M\.S,H6'/0_,1WKK]9^)D>G>(=4U6XNH?!%W D?V/33<E([:)QDL4QB3."">"
M<=JX:TH9=&6(E+E2ZMZ6Z_?8ZZ-.OF#6$PL')O6R6M^A8^#G['^E_P#!.O\
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MN,57!TWHK;:M]SAX-R_^PLN=+,ZT>:]]]$NVI[[K?QSUC6-PGU*9%.1M5MH
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M!&7@#L<]ZJW6O:M>S,RM,-P"-MX8XZ#\?2HYO#.J>()?)"M)N^13G.,=<_\
MUJ,/3]E)>S08B53$+FJLS]*MWOF;[N<DDD[JUK6 ^&;@-_%&N2#U/J:ZZW\
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M1^/[#Q3=WD=PFF^5>,?]/0_O..VW'7WQ7>?!C7(_#_A74M-FM8KC2[C]Y(C
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MAN^\<>)X66&::^FD#11H"^ .0J@>@_.O29?ACJ7B/19M2BC\I6Q+=;QM"%0
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M/EJAZ/CUXY[UTG[5/A6'PE]A\"^&-3;0-+M7%U#J:,[2W$VS;F1DY5E^Z%.
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MOL>-5H/XFKI'HO["5QK,VEZI-JEQ'J%O;AGBAV\84$A&9N"1TR22*\9_:?\
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M110 4444 %%%% !1110 4444 %%%% !BFM&LGWES]:=10 T1@+BG8HHH :X
M6J9U(1W$R>5*QCVG*KG<"<<5>HH ;'R*=BBB@ Q1110 4444 %%%% !1110
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M:Z*R_P"SSW[UN>'%^Q7*LR]#U%6[JS60Y5?EQP:EM; JN#_^NJ3L!V>EWO\
M:4*LGL.M: LFP/FK \,O]E4#WX%=.C[U!'>NR$U) 0K8\_,U%6**L#O****#
MT HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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$2!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>f424b5030718_424b55.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 f424b5030718_424b55.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X@OX24-#7U!23T9)3$4  0$   OH
M  (   !M;G1R4D="(%A96B 'V0 # !L %0 D !]A8W-P
M          $             ]M8  0    #3+0     I^#W>K_)5KGA"^N3*
M@SD-                                         !!D97-C   !1
M 'EB6%E:   !P    !1B5%)#   !U   " QD;61D   )X    (AG6%E:   *
M:    !1G5%)#   !U   " QL=6UI   *?    !1M96%S   *D    "1B:W!T
M   *M    !1R6%E:   *R    !1R5%)#   !U   " QT96-H   *W     QV
M=65D   *Z    (=W='!T   +<    !1C<')T   +A    #=C:&%D   +O
M "QD97-C         !]S4D="($E%0S8Q.38V+3(M,2!B;&%C:R!S8V%L960
M
M                                                6%E:(
M "2@   /A   ML]C=7)V        !      %  H #P 4 !D '@ C "@ +0 R
M #< .P!  $4 2@!/ %0 60!> &, : !M '( =P!\ ($ A@"+ )  E0": )\
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M>!%X;GC,>2IYB7GG>D9ZI7L$>V-[PGPA?(%\X7U!?:%^ 7YB?L)_(W^$?^6
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M(%-P86-E("T@<U)'0@
M
M  !865H@        8ID  +>%   8VEA96B            !0        ;65A
M<P         !                               "6%E:(         ,6
M   #,P   J1865H@        ;Z(  #CU   #D'-I9R      0U)4(&1E<V,
M        +5)E9F5R96YC92!6:65W:6YG($-O;F1I=&EO;B!I;B!)14,@-C$Y
M-C8M,BTQ
M                                                      !865H@
M        ]M8  0    #3+71E>'0     0V]P>7)I9VAT($EN=&5R;F%T:6]N
M86P@0V]L;W(@0V]N<V]R=&EU;2P@,C P.0  <V8S,@       0Q$   %W___
M\R8   >4  #]C___^Z'___VB   #VP  P'7_VP!#  4#! 0$ P4$! 0%!04&
M!PP(!P<'!P\+"PD,$0\2$A$/$1$3%AP7$Q0:%1$1&"$8&AT='Q\?$Q<B)"(>
M)!P>'Q[_VP!# 04%!0<&!PX(" X>%!$4'AX>'AX>'AX>'AX>'AX>'AX>'AX>
M'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'AX>'A[_P  1" !P +0# 2(  A$!
M Q$!_\0 '0   00# 0$               4&!P@#! D" ?_$ $80  $"!0$$
M!@0+! H#      $" P $!081!Q(A,5$($R)!87$4,H&1%18C0E)B<J&BL=%#
M@H/!,S1$4U1CDI.CX66RPO_$ !L!  (# 0$!               $ 0,%!@('
M_\0 ,1$  0," P0)! ,!         0 " P01!2$Q!A)!41,B87&!D:'1X10R
M0[$S0L%2_]H # ,!  (1 Q$ /P"Y<$$$"$0000(1!F/+BTH25*(  R28KWK#
MTA)>F.O4:Q@S.S:"4.U)8VF6SWAM/[0_6/9^U'A\C6"[DW1T4]9)T<(N?0=Y
M4W73<U!MF0,]7JM*4YCN4\Y@J\$IXJ/@ 8A:[.DU;\HI;%MT2<JJAD!Z85Z.
MUGF!@K(]@BL=<K%4KE2<J59J$S/SCGK//K*E>0Y#P&!&C"+ZQQR;DNSH]EJ>
M,7G)<?(>Y]%,E8Z1^H4XL^A(I%-1W!N5+BA[5D_E"&YKGJDM>U\:"GP3)L@?
M^D1O!%!FD/%;+,*HF"PB;Y7_ '=2E):_:GRZ@5UJ4FDCYK\BV?O2 8=-&Z45
MPR:@:[;$A4&1ZRY)Y3#@'/"MI)]XB!(!QB6U$C3JJ:C!**9I;T8!YC+]*[.G
MVN^GEX.MRK54-*J"]PE*D RI1Y)7DH5Y Y\(E$$<XY>5!@,OE('85O B3-)-
M<KPL-QF3=?76J(D@*D9IPE3:?\IPY*/(Y3X"-!DX(S7"U6%.B>6M.8X%7X@A
MJ::7_;>H%#^%+?G0YLD)F)9SLO2ZC\U:>[P(R#W&'7%X-UDN:6FQU1!!! H1
M!!! A$$$$"$0000(1!! 3@0(1'Q9 &\XB.M4M:M/-.@IFOUQ#E1 R*=)CKID
M^:1N1YJ($56U=Z6EQW32YRB6M16J#3YE!;<FGG2[-*0>(&,(1D;CZQQWQ!*D
M6)S3]Z1FL;]=F9FT[7FBBD-*+<Y-M*P9M0XH21^S'XO+C7V9J,A+;GYQALCN
M*QGW0PMNMU8X!FY@<DY"1[L"-N6M2J.#+G4,#ZRLGW"$9(PXWD<NSHL1DBB$
M5!3$CF>)YFWNG$]<]';SA];GV&S_ #C5<O"0!^3E9E?GLC^<:[%G)_;3ZCS"
M&_U,;;=I4Q([;DRO]\#\A%=J<<24WOX[+HUK?+Y6JJ\FL]FGK]KH_2//QR_\
M=_S?]0IIMBC#BPXKS=,>OBW1O\(?]Q7ZP;T'(J?I\=/Y6CR]DEIO)&>U3S['
M?^HS-WC*$]N2?3Y*28W3;-&/]F6/)U487+4I2O5])1Y.9_,0;U.>!1T..M_(
MT^7LM><N2ES320.O;6D[MIO=CS$8VI^2=]29;SR)Q^<>WK.ER"69UY)QN"T
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M&-VR#N.6F-WBN:J)Q"V_'@IYTSM&1L>RJ;;<AVD2C7RCN,%YT[UN'Q*B3X#
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
end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>f424b5030718_424b56.jpg
<DESCRIPTION>IMAGE
<TEXT>
begin 644 f424b5030718_424b56.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  H'!P@'!@H(" @+"@H+#A@0#@T-
M#AT5%A$8(Q\E)"(?(B$F*S<O)BDT*2$B,$$Q-#D[/CX^)2Y$24,\2#<]/CO_
MVP!# 0H+"PX-#AP0$!P[*"(H.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SL[
M.SL[.SL[.SL[.SL[.SL[.SL[.SL[.SO_P  1" !0 &4# 2(  A$! Q$!_\0
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CA/O12^"='OM'@U1;Z(1FXU"26/# [D.,'BBKA?EU%+<__]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
